BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, Camporez JP, Shulman GI, Gordon JI, Hoffman HM, Flavell RA. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012;482:179-185. [PMID: 22297845 DOI: 10.1038/nature10809] [Cited by in Crossref: 1446] [Cited by in F6Publishing: 1384] [Article Influence: 144.6] [Reference Citation Analysis]
Number Citing Articles
1 Neuschwander-Tetri BA. Therapeutic Landscape for NAFLD in 2020. Gastroenterology 2020;158:1984-1998.e3. [PMID: 32061596 DOI: 10.1053/j.gastro.2020.01.051] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
2 Yan T, Yan N, Wang P, Xia Y, Hao H, Wang G, Gonzalez FJ. Herbal drug discovery for the treatment of nonalcoholic fatty liver disease. Acta Pharm Sin B 2020;10:3-18. [PMID: 31993304 DOI: 10.1016/j.apsb.2019.11.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
3 Deshmukh HS, Liu Y, Menkiti OR, Mei J, Dai N, O'Leary CE, Oliver PM, Kolls JK, Weiser JN, Worthen GS. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat Med 2014;20:524-30. [PMID: 24747744 DOI: 10.1038/nm.3542] [Cited by in Crossref: 290] [Cited by in F6Publishing: 267] [Article Influence: 36.3] [Reference Citation Analysis]
4 Mei W, Hao Y, Xie H, Ni Y, Zhao R. Hepatic Inflammatory Response to Exogenous LPS Challenge is Exacerbated in Broilers with Fatty Liver Disease. Animals (Basel) 2020;10:E514. [PMID: 32204385 DOI: 10.3390/ani10030514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hwangbo H, Kim MY, Ji SY, Kim SY, Lee H, Kim GY, Park C, Keum YS, Hong SH, Cheong J, Choi YH. Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro. Antioxidants (Basel) 2020;9:E1040. [PMID: 33114221 DOI: 10.3390/antiox9111040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Ratsimandresy RA, Dorfleutner A, Stehlik C. An Update on PYRIN Domain-Containing Pattern Recognition Receptors: From Immunity to Pathology. Front Immunol 2013;4:440. [PMID: 24367371 DOI: 10.3389/fimmu.2013.00440] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 7.3] [Reference Citation Analysis]
7 Ohtani N. Microbiome and cancer. Semin Immunopathol. 2015;37:65-72. [PMID: 25404117 DOI: 10.1007/s00281-014-0457-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
8 Allin KH, Nielsen T, Pedersen O. Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus. Eur J Endocrinol. 2015;172:R167-R177. [PMID: 25416725 DOI: 10.1530/eje-14-0874] [Cited by in Crossref: 98] [Cited by in F6Publishing: 42] [Article Influence: 12.3] [Reference Citation Analysis]
9 Zhong CY, Sun WW, Ma Y, Zhu H, Yang P, Wei H, Zeng BH, Zhang Q, Liu Y, Li WX, Chen Y, Yu L, Song ZY. Microbiota prevents cholesterol loss from the body by regulating host gene expression in mice. Sci Rep 2015;5:10512. [PMID: 26015368 DOI: 10.1038/srep10512] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
10 Arslan N. Obesity, fatty liver disease and intestinal microbiota. World J Gastroenterol 2014; 20(44): 16452-16463 [PMID: 25469013 DOI: 10.3748/wjg.v20.i44.16452] [Cited by in CrossRef: 92] [Cited by in F6Publishing: 79] [Article Influence: 11.5] [Reference Citation Analysis]
11 Pamer EG. Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns. Mucosal Immunol. 2014;7:210-214. [PMID: 24399149 DOI: 10.1038/mi.2013.117] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 8.8] [Reference Citation Analysis]
12 Zhang Z, Ran C, Ding QW, Liu HL, Xie MX, Yang YL, Xie YD, Gao CC, Zhang HL, Zhou ZG. Ability of prebiotic polysaccharides to activate a HIF1α-antimicrobial peptide axis determines liver injury risk in zebrafish. Commun Biol 2019;2:274. [PMID: 31372513 DOI: 10.1038/s42003-019-0526-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
13 Piggott DA, Tuddenham S. The gut microbiome and frailty. Transl Res 2020;221:23-43. [PMID: 32360945 DOI: 10.1016/j.trsl.2020.03.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
14 Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol 2014; 20(43): 16079-16094 [PMID: 25473159 DOI: 10.3748/wjg.v20.i43.16079] [Cited by in CrossRef: 236] [Cited by in F6Publishing: 193] [Article Influence: 29.5] [Reference Citation Analysis]
15 Inserra A, Rogers GB, Licinio J, Wong M. The Microbiota-Inflammasome Hypothesis of Major Depression. BioEssays 2018;40:1800027. [DOI: 10.1002/bies.201800027] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
16 Hu KC, Wang HY, Liu SC, Liu CC, Hung CL, Bair MJ, Liu CJ, Wu MS, Shih SC. Nonalcoholic fatty liver disease: Updates in noninvasive diagnosis and correlation with cardiovascular disease. World J Gastroenterol 2014; 20(24): 7718-7729 [PMID: 24976709 DOI: 10.3748/wjg.v20.i24.7718] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
17 Dyson JK, McPherson S, Anstee QM. Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. Postgrad Med J. 2014;90:254-266. [PMID: 24737902 DOI: 10.1136/postgradmedj-2013-201620rep] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
18 Sawada Y, Kawaratani H, Kubo T, Fujinaga Y, Furukawa M, Saikawa S, Sato S, Seki K, Takaya H, Okura Y, Kaji K, Shimozato N, Mashitani T, Kitade M, Moriya K, Namisaki T, Akahane T, Mitoro A, Yamao J, Yoshiji H. Combining probiotics and an angiotensin‐II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non‐alcoholic steatohepatitis. Hepatol Res 2018;49:284-95. [DOI: 10.1111/hepr.13281] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
19 Yamanishi K, Maeda S, Kuwahara-Otani S, Watanabe Y, Yoshida M, Ikubo K, Okuzaki D, El-Darawish Y, Li W, Nakasho K, Nojima H, Yamanishi H, Hayakawa T, Okamura H, Matsunaga H. Interleukin-18-deficient mice develop dyslipidemia resulting in nonalcoholic fatty liver disease and steatohepatitis. Transl Res. 2016;173:101-114.e7. [PMID: 27063959 DOI: 10.1016/j.trsl.2016.03.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
20 Kim A. Dysbiosis: A Review Highlighting Obesity and Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 2015;49:S20-4. [DOI: 10.1097/mcg.0000000000000356] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
21 Doycheva I, Leise MD, Watt KD. The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know. Transplantation. 2016;100:61-68. [PMID: 26647107 DOI: 10.1097/tp.0000000000001008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
22 Yang X, Lu D, Zhuo J, Lin Z, Yang M, Xu X. The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases. Int J Biol Sci 2020;16:2357-66. [PMID: 32760203 DOI: 10.7150/ijbs.46405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
23 Caricilli AM, Saad MJ. The role of gut microbiota on insulin resistance. Nutrients 2013;5:829-51. [PMID: 23482058 DOI: 10.3390/nu5030829] [Cited by in Crossref: 109] [Cited by in F6Publishing: 95] [Article Influence: 12.1] [Reference Citation Analysis]
24 Tretina K, Park ES, Maminska A, MacMicking JD. Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease. J Exp Med 2019;216:482-500. [PMID: 30755454 DOI: 10.1084/jem.20182031] [Cited by in F6Publishing: 43] [Reference Citation Analysis]
25 Iacob S, Iacob DG. Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis. Front Microbiol 2019;10:1676. [PMID: 31447793 DOI: 10.3389/fmicb.2019.01676] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
26 Rajendiran E, Ramadass B, Ramprasath V. Understanding connections and roles of gut microbiome in cardiovascular diseases. Can J Microbiol 2021;67:101-11. [PMID: 33079568 DOI: 10.1139/cjm-2020-0043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Ma J, Hong Y, Zheng N, Xie G, Lyu Y, Gu Y, Xi C, Chen L, Wu G, Li Y, Tao X, Zhong J, Huang Z, Wu W, Yuan L, Lin M, Lu X, Zhang W, Jia W, Sheng L, Li H. Gut microbiota remodeling reverses aging-associated inflammation and dysregulation of systemic bile acid homeostasis in mice sex-specifically. Gut Microbes 2020;11:1450-74. [PMID: 32515683 DOI: 10.1080/19490976.2020.1763770] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
28 Hussain M, Umair Ijaz M, Ahmad MI, Khan IA, Bukhary SUF, Khan W, Hussain S, Hashmi MS, Li C. Gut inflammation exacerbates hepatic injury in C57BL/6J mice via gut-vascular barrier dysfunction with high-fat-incorporated meat protein diets. Food Funct 2020;11:9168-76. [PMID: 33026380 DOI: 10.1039/d0fo02153a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Zhou SS, Xu J, Zhu H, Wu J, Xu JD, Yan R, Li XY, Liu HH, Duan SM, Wang Z, Chen HB, Shen H, Li SL. Gut microbiota-involved mechanisms in enhancing systemic exposure of ginsenosides by coexisting polysaccharides in ginseng decoction. Sci Rep 2016;6:22474. [PMID: 26932472 DOI: 10.1038/srep22474] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 12.7] [Reference Citation Analysis]
30 Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016;65:1038-48. [DOI: 10.1016/j.metabol.2015.12.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Zhu Y, Ni T, Deng W, Lin J, Zheng L, Zhang C, Luo M. Effects of NLRP6 on the proliferation and activation of human hepatic stellate cells. Exp Cell Res 2018;370:383-8. [PMID: 29966662 DOI: 10.1016/j.yexcr.2018.06.040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
32 Vivarelli S, Salemi R, Candido S, Falzone L, Santagati M, Stefani S, Torino F, Banna GL, Tonini G, Libra M. Gut Microbiota and Cancer: From Pathogenesis to Therapy. Cancers (Basel) 2019;11:E38. [PMID: 30609850 DOI: 10.3390/cancers11010038] [Cited by in Crossref: 143] [Cited by in F6Publishing: 129] [Article Influence: 47.7] [Reference Citation Analysis]
33 Yin X, Liao W, Li Q, Zhang H, Liu Z, Zheng X, Zheng L, Feng X. Interactions between resveratrol and gut microbiota affect the development of hepatic steatosis: A fecal microbiota transplantation study in high-fat diet mice. Journal of Functional Foods 2020;67:103883. [DOI: 10.1016/j.jff.2020.103883] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Koch MA, Reiner GL, Lugo KA, Kreuk LS, Stanbery AG, Ansaldo E, Seher TD, Ludington WB, Barton GM. Maternal IgG and IgA Antibodies Dampen Mucosal T Helper Cell Responses in Early Life. Cell 2016;165:827-41. [PMID: 27153495 DOI: 10.1016/j.cell.2016.04.055] [Cited by in Crossref: 146] [Cited by in F6Publishing: 128] [Article Influence: 29.2] [Reference Citation Analysis]
35 Greiner AK, Papineni RV, Umar S. Chemoprevention in gastrointestinal physiology and disease. Natural products and microbiome. Am J Physiol Gastrointest Liver Physiol. 2014;307:G1-G15. [PMID: 24789206 DOI: 10.1152/ajpgi.00044.2014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
36 Frasca D, Blomberg BB. Adipose Tissue Inflammation Induces B Cell Inflammation and Decreases B Cell Function in Aging. Front Immunol 2017;8:1003. [PMID: 28894445 DOI: 10.3389/fimmu.2017.01003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
37 Adak M, Das D, Niyogi S, Nagalakshmi C, Ray D, Chakrabarti P. Inflammasome activation in Kupffer cells confers a protective response in nonalcoholic steatohepatitis through pigment epithelium‐derived factor expression. FASEB j 2018;32:6510-24. [DOI: 10.1096/fj.201800190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
38 Westerterp M, Fotakis P, Ouimet M, Bochem AE, Zhang H, Molusky MM, Wang W, Abramowicz S, la Bastide-van Gemert S, Wang N, Welch CL, Reilly MP, Stroes ES, Moore KJ, Tall AR. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis. Circulation 2018;138:898-912. [PMID: 29588315 DOI: 10.1161/CIRCULATIONAHA.117.032636] [Cited by in Crossref: 94] [Cited by in F6Publishing: 64] [Article Influence: 31.3] [Reference Citation Analysis]
39 Caussy C, Hsu C, Singh S, Bassirian S, Kolar J, Faulkner C, Sinha N, Bettencourt R, Gara N, Valasek MA, Schnabl B, Richards L, Brenner DA, Hofmann AF, Loomba R. Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD. Aliment Pharmacol Ther 2019;49:183-93. [PMID: 30506692 DOI: 10.1111/apt.15035] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
40 Weston CJ, Zimmermann HW, Adams DH. The Role of Myeloid-Derived Cells in the Progression of Liver Disease. Front Immunol 2019;10:893. [PMID: 31068952 DOI: 10.3389/fimmu.2019.00893] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
41 Valenti L, Pedica F, Colombo M. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. Dig Liver Dis 2021:S1590-8658(21)00337-6. [PMID: 34294580 DOI: 10.1016/j.dld.2021.06.023] [Reference Citation Analysis]
42 Mehta G, Macdonald S, Cronberg A, Rosselli M, Khera-Butler T, Sumpter C, Al-Khatib S, Jain A, Maurice J, Charalambous C, Gander A, Ju C, Hakan T, Sherwood R, Nair D, Jalan R, Moore KP. Short-term abstinence from alcohol and changes in cardiovascular risk factors, liver function tests and cancer-related growth factors: a prospective observational study. BMJ Open 2018;8:e020673. [PMID: 29730627 DOI: 10.1136/bmjopen-2017-020673] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
43 Martin BN, Wang C, Willette-Brown J, Herjan T, Gulen MF, Zhou H, Bulek K, Franchi L, Sato T, Alnemri ES, Narla G, Zhong XP, Thomas J, Klinman D, Fitzgerald KA, Karin M, Nuñez G, Dubyak G, Hu Y, Li X. IKKα negatively regulates ASC-dependent inflammasome activation. Nat Commun 2014;5:4977. [PMID: 25266676 DOI: 10.1038/ncomms5977] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 7.6] [Reference Citation Analysis]
44 Wellhöner F, Döscher N, Woelfl F, Vital M, Plumeier I, Kahl S, Potthoff A, Manns MP, Pieper DH, Cornberg M, Wedemeyer H, Heidrich B. Eradication of Chronic HCV Infection: Improvement of Dysbiosis Only in Patients Without Liver Cirrhosis. Hepatology 2021;74:72-82. [PMID: 33411981 DOI: 10.1002/hep.31700] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Arimatsu K, Yamada H, Miyazawa H, Minagawa T, Nakajima M, Ryder MI, Gotoh K, Motooka D, Nakamura S, Iida T, Yamazaki K. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Sci Rep 2014;4:4828. [PMID: 24797416 DOI: 10.1038/srep04828] [Cited by in Crossref: 196] [Cited by in F6Publishing: 196] [Article Influence: 24.5] [Reference Citation Analysis]
46 Horn P, Newsome PN. Emerging therapeutic targets for NASH: key innovations at the preclinical level. Expert Opin Ther Targets 2020;24:175-86. [PMID: 32053033 DOI: 10.1080/14728222.2020.1728742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Pan C, Chen Y, Wang S, Li M, Qu S. The study of routine laboratory factors in children with mycoplasma pneumoniae pneumonia: serum uric acid may have anti-inflammatory effect. J Clin Lab Anal 2021;35:e24026. [PMID: 34655117 DOI: 10.1002/jcla.24026] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Zeissig S, Blumberg RS. Commensal microbial regulation of natural killer T cells at the frontiers of the mucosal immune system. FEBS Lett. 2014;588:4188-4194. [PMID: 24983499 DOI: 10.1016/j.febslet.2014.06.042] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
49 Dixon A, Robertson K, Yung A, Que M, Randall H, Wellalagodage D, Cox T, Robertson D, Chi C, Sun J. Efficacy of Probiotics in Patients of Cardiovascular Disease Risk: a Systematic Review and Meta-analysis. Curr Hypertens Rep 2020;22:74. [PMID: 32860083 DOI: 10.1007/s11906-020-01080-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
50 Knorr J, Wree A, Feldstein AE. Pyroptosis in Steatohepatitis and Liver Diseases. J Mol Biol 2021;:167271. [PMID: 34592216 DOI: 10.1016/j.jmb.2021.167271] [Reference Citation Analysis]
51 Man SM, Kanneganti TD. Regulation of inflammasome activation. Immunol Rev 2015;265:6-21. [PMID: 25879280 DOI: 10.1111/imr.12296] [Cited by in Crossref: 393] [Cited by in F6Publishing: 373] [Article Influence: 65.5] [Reference Citation Analysis]
52 Mohseni AH, Casolaro V, Bermúdez-Humarán LG, Keyvani H, Taghinezhad-S S. Modulation of the PI3K/Akt/mTOR signaling pathway by probiotics as a fruitful target for orchestrating the immune response. Gut Microbes 2021;13:1-17. [PMID: 33615993 DOI: 10.1080/19490976.2021.1886844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Knoop KA, McDonald KG, Kulkarni DH, Newberry RD. Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut. 2015;pii:gutjnl-2014-309059. [PMID: 26045138 DOI: 10.1136/gutjnl-2014-309059] [Cited by in Crossref: 122] [Cited by in F6Publishing: 115] [Article Influence: 17.4] [Reference Citation Analysis]
54 De Minicis S, Agostinelli L, Rychlicki C, Sorice GP, Saccomanno S, Candelaresi C, Giaccari A, Trozzi L, Pierantonelli I, Mingarelli E. HCC development is associated to peripheral insulin resistance in a mouse model of NASH. PLoS One. 2014;9:e97136. [PMID: 24853141 DOI: 10.1371/journal.pone.0097136] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 6.4] [Reference Citation Analysis]
55 Chen R, Huang S, Lin T, Ma H, Shan W, Duan F, Lv J, Zhang J, Ren L, Nie L. Photoacoustic molecular imaging-escorted adipose photodynamic–browning synergy for fighting obesity with virus-like complexes. Nat Nanotechnol 2021;16:455-65. [DOI: 10.1038/s41565-020-00844-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
56 Horst AK, Neumann K, Diehl L, Tiegs G. Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells. Cell Mol Immunol. 2016;13:277-292. [PMID: 27041638 DOI: 10.1038/cmi.2015.112] [Cited by in Crossref: 115] [Cited by in F6Publishing: 116] [Article Influence: 19.2] [Reference Citation Analysis]
57 Rajpal DK, Brown JR. Modulating the human gut microbiome as an emerging therapeutic paradigm. Sci Prog 2013;96:224-36. [PMID: 24244970 DOI: 10.3184/003685013X13691404141587] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
58 Stacchiotti A, Favero G, Rodella LF. Impact of Melatonin on Skeletal Muscle and Exercise. Cells 2020;9:E288. [PMID: 31991655 DOI: 10.3390/cells9020288] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
59 Caesar R, Tremaroli V, Kovatcheva-Datchary P, Cani PD, Bäckhed F. Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling. Cell Metab 2015;22:658-68. [PMID: 26321659 DOI: 10.1016/j.cmet.2015.07.026] [Cited by in Crossref: 481] [Cited by in F6Publishing: 425] [Article Influence: 68.7] [Reference Citation Analysis]
60 Fan S, Wang Y, Wang C, Jin H, Wu Z, Lu J, Zhang Z, Sun C, Shan Q, Wu D, Zhuang J, Sheng N, Xie Y, Li M, Hu B, Fang J, Zheng Y, Qin W. Hepatocyte-specific deletion of LASS2 protects against diet-induced hepatic steatosis and insulin resistance. Free Radical Biology and Medicine 2018;120:330-41. [DOI: 10.1016/j.freeradbiomed.2018.04.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
61 Chiu CC, Ching YH, Li YP, Liu JY, Huang YT, Huang YW, Yang SS, Huang WC, Chuang HL. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis. Nutrients 2017;9:E1220. [PMID: 29113135 DOI: 10.3390/nu9111220] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 12.4] [Reference Citation Analysis]
62 Klaikeaw N, Wongphoom J, Werawatganon D, Chayanupatkul M, Siriviriyakul P. Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitis. World J Hepatol 2020; 12(7): 363-377 [PMID: 32821335 DOI: 10.4254/wjh.v12.i7.363] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
63 Maradana MR, Thomas R, O’Sullivan BJ. Targeted delivery of curcumin for treating type 2 diabetes. Mol Nutr Food Res. 2013;57:1550-1556. [PMID: 23495213 DOI: 10.1002/mnfr.201200791] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
64 Hu Y, Zhang H, Li J, Cong X, Chen Y, He G, Chi Y, Liu Y. Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model: Cross talk between the gut and liver. Journal of Gastroenterology and Hepatology 2016;31:676-84. [DOI: 10.1111/jgh.13183] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
65 Fung TC, Artis D, Sonnenberg GF. Anatomical localization of commensal bacteria in immune cell homeostasis and disease. Immunol Rev 2014;260:35-49. [PMID: 24942680 DOI: 10.1111/imr.12186] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 6.1] [Reference Citation Analysis]
66 Qian CL, Ding CL, Tang HL, Qi ZT, Wang W. Retinoic acid induced 16 deficiency exacerbates high-fat diet-induced steatohepatitis in mice. Cell Biochem Funct 2020;38:753-60. [PMID: 32289885 DOI: 10.1002/cbf.3542] [Reference Citation Analysis]
67 Gálvez EJC, Iljazovic A, Gronow A, Flavell R, Strowig T. Shaping of Intestinal Microbiota in Nlrp6- and Rag2-Deficient Mice Depends on Community Structure. Cell Rep 2017;21:3914-26. [PMID: 29281837 DOI: 10.1016/j.celrep.2017.12.027] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 14.7] [Reference Citation Analysis]
68 Meijers B, Evenepoel P, Anders H. Intestinal microbiome and fitness in kidney disease. Nat Rev Nephrol 2019;15:531-45. [DOI: 10.1038/s41581-019-0172-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 14.0] [Reference Citation Analysis]
69 Wang Y, Wang H, Deng P, Tao T, Liu H, Wu S, Chen W, Qin J. Modeling Human Nonalcoholic Fatty Liver Disease (NAFLD) with an Organoids-on-a-Chip System. ACS Biomater Sci Eng 2020;6:5734-43. [DOI: 10.1021/acsbiomaterials.0c00682] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
70 Jiang S, Xie S, Lv D, Wang P, He H, Zhang T, Zhou Y, Lin Q, Zhou H, Jiang J, Nie J, Hou F, Chen Y. Alteration of the gut microbiota in Chinese population with chronic kidney disease. Sci Rep 2017;7:2870. [PMID: 28588309 DOI: 10.1038/s41598-017-02989-2] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 13.8] [Reference Citation Analysis]
71 de Souza AB, Chaud MV, Santana MHA. Hyaluronic acid behavior in oral administration and perspectives for nanotechnology-based formulations: A review. Carbohydrate Polymers 2019;222:115001. [DOI: 10.1016/j.carbpol.2019.115001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
72 Papaefthymiou A, Potamianos S, Goulas A, Doulberis M, Kountouras J, Polyzos SA. Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents. J Crohns Colitis 2021:jjab212. [PMID: 34972203 DOI: 10.1093/ecco-jcc/jjab212] [Reference Citation Analysis]
73 Caligiuri A, Gentilini A, Marra F. Molecular Pathogenesis of NASH. Int J Mol Sci. 2016;17. [PMID: 27657051 DOI: 10.3390/ijms17091575] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 13.2] [Reference Citation Analysis]
74 Ramadori P, Kroy D, Streetz KL. Immunoregulation by lipids during the development of non-alcoholic steatohepatitis. Hepatobiliary Surg Nutr 2015;4:11-23. [PMID: 25713801 DOI: 10.3978/j.issn.2304-3881.2015.01.02] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
75 Tsutsui H, Cai X, Hayashi S. Interleukin-1 Family Cytokines in Liver Diseases. Mediators Inflamm 2015;2015:630265. [PMID: 26549942 DOI: 10.1155/2015/630265] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
76 Correa-Fiz F, Fraile L, Aragon V. Piglet nasal microbiota at weaning may influence the development of Glässer's disease during the rearing period. BMC Genomics 2016;17:404. [PMID: 27230662 DOI: 10.1186/s12864-016-2700-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
77 Cai J, Zhang XJ, Li H. Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease. Trends Endocrinol Metab 2018;29:712-22. [PMID: 30131212 DOI: 10.1016/j.tem.2018.08.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
78 Nadanaka S, Hashiguchi T, Kitagawa H. Aberrant glycosaminoglycan biosynthesis by tumor suppressor EXTL2 deficiency promotes liver inflammation and tumorigenesis through Toll-like 4 receptor signaling. FASEB J 2020;34:8385-401. [PMID: 32347583 DOI: 10.1096/fj.201902076R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
79 Yu Y, Raka F, Adeli K. The Role of the Gut Microbiota in Lipid and Lipoprotein Metabolism. J Clin Med 2019;8:E2227. [PMID: 31861086 DOI: 10.3390/jcm8122227] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
80 Arab JP, Martin-Mateos RM, Shah VH. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg. Hepatol Int. 2018;12:24-33. [PMID: 28550391 DOI: 10.1007/s12072-017-9798-x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 11.6] [Reference Citation Analysis]
81 de Jong PR, González-Navajas JM, Jansen NJ. The digestive tract as the origin of systemic inflammation. Crit Care 2016;20:279. [PMID: 27751165 DOI: 10.1186/s13054-016-1458-3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
82 Liang X, Pei H, Ma L, Ran Y, Chen J, Wang G, Chen L. Synthesis and biological evaluation of novel urea- and guanidine-based derivatives for the treatment of obesity-related hepatic steatosis. Molecules 2014;19:6163-83. [PMID: 24838072 DOI: 10.3390/molecules19056163] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
83 van den Munckhof ICL, Kurilshikov A, ter Horst R, Riksen NP, Joosten LAB, Zhernakova A, Fu J, Keating ST, Netea MG, de Graaf J, Rutten JHW. Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies: Impact of gut microbiota on low-grade inflammation. Obesity Reviews 2018;19:1719-34. [DOI: 10.1111/obr.12750] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 16.0] [Reference Citation Analysis]
84 Rovira-Llopis S, Apostolova N, Bañuls C, Muntané J, Rocha M, Victor VM. Mitochondria, the NLRP3 Inflammasome, and Sirtuins in Type 2 Diabetes: New Therapeutic Targets. Antioxid Redox Signal 2018;29:749-91. [PMID: 29256638 DOI: 10.1089/ars.2017.7313] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
85 Biswas A, Kobayashi KS. Regulation of intestinal microbiota by the NLR protein family. Int Immunol 2013;25:207-14. [PMID: 23325116 DOI: 10.1093/intimm/dxs116] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
86 Mann JP, Raponi M, Nobili V. Clinical implications of understanding the association between oxidative stress and pediatric NAFLD. Expert Rev Gastroenterol Hepatol. 2017;11:371-382. [PMID: 28162008 DOI: 10.1080/17474124.2017.1291340] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
87 Lau E, Carvalho D, Freitas P. Gut Microbiota: Association with NAFLD and Metabolic Disturbances. Biomed Res Int. 2015;2015:979515. [PMID: 26090468 DOI: 10.1155/2015/979515] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
88 Schuppan D, Surabattula R, Wang XY. Determinants of fibrosis progression and regression in NASH. J Hepatol. 2018;68:238-250. [PMID: 29154966 DOI: 10.1016/j.jhep.2017.11.012] [Cited by in Crossref: 160] [Cited by in F6Publishing: 151] [Article Influence: 32.0] [Reference Citation Analysis]
89 Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, Quraishi MN, Kinross J, Smidt H, Tuohy KM, Thomas LV, Zoetendal EG, Hart A. The gut microbiota and host health: a new clinical frontier. Gut. 2016;65:330-339. [PMID: 26338727 DOI: 10.1136/gutjnl-2015-309990] [Cited by in Crossref: 997] [Cited by in F6Publishing: 878] [Article Influence: 142.4] [Reference Citation Analysis]
90 Ahluwalia V, Betrapally NS, Hylemon PB, White MB, Gillevet PM, Unser AB, Fagan A, Daita K, Heuman DM, Zhou H, Sikaroodi M, Bajaj JS. Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis. Sci Rep. 2016;6:26800. [PMID: 27225869 DOI: 10.1038/srep26800] [Cited by in Crossref: 90] [Cited by in F6Publishing: 82] [Article Influence: 15.0] [Reference Citation Analysis]
91 Lukens JR, Kanneganti TD. Beyond canonical inflammasomes: emerging pathways in IL-1-mediated autoinflammatory disease. Semin Immunopathol 2014;36:595-609. [PMID: 24838628 DOI: 10.1007/s00281-014-0434-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
92 Karlsen TH, Boberg KM. Update on primary sclerosing cholangitis. J Hepatol. 2013;59:571-582. [PMID: 23603668 DOI: 10.1016/j.jhep.2013.03.015] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 8.6] [Reference Citation Analysis]
93 Portela-Cidade JP, Borges-Canha M, Leite-Moreira AF, Pimentel-Nunes P. Systematic Review of the Relation Between Intestinal Microbiota and Toll-Like Receptors in the Metabolic Syndrome: What Do We Know So Far? GE Port J Gastroenterol 2015;22:240-58. [PMID: 28868416 DOI: 10.1016/j.jpge.2015.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
94 Bieghs V, Trautwein C. The innate immune response during liver inflammation and metabolic disease. Trends Immunol. 2013;34:446-452. [PMID: 23668977 DOI: 10.1016/j.it.2013.04.005] [Cited by in Crossref: 104] [Cited by in F6Publishing: 104] [Article Influence: 11.6] [Reference Citation Analysis]
95 Wada N, Takaki A, Ikeda F, Yasunaka T, Onji M, Nouso K, Nakatsuka A, Wada J, Koike K, Miyahara K, Shiraha H, Yamamoto K, Okada H. Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease. Hepatol Int 2017;11:115-24. [PMID: 27826704 DOI: 10.1007/s12072-016-9773-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
96 Ding Y, Wang L, Im S, Hwang O, Kim HS, Kang MC, Lee SH. Anti-Obesity Effect of Diphlorethohydroxycarmalol Isolated from Brown Alga Ishige okamurae in High-Fat Diet-Induced Obese Mice. Mar Drugs 2019;17:E637. [PMID: 31717668 DOI: 10.3390/md17110637] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
97 Nettleton JE, Cho NA, Klancic T, Nicolucci AC, Shearer J, Borgland SL, Johnston LA, Ramay HR, Noye Tuplin E, Chleilat F, Thomson C, Mayengbam S, McCoy KD, Reimer RA. Maternal low-dose aspartame and stevia consumption with an obesogenic diet alters metabolism, gut microbiota and mesolimbic reward system in rat dams and their offspring. Gut 2020;69:1807-17. [PMID: 31996393 DOI: 10.1136/gutjnl-2018-317505] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
98 Ding C, Zhao Y, Shi X, Zhang N, Zu G, Li Z, Zhou J, Gao D, Lv L, Tian X, Yao J. New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats. Sci Rep 2016;6:28734. [PMID: 27345365 DOI: 10.1038/srep28734] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 8.0] [Reference Citation Analysis]
99 Tran A, Gual P. Non-alcoholic steatohepatitis in morbidly obese patients. Clin Res Hepatol Gastroenterol. 2013;37:17-29. [PMID: 23347840 DOI: 10.1016/j.clinre.2012.07.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
100 Febbraio MA. Role of interleukins in obesity: implications for metabolic disease. Trends Endocrinol Metab 2014;25:312-9. [PMID: 24698032 DOI: 10.1016/j.tem.2014.02.004] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 7.5] [Reference Citation Analysis]
101 Johnson AMF, Hou S, Li P. Inflammation and insulin resistance: New targets encourage new thinking: Galectin-3 and LTB4 are pro-inflammatory molecules that can be targeted to restore insulin sensitivity. Bioessays 2017;39. [PMID: 28752547 DOI: 10.1002/bies.201700036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
102 Mueller JL, Feeney ER, Zheng H, Misdraji J, Kruger AJ, Alatrakchi N, King LY, Gelrud L, Corey KE, Chung RT. Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease. Clin Transl Gastroenterol 2015;6:e114. [PMID: 26448455 DOI: 10.1038/ctg.2015.36] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
103 Macia L, Tan J, Vieira AT, Leach K, Stanley D, Luong S, Maruya M, Ian McKenzie C, Hijikata A, Wong C, Binge L, Thorburn AN, Chevalier N, Ang C, Marino E, Robert R, Offermanns S, Teixeira MM, Moore RJ, Flavell RA, Fagarasan S, Mackay CR. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun. 2015;6:6734. [PMID: 25828455 DOI: 10.1038/ncomms7734] [Cited by in Crossref: 532] [Cited by in F6Publishing: 513] [Article Influence: 76.0] [Reference Citation Analysis]
104 Ali O, Darwish HA, Eldeib KM, Abdel Azim SA. miR-26a Potentially Contributes to the Regulation of Fatty Acid and Sterol Metabolism In Vitro Human HepG2 Cell Model of Nonalcoholic Fatty Liver Disease. Oxid Med Cell Longev 2018;2018:8515343. [PMID: 30402207 DOI: 10.1155/2018/8515343] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
105 Wang Y, Tong J, Chang B, Wang BF, Zhang D, Wang BY. Relationship of SREBP-2 rs2228314 G>C polymorphism with nonalcoholic fatty liver disease in a Han Chinese population. Genet Test Mol Biomarkers 2014;18:653-7. [PMID: 24992162 DOI: 10.1089/gtmb.2014.0116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
106 Delzenne NM, Knudsen C, Beaumont M, Rodriguez J, Neyrinck AM, Bindels LB. Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut–liver axis. Proc Nutr Soc 2019;78:319-28. [DOI: 10.1017/s0029665118002756] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 11.7] [Reference Citation Analysis]
107 Sanmiguel C, Gupta A, Mayer EA. Gut Microbiome and Obesity: A Plausible Explanation for Obesity. Curr Obes Rep. 2015;4:250-261. [PMID: 26029487 DOI: 10.1007/s13679-015-0152-0] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 13.2] [Reference Citation Analysis]
108 Barretto SA, Lasserre F, Huillet M, Régnier M, Polizzi A, Lippi Y, Fougerat A, Person E, Bruel S, Bétoulières C, Naylies C, Lukowicz C, Smati S, Guzylack L, Olier M, Théodorou V, Mselli-Lakhal L, Zalko D, Wahli W, Loiseau N, Gamet-Payrastre L, Guillou H, Ellero-Simatos S. The pregnane X receptor drives sexually dimorphic hepatic changes in lipid and xenobiotic metabolism in response to gut microbiota in mice. Microbiome 2021;9:93. [PMID: 33879258 DOI: 10.1186/s40168-021-01050-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Opipari A, Franchi L. Role of Inflammasomes in Intestinal Inflammation and Crohnʼs Disease: . Inflammatory Bowel Diseases 2015;21:173-81. [DOI: 10.1097/mib.0000000000000230] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
110 Wang S, Wang J, Liu Y, Li H, Wang Q, Huang Z, Liu W, Shi P. Trivalent Chromium Supplementation Ameliorates Oleic Acid-Induced Hepatic Steatosis in Mice. Biol Trace Elem Res 2019;187:192-201. [PMID: 29797206 DOI: 10.1007/s12011-018-1368-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
111 Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. Journal of Hepatology 2015;63:1272-84. [DOI: 10.1016/j.jhep.2015.07.004] [Cited by in Crossref: 272] [Cited by in F6Publishing: 231] [Article Influence: 38.9] [Reference Citation Analysis]
112 Li DY, Yang M, Edwards S, Ye SQ. Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota? JPEN J Parenter Enteral Nutr. 2013;37:787-793. [PMID: 23538296 DOI: 10.1177/0148607113481623] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
113 Mu H, Zhou Q, Yang R, Zeng J, Li X, Zhang R, Tang W, Li H, Wang S, Shen T, Huang X, Dou L, Dong J. Naringin Attenuates High Fat Diet Induced Non-alcoholic Fatty Liver Disease and Gut Bacterial Dysbiosis in Mice. Front Microbiol 2020;11:585066. [PMID: 33281780 DOI: 10.3389/fmicb.2020.585066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
114 Nagao-Kitamoto H, Kitamoto S, Kuffa P, Kamada N. Pathogenic role of the gut microbiota in gastrointestinal diseases. Intest Res. 2016;14:127-138. [PMID: 27175113 DOI: 10.5217/ir.2016.14.2.127] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 12.0] [Reference Citation Analysis]
115 Sanz Y, Moya-pérez A. Microbiota, Inflammation and Obesity. In: Lyte M, Cryan JF, editors. Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease. New York: Springer; 2014. pp. 291-317. [DOI: 10.1007/978-1-4939-0897-4_14] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 8.8] [Reference Citation Analysis]
116 Jimenez MT, Michieletto MF, Henao-Mejia J. A new perspective on mesenchymal-immune interactions in adipose tissue. Trends Immunol 2021;42:375-88. [PMID: 33849777 DOI: 10.1016/j.it.2021.03.001] [Reference Citation Analysis]
117 Tsai M, Chen Y, Chen C, Tsai M, Han C, Chen Y, Mersmann HJ, Ding S. Identification of Potential Plasma Biomarkers for Nonalcoholic Fatty Liver Disease by Integrating Transcriptomics and Proteomics in Laying Hens. The Journal of Nutrition 2017;147:293-303. [DOI: 10.3945/jn.116.240358] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
118 Serino M. Molecular Paths Linking Metabolic Diseases, Gut Microbiota Dysbiosis and Enterobacteria Infections. J Mol Biol. 2018;430:581-590. [PMID: 29374557 DOI: 10.1016/j.jmb.2018.01.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
119 Czaja AJ. Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management. Dig Dis Sci 2018;63:1706-25. [DOI: 10.1007/s10620-018-5072-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
120 Subramaniam A, Landstrom M, Luu A, Hayes KC. The Nile Rat (Arvicanthis niloticus) as a Superior Carbohydrate-Sensitive Model for Type 2 Diabetes Mellitus (T2DM). Nutrients 2018;10:E235. [PMID: 29463026 DOI: 10.3390/nu10020235] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
121 Kubes P, Mehal WZ. Sterile inflammation in the liver. Gastroenterology 2012;143:1158-72. [PMID: 22982943 DOI: 10.1053/j.gastro.2012.09.008] [Cited by in Crossref: 387] [Cited by in F6Publishing: 369] [Article Influence: 38.7] [Reference Citation Analysis]
122 Takakura K, Oikawa T, Nakano M, Saeki C, Torisu Y, Kajihara M, Saruta M. Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma.Front Oncol. 2019;9:762. [PMID: 31456946 DOI: 10.3389/fonc.2019.00762] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
123 Zhong Y, Kinio A, Saleh M. Functions of NOD-Like Receptors in Human Diseases. Front Immunol 2013;4:333. [PMID: 24137163 DOI: 10.3389/fimmu.2013.00333] [Cited by in Crossref: 138] [Cited by in F6Publishing: 124] [Article Influence: 15.3] [Reference Citation Analysis]
124 Nijhawan S, Richards W, O'Hea MF, Audia JP, Alvarez DF. Bariatric surgery rapidly improves mitochondrial respiration in morbidly obese patients. Surg Endosc 2013;27:4569-73. [PMID: 23982645 DOI: 10.1007/s00464-013-3125-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
125 Mima K, Nakagawa S, Sawayama H, Ishimoto T, Imai K, Iwatsuki M, Hashimoto D, Baba Y, Yamashita YI, Yoshida N, Chikamoto A, Baba H. The microbiome and hepatobiliary-pancreatic cancers.Cancer Lett. 2017;402:9-15. [PMID: 28527946 DOI: 10.1016/j.canlet.2017.05.001] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 11.4] [Reference Citation Analysis]
126 Domerecka W, Kowalska-Kępczyńska A, Michalak A, Homa-Mlak I, Mlak R, Cichoż-Lach H, Małecka-Massalska T. Etiopathogenesis and Diagnostic Strategies in Autoimmune Hepatitis. Diagnostics (Basel) 2021;11:1418. [PMID: 34441353 DOI: 10.3390/diagnostics11081418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Buccigrossi V, Nicastro E, Guarino A. Functions of intestinal microflora in children. Curr Opin Gastroenterol. 2013;29:31-38. [PMID: 23196853 DOI: 10.1097/mog.0b013e32835a3500] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
128 Ferreira DM, Simão AL, Rodrigues CM, Castro RE. Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease. FEBS J 2014;281:2503-24. [PMID: 24702768 DOI: 10.1111/febs.12806] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
129 Szabo G, Iracheta-vellve A. Inflammasome activation in the liver: Focus on alcoholic and non-alcoholic steatohepatitis. Clinics and Research in Hepatology and Gastroenterology 2015;39:S18-23. [DOI: 10.1016/j.clinre.2015.06.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
130 Barrera F, George J. Non-alcoholic fatty liver disease: more than just ectopic fat accumulation. Drug Discovery Today: Disease Mechanisms 2013;10:e47-54. [DOI: 10.1016/j.ddmec.2013.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
131 Elinav E, Henao-Mejia J, Strowig T, Flavell R. NLRP6 and Dysbiosis: Avoiding the Luring Attraction of Over-Simplification. Immunity 2018;48:603-4. [PMID: 29669238 DOI: 10.1016/j.immuni.2018.04.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
132 Reid D, Mcdonald B, Khalid T, Vo T, Schenck L, Surette M, Beck P, Reimer R, Probert C, Rioux K, Eksteen B. Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2016;1862:1337-44. [DOI: 10.1016/j.bbadis.2016.04.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
133 Portincasa P, Bonfrate L, Khalil M, Angelis MD, Calabrese FM, D’amato M, Wang DQ, Di Ciaula A. Intestinal Barrier and Permeability in Health, Obesity and NAFLD. Biomedicines 2022;10:83. [DOI: 10.3390/biomedicines10010083] [Reference Citation Analysis]
134 Olesen SW, Alm EJ. Dysbiosis is not an answer. Nat Microbiol 2016;1. [DOI: 10.1038/nmicrobiol.2016.228] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 9.2] [Reference Citation Analysis]
135 Usami M, Miyoshi M, Yamashita H. Gut microbiota and host metabolism in liver cirrhosis. World J Gastroenterol 2015; 21(41): 11597-11608 [PMID: 26556989 DOI: 10.3748/wjg.v21.i41.11597] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 51] [Article Influence: 8.0] [Reference Citation Analysis]
136 Zhong Z, Umemura A, Sanchez-Lopez E, Liang S, Shalapour S, Wong J, He F, Boassa D, Perkins G, Ali SR, McGeough MD, Ellisman MH, Seki E, Gustafsson AB, Hoffman HM, Diaz-Meco MT, Moscat J, Karin M. NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria. Cell 2016;164:896-910. [PMID: 26919428 DOI: 10.1016/j.cell.2015.12.057] [Cited by in Crossref: 497] [Cited by in F6Publishing: 491] [Article Influence: 82.8] [Reference Citation Analysis]
137 Panasevich MR, Meers GM, Linden MA, Booth FW, Perfield JW 2nd, Fritsche KL, Wankhade UD, Chintapalli SV, Shankar K, Ibdah JA, Rector RS. High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine. Am J Physiol Endocrinol Metab 2018;314:E78-92. [PMID: 28899857 DOI: 10.1152/ajpendo.00015.2017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
138 Goldsmith JR, Sartor RB. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol. 2014;49:785-798. [PMID: 24652102 DOI: 10.1007/s00535-014-0953-z] [Cited by in Crossref: 115] [Cited by in F6Publishing: 109] [Article Influence: 14.4] [Reference Citation Analysis]
139 Solinas G. Molecular pathways linking metabolic inflammation and thermogenesis. Obes Rev 2012;13 Suppl 2:69-82. [PMID: 23107261 DOI: 10.1111/j.1467-789X.2012.01047.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
140 Ouyang S, Mo Z, Sun S, Yin K, Lv Y. Emerging role of Insig-1 in lipid metabolism and lipid disorders. Clin Chim Acta 2020;508:206-12. [PMID: 32461046 DOI: 10.1016/j.cca.2020.05.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
141 Picca A, Fanelli F, Calvani R, Mulè G, Pesce V, Sisto A, Pantanelli C, Bernabei R, Landi F, Marzetti E. Gut Dysbiosis and Muscle Aging: Searching for Novel Targets against Sarcopenia. Mediators Inflamm 2018;2018:7026198. [PMID: 29686533 DOI: 10.1155/2018/7026198] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 11.0] [Reference Citation Analysis]
142 Noureddin M, Anstee QM, Loomba R. Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2016;43:1109-23. [PMID: 27061197 DOI: 10.1111/apt.13620] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 5.7] [Reference Citation Analysis]
143 Thaiss CA, Levy M, Itav S, Elinav E. Integration of Innate Immune Signaling. Trends Immunol. 2016;37:84-101. [PMID: 26755064 DOI: 10.1016/j.it.2015.12.003] [Cited by in Crossref: 99] [Cited by in F6Publishing: 87] [Article Influence: 16.5] [Reference Citation Analysis]
144 du Plessis J, Korf H, van Pelt J, Windmolders P, Vander Elst I, Verrijken A, Hubens G, Van Gaal L, Cassiman D, Nevens F, Francque S, van der Merwe S. Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD. PLoS One 2016;11:e0166048. [PMID: 27992443 DOI: 10.1371/journal.pone.0166048] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
145 Huang EY, Inoue T, Leone VA, Dalal S, Touw K, Wang Y, Musch MW, Theriault B, Higuchi K, Donovan S, Gilbert J, Chang EB. Using corticosteroids to reshape the gut microbiome: implications for inflammatory bowel diseases. Inflamm Bowel Dis 2015;21:963-72. [PMID: 25738379 DOI: 10.1097/MIB.0000000000000332] [Cited by in Crossref: 86] [Cited by in F6Publishing: 37] [Article Influence: 14.3] [Reference Citation Analysis]
146 Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol. 2013;13:790-801. [PMID: 24096337 DOI: 10.1038/nri3535] [Cited by in Crossref: 738] [Cited by in F6Publishing: 654] [Article Influence: 82.0] [Reference Citation Analysis]
147 Talavera-Urquijo E, Beisani M, Balibrea JM, Alverdy JC. Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review. Surg Obes Relat Dis 2020;16:1361-9. [PMID: 32336663 DOI: 10.1016/j.soard.2020.03.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
148 Zhang Y, Li F, Jiang X, Jiang X, Wang Y, Zhang H, Zhang L, Fan S, Xin L, Yang B, Ji G, Huang C. Sophoricoside is a selective LXRβ antagonist with potent therapeutic effects on hepatic steatosis of mice. Phytother Res 2020;34:3168-79. [PMID: 32592532 DOI: 10.1002/ptr.6747] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
149 Knaapen M, Kootte R, Zoetendal E, de Vos W, Dallinga-thie G, Levi M, Stroes E, Nieuwdorp M. Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota? Clinical Microbiology and Infection 2013;19:331-7. [DOI: 10.1111/1469-0691.12170] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
150 Rook GA, Raison CL, Lowry CA. Microbiota, immunoregulatory old friends and psychiatric disorders. Adv Exp Med Biol 2014;817:319-56. [PMID: 24997041 DOI: 10.1007/978-1-4939-0897-4_15] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 8.6] [Reference Citation Analysis]
151 Kim SE, Park JW, Kim HS, Jang MK, Suk KT, Kim DJ. The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure. Int J Mol Sci 2021;22:11680. [PMID: 34769109 DOI: 10.3390/ijms222111680] [Reference Citation Analysis]
152 . RETRACTED ARTICLE: Short hairpin RNA gene silencing of NLRP3 confers protection against sepsis-induced hyperbilirubinemia in a rat model. Immunol Res 2015;62:127. [PMID: 25550085 DOI: 10.1007/s12026-014-8613-1] [Reference Citation Analysis]
153 Madsen L, Myrmel LS, Fjære E, Liaset B, Kristiansen K. Links between Dietary Protein Sources, the Gut Microbiota, and Obesity. Front Physiol 2017;8:1047. [PMID: 29311977 DOI: 10.3389/fphys.2017.01047] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
154 Tsutsui H, Nakanishi K. Immunotherapeutic applications of IL-18. Immunotherapy 2012;4:1883-94. [PMID: 23240755 DOI: 10.2217/imt.12.137] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
155 Anand PK, Malireddi RK, Lukens JR, Vogel P, Bertin J, Lamkanfi M, Kanneganti TD. NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature 2012;488:389-93. [PMID: 22763455 DOI: 10.1038/nature11250] [Cited by in Crossref: 232] [Cited by in F6Publishing: 230] [Article Influence: 23.2] [Reference Citation Analysis]
156 Burcelin R. Regulation of Metabolism: A Cross Talk Between Gut Microbiota and Its Human Host. Physiology 2012;27:300-7. [DOI: 10.1152/physiol.00023.2012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
157 Korn T, Kallies A. T cell responses in the central nervous system. Nat Rev Immunol 2017;17:179-94. [PMID: 28138136 DOI: 10.1038/nri.2016.144] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 25.0] [Reference Citation Analysis]
158 Hazen SL, Smith JD. An antiatherosclerotic signaling cascade involving intestinal microbiota, microRNA-10b, and ABCA1/ABCG1-mediated reverse cholesterol transport. Circ Res 2012;111:948-50. [PMID: 23023503 DOI: 10.1161/CIRCRESAHA.112.277277] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
159 Khan A, Ding Z, Ishaq M, Bacha AS, Khan I, Hanif A, Li W, Guo X. Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates. Int J Biol Sci 2021;17:818-33. [PMID: 33767591 DOI: 10.7150/ijbs.56214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
160 Harsch IA, Konturek PC. The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into "Old" Diseases. Med Sci (Basel). 2018;6:pii: E3. [PMID: 29673211 DOI: 10.3390/medsci6020032] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 12.0] [Reference Citation Analysis]
161 Takahashi H, Kotani K, Tanaka K, Egucih Y, Anzai K. Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms. Front Endocrinol (Lausanne). 2018;9:588. [PMID: 30374329 DOI: 10.3389/fendo.2018.00588] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
162 Mavrommatis B, Young GR, Kassiotis G. Counterpoise between the microbiome, host immune activation and pathology. Curr Opin Immunol 2013;25:456-62. [PMID: 23743081 DOI: 10.1016/j.coi.2013.05.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
163 Joshi-Barve S, Kirpich I, Cave MC, Marsano LS, McClain CJ. Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences. Cell Mol Gastroenterol Hepatol 2015;1:356-67. [PMID: 28210688 DOI: 10.1016/j.jcmgh.2015.05.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
164 Sharpton SR, Ajmera V, Loomba R. Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function. Clin Gastroenterol Hepatol 2019;17:296-306. [PMID: 30196156 DOI: 10.1016/j.cgh.2018.08.065] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 15.5] [Reference Citation Analysis]
165 Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908-922. [PMID: 29967350 DOI: 10.1038/s41591-018-0104-9] [Cited by in Crossref: 777] [Cited by in F6Publishing: 742] [Article Influence: 194.3] [Reference Citation Analysis]
166 Bellone M, Brevi A, Huber S. Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer. Microbiol Mol Biol Rev 2020;84:e00064-19. [PMID: 32132244 DOI: 10.1128/MMBR.00064-19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
167 Ericsson AC, Franklin CL. Manipulating the Gut Microbiota: Methods and Challenges. ILAR J 2015;56:205-17. [PMID: 26323630 DOI: 10.1093/ilar/ilv021] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 9.5] [Reference Citation Analysis]
168 Fuchs CD, Claudel T, Trauner M. Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD. Trends Endocrinol Metab 2014;25:576-85. [PMID: 25183341 DOI: 10.1016/j.tem.2014.08.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
169 Hong Y, Li B, Zheng N, Wu G, Ma J, Tao X, Chen L, Zhong J, Sheng L, Li H. Integrated Metagenomic and Metabolomic Analyses of the Effect of Astragalus Polysaccharides on Alleviating High-Fat Diet-Induced Metabolic Disorders. Front Pharmacol 2020;11:833. [PMID: 32587515 DOI: 10.3389/fphar.2020.00833] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
170 Mamantopoulos M, Ronchi F, Van Hauwermeiren F, Vieira-Silva S, Yilmaz B, Martens L, Saeys Y, Drexler SK, Yazdi AS, Raes J, Lamkanfi M, McCoy KD, Wullaert A. Nlrp6- and ASC-Dependent Inflammasomes Do Not Shape the Commensal Gut Microbiota Composition. Immunity 2017;47:339-348.e4. [PMID: 28801232 DOI: 10.1016/j.immuni.2017.07.011] [Cited by in Crossref: 95] [Cited by in F6Publishing: 92] [Article Influence: 19.0] [Reference Citation Analysis]
171 Ong HS, Yim HCH. Microbial Factors in Inflammatory Diseases and Cancers. Adv Exp Med Biol 2017;1024:153-74. [PMID: 28921469 DOI: 10.1007/978-981-10-5987-2_7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
172 Mu HN, Zhou Q, Yang RY, Tang WQ, Li HX, Wang SM, Li J, Chen WX, Dong J. Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice. Food Res Int 2021;143:110240. [PMID: 33992352 DOI: 10.1016/j.foodres.2021.110240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
173 Caesar R. Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes. Can J Diabetes 2019;43:224-31. [PMID: 30929665 DOI: 10.1016/j.jcjd.2019.01.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
174 Safari Z, Gérard P. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cell Mol Life Sci 2019;76:1541-58. [PMID: 30683985 DOI: 10.1007/s00018-019-03011-w] [Cited by in Crossref: 101] [Cited by in F6Publishing: 91] [Article Influence: 33.7] [Reference Citation Analysis]
175 Schroeder BO, Bäckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med 2016;22:1079-89. [PMID: 27711063 DOI: 10.1038/nm.4185] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
176 Lukens JR, Gross JM, Kanneganti TD. IL-1 family cytokines trigger sterile inflammatory disease. Front Immunol 2012;3:315. [PMID: 23087690 DOI: 10.3389/fimmu.2012.00315] [Cited by in Crossref: 102] [Cited by in F6Publishing: 97] [Article Influence: 10.2] [Reference Citation Analysis]
177 Bagarolli RA, Tobar N, Oliveira AG, Araújo TG, Carvalho BM, Rocha GZ, Vecina JF, Calisto K, Guadagnini D, Prada PO, Santos A, Saad STO, Saad MJA. Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice. J Nutr Biochem 2017;50:16-25. [PMID: 28968517 DOI: 10.1016/j.jnutbio.2017.08.006] [Cited by in Crossref: 98] [Cited by in F6Publishing: 86] [Article Influence: 19.6] [Reference Citation Analysis]
178 Periyalil HA, Gibson PG, Wood LG. Immunometabolism in obese asthmatics: are we there yet? Nutrients 2013;5:3506-30. [PMID: 24025484 DOI: 10.3390/nu5093506] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
179 Wang Y, Wu Y, Wang B, Xu H, Mei X, Xu X, Zhang X, Ni J, Li W. Bacillus amyloliquefaciens SC06 Protects Mice Against High-Fat Diet-Induced Obesity and Liver Injury via Regulating Host Metabolism and Gut Microbiota. Front Microbiol 2019;10:1161. [PMID: 31191487 DOI: 10.3389/fmicb.2019.01161] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
180 Busch CJ, Hendrikx T, Weismann D, Jäckel S, Walenbergh SM, Rendeiro AF, Weißer J, Puhm F, Hladik A, Göderle L, Papac-Milicevic N, Haas G, Millischer V, Subramaniam S, Knapp S, Bennett KL, Bock C, Reinhardt C, Shiri-Sverdlov R, Binder CJ. Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice. Hepatology 2017;65:1181-95. [PMID: 27981604 DOI: 10.1002/hep.28970] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
181 Levy M, Thaiss CA, Elinav E. Metabolites: messengers between the microbiota and the immune system. Genes Dev. 2016;30:1589-1597. [PMID: 27474437 DOI: 10.1101/gad.284091.116] [Cited by in Crossref: 171] [Cited by in F6Publishing: 157] [Article Influence: 34.2] [Reference Citation Analysis]
182 Saiman Y, Hooks R, Carr RM. High-Risk Groups for Non-alcoholic Fatty Liver and Non-alcoholic Steatohepatitis Development and Progression. Curr Hepatology Rep 2020;19:412-9. [DOI: 10.1007/s11901-020-00539-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Greer RL, Morgun A, Shulzhenko N. Bridging immunity and lipid metabolism by gut microbiota. J Allergy Clin Immunol. 2013;132:253-262; quiz 263. [PMID: 23905915 DOI: 10.1016/j.jaci.2013.06.025] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
184 Zarrinpar A, Chaix A, Panda S. Daily Eating Patterns and Their Impact on Health and Disease. Trends Endocrinol Metab 2016;27:69-83. [PMID: 26706567 DOI: 10.1016/j.tem.2015.11.007] [Cited by in Crossref: 113] [Cited by in F6Publishing: 102] [Article Influence: 16.1] [Reference Citation Analysis]
185 Seo YS, Shah VH. The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension. Clin Mol Hepatol 2012;18:337-46. [PMID: 23323248 DOI: 10.3350/cmh.2012.18.4.337] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 8.0] [Reference Citation Analysis]
186 Panasevich MR, Peppler WT, Oerther DB, Wright DC, Rector RS. Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification. Physiol Genomics. 2017;49:385-399. [PMID: 28600319 DOI: 10.1152/physiolgenomics.00012.2017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
187 Dali-Youcef N, Mecili M, Ricci R, Andrès E. Metabolic inflammation: connecting obesity and insulin resistance. Ann Med 2013;45:242-53. [PMID: 22834949 DOI: 10.3109/07853890.2012.705015] [Cited by in Crossref: 99] [Cited by in F6Publishing: 91] [Article Influence: 9.9] [Reference Citation Analysis]
188 Macpherson AJ, McCoy KD. Standardised animal models of host microbial mutualism. Mucosal Immunol 2015;8:476-86. [PMID: 25492472 DOI: 10.1038/mi.2014.113] [Cited by in Crossref: 83] [Cited by in F6Publishing: 76] [Article Influence: 10.4] [Reference Citation Analysis]
189 Svistunov AA, Osadchuk MA, Kireeva NV, Hudarova AA, Achkasov EE. NSAID-induced enteropathy: the current state of the problem. Ter Arkh 2018;90:95-100. [PMID: 30701943 DOI: 10.26442/terarkh201890895-100] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
190 Suppli MP, Bagger JI, Lelouvier B, Broha A, Demant M, Kønig MJ, Strandberg C, Lund A, Vilsbøll T, Knop FK. Hepatic microbiome in healthy lean and obese humans. JHEP Rep 2021;3:100299. [PMID: 34169247 DOI: 10.1016/j.jhepr.2021.100299] [Reference Citation Analysis]
191 Ganz M, Szabo G. Immune and inflammatory pathways in NASH. Hepatol Int. 2013;7 Suppl 2:771-781. [PMID: 24587847 DOI: 10.1007/s12072-013-9468-6] [Cited by in Crossref: 104] [Cited by in F6Publishing: 100] [Article Influence: 11.6] [Reference Citation Analysis]
192 Hartmann P, Schnabl B. New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease. Semin Liver Dis 2021;41:87-102. [PMID: 33957682 DOI: 10.1055/s-0040-1719174] [Reference Citation Analysis]
193 Cremonese C, Schierwagen R, Uschner FE, Torres S, Tyc O, Ortiz C, Schulz M, Queck A, Kristiansen G, Bader M, Sauerbruch T, Weiskirchen R, Walther T, Trebicka J, Klein S. Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats. Int J Mol Sci 2020;21:E3308. [PMID: 32392802 DOI: 10.3390/ijms21093308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
194 Raselli T, Hearn T, Wyss A, Atrott K, Peter A, Frey-Wagner I, Spalinger MR, Maggio EM, Sailer AW, Schmitt J, Schreiner P, Moncsek A, Mertens J, Scharl M, Griffiths WJ, Bueter M, Geier A, Rogler G, Wang Y, Misselwitz B. Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis. J Lipid Res 2019;60:1270-83. [PMID: 31113816 DOI: 10.1194/jlr.M093229] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
195 Boursier J, Diehl AM. Implication of gut microbiota in nonalcoholic fatty liver disease. PLoS Pathog. 2015;11:e1004559. [PMID: 25625278 DOI: 10.1371/journal.ppat.1004559] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 10.3] [Reference Citation Analysis]
196 Omer E, Atassi H. The Microbiome That Shapes Us: Can It Cause Obesity? Curr Gastroenterol Rep 2017;19. [DOI: 10.1007/s11894-017-0600-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
197 Prada PO, Saad MJ. Tyrosine kinase inhibitors as novel drugs for the treatment of diabetes. Expert Opin Investig Drugs 2013;22:751-63. [PMID: 23705634 DOI: 10.1517/13543784.2013.802768] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
198 Wang ZB, Xin SS, Ding LN, Ding WY, Hou YL, Liu CQ, Zhang XD. The Potential Role of Probiotics in Controlling Overweight/Obesity and Associated Metabolic Parameters in Adults: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2019;2019:3862971. [PMID: 31118956 DOI: 10.1155/2019/3862971] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
199 Pan X, Kaminga AC, Liu A, Wen SW, Luo M, Luo J. Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease. Front Cell Infect Microbiol 2021;11:683743. [PMID: 34778099 DOI: 10.3389/fcimb.2021.683743] [Reference Citation Analysis]
200 Du H, Zhao A, Wang Q, Yang X, Ren D. Supplementation of Inulin with Various Degree of Polymerization Ameliorates Liver Injury and Gut Microbiota Dysbiosis in High Fat-Fed Obese Mice. J Agric Food Chem 2020;68:779-87. [DOI: 10.1021/acs.jafc.9b06571] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
201 Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E. Bile acids in glucose metabolism in health and disease. J Exp Med 2018;215:383-96. [PMID: 29339445 DOI: 10.1084/jem.20171965] [Cited by in Crossref: 127] [Cited by in F6Publishing: 118] [Article Influence: 31.8] [Reference Citation Analysis]
202 Lo BC, Chen GY, Núñez G, Caruso R. Gut microbiota and systemic immunity in health and disease. Int Immunol 2021;33:197-209. [PMID: 33367688 DOI: 10.1093/intimm/dxaa079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
203 Murphy AJ, Kraakman MJ, Kammoun HL, Dragoljevic D, Lee MK, Lawlor KE, Wentworth JM, Vasanthakumar A, Gerlic M, Whitehead LW, DiRago L, Cengia L, Lane RM, Metcalf D, Vince JE, Harrison LC, Kallies A, Kile BT, Croker BA, Febbraio MA, Masters SL. IL-18 Production from the NLRP1 Inflammasome Prevents Obesity and Metabolic Syndrome. Cell Metab 2016;23:155-64. [PMID: 26603191 DOI: 10.1016/j.cmet.2015.09.024] [Cited by in Crossref: 89] [Cited by in F6Publishing: 85] [Article Influence: 12.7] [Reference Citation Analysis]
204 Chassaing B, Raja SM, Lewis JD, Srinivasan S, Gewirtz AT. Colonic Microbiota Encroachment Correlates With Dysglycemia in Humans. Cell Mol Gastroenterol Hepatol 2017;4:205-21. [PMID: 28649593 DOI: 10.1016/j.jcmgh.2017.04.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 9.8] [Reference Citation Analysis]
205 Singh RK, Wheildon N, Ishikawa S. Food Additive P-80 Impacts Mouse Gut Microbiota Promoting Intestinal Inflammation, Obesity and Liver Dysfunction. SOJ Microbiol Infect Dis 2016;4. [PMID: 27430014 DOI: 10.15226/sojmid/4/1/00148] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
206 Trivedi I, Rinella ME. NAFLD and Cardiovascular Disease: Can the Real Association Be Determined? Curr Hepatology Rep 2014;13:130-41. [DOI: 10.1007/s11901-014-0231-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
207 Grainger J, Daw R, Wemyss K. Systemic instruction of cell-mediated immunity by the intestinal microbiome. F1000Res 2018;7:F1000 Faculty Rev-1910. [PMID: 30631436 DOI: 10.12688/f1000research.14633.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
208 Giorgio V, Miele L, Principessa L, Ferretti F, Villa MP, Negro V, Grieco A, Alisi A, Nobili V. Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity. Dig Liver Dis. 2014;46:556-560. [PMID: 24631029 DOI: 10.1016/j.dld.2014.02.010] [Cited by in Crossref: 98] [Cited by in F6Publishing: 95] [Article Influence: 12.3] [Reference Citation Analysis]
209 Chassaing B, Gewirtz AT. Has provoking microbiota aggression driven the obesity epidemic? Bioessays 2016;38:122-8. [PMID: 26749135 DOI: 10.1002/bies.201500116] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
210 Chen G, Ni Y, Nagata N, Xu L, Ota T. Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease. Int J Mol Sci. 2016;17:1379. [PMID: 27563875 DOI: 10.3390/ijms17091379] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
211 Li K, Dan Z, Gesang L, Wang H, Zhou Y, Du Y, Ren Y, Shi Y, Nie Y. Comparative Analysis of Gut Microbiota of Native Tibetan and Han Populations Living at Different Altitudes. PLoS One 2016;11:e0155863. [PMID: 27232599 DOI: 10.1371/journal.pone.0155863] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
212 Osawa Y, Kojika E, Hayashi Y, Kimura M, Nishikawa K, Yoshio S, Doi H, Kanto T, Kimura K. Tumor necrosis factor-α-mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice. Hepatol Commun 2018;2:407-20. [PMID: 29619419 DOI: 10.1002/hep4.1158] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
213 Compan V, Martín-Sánchez F, Baroja-Mazo A, López-Castejón G, Gomez AI, Verkhratsky A, Brough D, Pelegrín P. Apoptosis-associated speck-like protein containing a CARD forms specks but does not activate caspase-1 in the absence of NLRP3 during macrophage swelling. J Immunol 2015;194:1261-73. [PMID: 25552542 DOI: 10.4049/jimmunol.1301676] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
214 Kriss M, Hazleton KZ, Nusbacher NM, Martin CG, Lozupone CA. Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery. Curr Opin Microbiol. 2018;44:34-40. [PMID: 30036705 DOI: 10.1016/j.mib.2018.07.003] [Cited by in Crossref: 105] [Cited by in F6Publishing: 96] [Article Influence: 26.3] [Reference Citation Analysis]
215 Chu H, Williams B, Schnabl B. Gut microbiota, fatty liver disease, and hepatocellular carcinoma. Liver Res. 2018;2:43-51. [PMID: 30416839 DOI: 10.1016/j.livres.2017.11.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
216 He Q, Zhang Y, Ma D, Zhang W, Zhang H. Lactobacillus casei Zhang exerts anti-obesity effect to obese glut1 and gut-specific-glut1 knockout mice via gut microbiota modulation mediated different metagenomic pathways. Eur J Nutr 2022. [PMID: 34984487 DOI: 10.1007/s00394-021-02764-0] [Reference Citation Analysis]
217 Lieber AD, Beier UH, Xiao H, Wilkins BJ, Jiao J, Li XS, Schugar RC, Strauch CM, Wang Z, Brown JM, Hazen SL, Bokulich NA, Ruggles KV, Akimova T, Hancock WW, Blaser MJ. Loss of HDAC6 alters gut microbiota and worsens obesity. FASEB J 2019;33:1098-109. [PMID: 30102568 DOI: 10.1096/fj.201701586R] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
218 Arriola Benitez PC, Pesce Viglietti AI, Gomes MTR, Oliveira SC, Quarleri JF, Giambartolomei GH, Delpino MV. Brucella abortus Infection Elicited Hepatic Stellate Cell-Mediated Fibrosis Through Inflammasome-Dependent IL-1β Production. Front Immunol 2019;10:3036. [PMID: 32038610 DOI: 10.3389/fimmu.2019.03036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
219 Ma J, Li H. The Role of Gut Microbiota in Atherosclerosis and Hypertension. Front Pharmacol 2018;9:1082. [PMID: 30319417 DOI: 10.3389/fphar.2018.01082] [Cited by in Crossref: 92] [Cited by in F6Publishing: 77] [Article Influence: 23.0] [Reference Citation Analysis]
220 Da Silva L, Godejohann M, Martin FP, Collino S, Bürkle A, Moreno-Villanueva M, Bernhardt J, Toussaint O, Grubeck-Loebenstein B, Gonos ES, Sikora E, Grune T, Breusing N, Franceschi C, Hervonen A, Spraul M, Moco S. High-resolution quantitative metabolome analysis of urine by automated flow injection NMR. Anal Chem 2013;85:5801-9. [PMID: 23718684 DOI: 10.1021/ac4004776] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
221 Ma Y, Chen K, Lv L, Wu S, Guo Z. Ferulic acid ameliorates nonalcoholic fatty liver disease and modulates the gut microbiota composition in high-fat diet fed ApoE-/- mice. Biomed Pharmacother 2019;113:108753. [PMID: 30856537 DOI: 10.1016/j.biopha.2019.108753] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
222 Bertoletti A, Hong M. Age-Dependent Immune Events during HBV Infection from Birth to Adulthood: An Alternative Interpretation. Front Immunol. 2014;5:441. [PMID: 25295036 DOI: 10.3389/fimmu.2014.00441] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
223 Liu Z, Cao AT, Cong Y. Microbiota regulation of inflammatory bowel disease and colorectal cancer. Semin Cancer Biol. 2013;23:543-552. [PMID: 24071482 DOI: 10.1016/j.semcancer.2013.09.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
224 Betrapally NS, Gillevet PM, Bajaj JS. Gut microbiome and liver disease. Transl Res. 2017;179:49-59. [PMID: 27477080 DOI: 10.1016/j.trsl.2016.07.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 7.2] [Reference Citation Analysis]
225 Norris GH, Jiang C, Ryan J, Porter CM, Blesso CN. Milk sphingomyelin improves lipid metabolism and alters gut microbiota in high fat diet-fed mice. The Journal of Nutritional Biochemistry 2016;30:93-101. [DOI: 10.1016/j.jnutbio.2015.12.003] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 13.7] [Reference Citation Analysis]
226 Naka S, Nomura R, Takashima Y, Okawa R, Ooshima T, Nakano K. A specific Streptococcus mutans strain aggravates non-alcoholic fatty liver disease. Oral Dis 2014;20:700-6. [PMID: 25360469 DOI: 10.1111/odi.12191] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
227 Seth RK, Kimono D, Alhasson F, Sarkar S, Albadrani M, Lasley SK, Horner R, Janulewicz P, Nagarkatti M, Nagarkatti P, Sullivan K, Chatterjee S. Increased butyrate priming in the gut stalls microbiome associated-gastrointestinal inflammation and hepatic metabolic reprogramming in a mouse model of Gulf War Illness. Toxicol Appl Pharmacol 2018;350:64-77. [PMID: 29751049 DOI: 10.1016/j.taap.2018.05.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
228 Johnson AM, Olefsky JM. The origins and drivers of insulin resistance. Cell. 2013;152:673-684. [PMID: 23415219 DOI: 10.1016/j.cell.2013.01.041] [Cited by in Crossref: 378] [Cited by in F6Publishing: 356] [Article Influence: 42.0] [Reference Citation Analysis]
229 Benetti E, Chiazza F, Patel NS, Collino M. The NLRP3 Inflammasome as a novel player of the intercellular crosstalk in metabolic disorders. Mediators Inflamm. 2013;2013:678627. [PMID: 23843683 DOI: 10.1155/2013/678627] [Cited by in Crossref: 54] [Cited by in F6Publishing: 65] [Article Influence: 6.0] [Reference Citation Analysis]
230 Org E, Parks BW, Joo JW, Emert B, Schwartzman W, Kang EY, Mehrabian M, Pan C, Knight R, Gunsalus R, Drake TA, Eskin E, Lusis AJ. Genetic and environmental control of host-gut microbiota interactions. Genome Res 2015;25:1558-69. [PMID: 26260972 DOI: 10.1101/gr.194118.115] [Cited by in Crossref: 181] [Cited by in F6Publishing: 153] [Article Influence: 25.9] [Reference Citation Analysis]
231 Schroeder BO, Bäckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med 2016;22:1079-89. [DOI: 10.1038/nm.4185] [Cited by in Crossref: 504] [Cited by in F6Publishing: 477] [Article Influence: 84.0] [Reference Citation Analysis]
232 Ringling RE, Gastecki ML, Woodford ML, Lum-Naihe KJ, Grant RW, Pulakat L, Vieira-Potter VJ, Padilla J. Loss of Nlrp3 Does Not Protect Mice from Western Diet-Induced Adipose Tissue Inflammation and Glucose Intolerance. PLoS One 2016;11:e0161939. [PMID: 27583382 DOI: 10.1371/journal.pone.0161939] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
233 Altamirano-barrera A, Uribe M, Chávez-tapia NC, Nuño-lámbarri N. The role of the gut microbiota in the pathology and prevention of liver disease. The Journal of Nutritional Biochemistry 2018;60:1-8. [DOI: 10.1016/j.jnutbio.2018.03.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
234 Grivennikov SI. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol. 2013;35:229-244. [PMID: 23161445 DOI: 10.1007/s00281-012-0352-6] [Cited by in Crossref: 291] [Cited by in F6Publishing: 277] [Article Influence: 29.1] [Reference Citation Analysis]
235 Lau LHS, Wong SH. Microbiota, Obesity and NAFLD. Adv Exp Med Biol. 2018;1061:111-125. [PMID: 29956210 DOI: 10.1007/978-981-10-8684-7_9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
236 Bird L. Gut microbiota influences liver disease. Nat Rev Immunol 2012;12:153. [PMID: 22343570 DOI: 10.1038/nri3177] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
237 Dou JP, Han ZY, Liu F, Cheng Z, Yu X, Yu J, Liang P. Beneficial body mass index to enhance survival outcomes in patients with early-stage hepatocellular carcinoma following microwave ablation treatment. Int J Hyperthermia 2020;37:110-8. [PMID: 31969030 DOI: 10.1080/02656736.2020.1712482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Aller MA, Arias N, Peral I, García-Higarza S, Arias JL, Arias J. Embrionary way to create a fatty liver in portal hypertension. World J Gastrointest Pathophysiol 2017; 8(2): 39-50 [PMID: 28573066 DOI: 10.4291/wjgp.v8.i2.39] [Reference Citation Analysis]
239 Zheng D, Kern L, Elinav E. The NLRP6 inflammasome. Immunology 2021;162:281-9. [PMID: 33314083 DOI: 10.1111/imm.13293] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
240 Wani K, AlHarthi H, Alghamdi A, Sabico S, Al-Daghri NM. Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders. Int J Environ Res Public Health 2021;18:E511. [PMID: 33435142 DOI: 10.3390/ijerph18020511] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
241 Endo H, Niioka M, Kobayashi N, Tanaka M, Watanabe T. Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis. PLoS One. 2013;8:e63388. [PMID: 23696823 DOI: 10.1371/journal.pone.0063388] [Cited by in Crossref: 183] [Cited by in F6Publishing: 176] [Article Influence: 20.3] [Reference Citation Analysis]
242 Dfanmica H. Obesity and Cancer: Concepts and Challenges. Indian Assoc Surg Oncol. 2015;. [PMID: 27081257 DOI: 10.1007/s13193-015-0483-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
243 Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BA, Forslund K, Hildebrand F, Prifti E, Falony G. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535:376-381. [PMID: 27409811 DOI: 10.1038/nature18646] [Cited by in Crossref: 814] [Cited by in F6Publishing: 727] [Article Influence: 135.7] [Reference Citation Analysis]
244 Wu X, Dong L, Lin X, Li J. Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease. Front Immunol 2017;8:1728. [PMID: 29312290 DOI: 10.3389/fimmu.2017.01728] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 8.6] [Reference Citation Analysis]
245 Kim EH, Park P. Globular adiponectin protects rat hepatocytes against acetaminophen-induced cell death via modulation of the inflammasome activation and ER stress: Critical role of autophagy induction. Biochemical Pharmacology 2018;154:278-92. [DOI: 10.1016/j.bcp.2018.05.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
246 Bansal A, Henao-Mejia J, Simmons RA. Immune System: An Emerging Player in Mediating Effects of Endocrine Disruptors on Metabolic Health. Endocrinology 2018;159:32-45. [PMID: 29145569 DOI: 10.1210/en.2017-00882] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 12.8] [Reference Citation Analysis]
247 Huang EY, Devkota S, Moscoso D, Chang EB, Leone VA. The role of diet in triggering human inflammatory disorders in the modern age. Microbes Infect. 2013;15:765-774. [PMID: 23876436 DOI: 10.1016/j.micinf.2013.07.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
248 Winer DA, Luck H, Tsai S, Winer S. The Intestinal Immune System in Obesity and Insulin Resistance. Cell Metab. 2016;23:413-426. [PMID: 26853748 DOI: 10.1016/j.cmet.2016.01.003] [Cited by in Crossref: 202] [Cited by in F6Publishing: 189] [Article Influence: 33.7] [Reference Citation Analysis]
249 Brandl K, Schnabl B. Intestinal microbiota and nonalcoholic steatohepatitis. Curr Opin Gastroenterol 2017;33:128-33. [PMID: 28257306 DOI: 10.1097/MOG.0000000000000349] [Cited by in Crossref: 70] [Cited by in F6Publishing: 36] [Article Influence: 14.0] [Reference Citation Analysis]
250 Carvalho BM, Guadagnini D, Tsukumo DML, Schenka AA, Latuf-Filho P, Vassallo J, Dias JC, Kubota LT, Carvalheira JBC, Saad MJA. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 2012;55:2823-34. [PMID: 22828956 DOI: 10.1007/s00125-012-2648-4] [Cited by in Crossref: 196] [Cited by in F6Publishing: 177] [Article Influence: 19.6] [Reference Citation Analysis]
251 Yu Y, Chen D, Zhao Y, Zhu J, Dong X. Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice. Int J Immunopathol Pharmacol 2021;35:20587384211036819. [PMID: 34399601 DOI: 10.1177/20587384211036819] [Reference Citation Analysis]
252 Putignani L, Del Chierico F, Petrucca A, Vernocchi P, Dallapiccola B. The human gut microbiota: a dynamic interplay with the host from birth to senescence settled during childhood. Pediatr Res. 2014;76:2-10. [PMID: 24732106 DOI: 10.1038/pr.2014.49] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 15.1] [Reference Citation Analysis]
253 Li TT, Liu YY, Wan XZ, Huang ZR, Liu B, Zhao C. Regulatory Efficacy of the Polyunsaturated Fatty Acids from Microalgae Spirulina platensis on Lipid Metabolism and Gut Microbiota in High-Fat Diet Rats. Int J Mol Sci 2018;19:E3075. [PMID: 30304774 DOI: 10.3390/ijms19103075] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
254 Qu H, Yu H, Gu R, Chen D, Chen X, Huang Y, Xi W, Huang Y. Proteomics for studying the effects of L. rhamnosus LV108 against non-alcoholic fatty liver disease in rats. RSC Adv 2018;8:38517-28. [DOI: 10.1039/c8ra06771f] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
255 Rosenbaum JT, Lin P, Asquith M, Costello ME, Kenna TJ, Brown MA. Does the microbiome play a causal role in spondyloarthritis? Clin Rheumatol 2014;33:763-7. [PMID: 24810703 DOI: 10.1007/s10067-014-2664-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
256 Yeo YH, Lai YC. Redox Regulation of Metabolic Syndrome: Recent Developments in Skeletal Muscle Insulin Resistance and Non-alcoholic Fatty Liver Disease (NAFLD). Curr Opin Physiol 2019;9:79-86. [PMID: 32818162 DOI: 10.1016/j.cophys.2019.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
257 Zechner EL. Inflammatory disease caused by intestinal pathobionts. Current Opinion in Microbiology 2017;35:64-9. [DOI: 10.1016/j.mib.2017.01.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
258 Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, Guy CD, Seed PC, Rawls JF, David LA. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology. 2016;63:764-775. [PMID: 26600078 DOI: 10.1002/hep.28356 doi: 10.1002/hep.28356] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
259 Gao Y, Tian R, Liu H, Xue H, Zhang R, Han S, Ji L, Huang W, Zhan J, You Y. Research progress on intervention effect and mechanism of protocatechuic acid on nonalcoholic fatty liver disease. Crit Rev Food Sci Nutr 2021;:1-23. [PMID: 34142875 DOI: 10.1080/10408398.2021.1939265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
260 Hundertmark J, Krenkel O, Tacke F. Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease. Front Immunol 2018;9:2418. [PMID: 30405618 DOI: 10.3389/fimmu.2018.02418] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
261 Friedman SL. Liver fibrosis in 2012: Convergent pathways that cause hepatic fibrosis in NASH. Nat Rev Gastroenterol Hepatol. 2013;10:71-72. [PMID: 23296246 DOI: 10.1038/nrgastro.2012.256] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
262 Hara T, Kashihara D, Ichimura A, Kimura I, Tsujimoto G, Hirasawa A. Role of free fatty acid receptors in the regulation of energy metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2014;1841:1292-300. [DOI: 10.1016/j.bbalip.2014.06.002] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 12.6] [Reference Citation Analysis]
263 Henao-Mejia J, Elinav E, Strowig T, Flavell RA. Inflammasomes: far beyond inflammation. Nat Immunol. 2012;13:321-324. [PMID: 22430784 DOI: 10.1038/ni.2257] [Cited by in Crossref: 124] [Cited by in F6Publishing: 112] [Article Influence: 12.4] [Reference Citation Analysis]
264 Sutti S, Albano E. Adaptive immunity: an emerging player in the progression of NAFLD. Nat Rev Gastroenterol Hepatol 2020;17:81-92. [PMID: 31605031 DOI: 10.1038/s41575-019-0210-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 17.0] [Reference Citation Analysis]
265 Liu W, Bai F, Wang H, Liang Y, Du X, Liu C, Cai D, Peng J, Zhong G, Liang X, Ma C, Gao L. Tim-4 Inhibits NLRP3 Inflammasome via the LKB1/AMPKα Pathway in Macrophages. J I 2019;203:990-1000. [DOI: 10.4049/jimmunol.1900117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
266 Mendrick DL, Diehl AM, Topor LS, Dietert RR, Will Y, La Merrill MA, Bouret S, Varma V, Hastings KL, Schug TT, Emeigh Hart SG, Burleson FG. Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic. Toxicol Sci 2018;162:36-42. [PMID: 29106690 DOI: 10.1093/toxsci/kfx233] [Cited by in Crossref: 57] [Cited by in F6Publishing: 40] [Article Influence: 19.0] [Reference Citation Analysis]
267 Han C, Guo N, Bu Y, Peng Y, Li X, Ma X, Yang M, Jia X, Zhang J, Liu X, Yu K, Wang C. Intestinal microbiota and antibiotic-associated acute gastrointestinal injury in sepsis mice. Aging (Albany NY) 2021;13:10099-111. [PMID: 33818419 DOI: 10.18632/aging.202768] [Reference Citation Analysis]
268 Sundaram V, Morgan TR. Will Studies in Nonalcoholic Steatohepatitis Help Manage Alcoholic Steatohepatitis? Clinics in Liver Disease 2019;23:157-65. [DOI: 10.1016/j.cld.2018.09.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
269 Thaiss CA, Levy M, Suez J, Elinav E. The interplay between the innate immune system and the microbiota. Curr Opin Immunol 2014;26:41-8. [PMID: 24556399 DOI: 10.1016/j.coi.2013.10.016] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 8.6] [Reference Citation Analysis]
270 Skonieczna-Żydecka K, Łoniewski I, Misera A, Stachowska E, Maciejewska D, Marlicz W, Galling B. Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome. Psychopharmacology (Berl) 2019;236:1491-512. [PMID: 30460516 DOI: 10.1007/s00213-018-5102-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 8.5] [Reference Citation Analysis]
271 Ding S, Yuan C, Si B, Wang M, Da S, Bai L, Wu W. Combined effects of ambient particulate matter exposure and a high-fat diet on oxidative stress and steatohepatitis in mice. PLoS One 2019;14:e0214680. [PMID: 30921449 DOI: 10.1371/journal.pone.0214680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
272 Bieghs V, Trautwein C. Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr. 2014;3:377-385. [PMID: 25568861 DOI: 10.3978/j.issn.2304-3881.2014.12.04] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
273 Castillo-Castro C, Martagón-Rosado AJ, Ortiz-Lopez R, Garrido-Treviño LF, Villegas-Albo M, Bosques-Padilla FJ. Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome. World J Hepatol 2021; 13(11): 1494-1511 [PMID: 34904026 DOI: 10.4254/wjh.v13.i11.1494] [Reference Citation Analysis]
274 Kang L, Li P, Wang D, Wang T, Hao D, Qu X. Alterations in intestinal microbiota diversity, composition, and function in patients with sarcopenia. Sci Rep 2021;11:4628. [PMID: 33633246 DOI: 10.1038/s41598-021-84031-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
275 Velázquez-Miranda E, Díaz-Muñoz M, Vázquez-Cuevas FG. Purinergic signaling in hepatic disease. Purinergic Signal 2019;15:477-89. [PMID: 31576486 DOI: 10.1007/s11302-019-09680-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
276 Ren G, Fan X, Teng C, Li Y, Everaert N, Blecker C. The Beneficial Effect of Coarse Cereals on Chronic Diseases through Regulating Gut Microbiota. Foods 2021;10:2891. [PMID: 34829172 DOI: 10.3390/foods10112891] [Reference Citation Analysis]
277 Li X, Watanabe K, Kimura I. Gut Microbiota Dysbiosis Drives and Implies Novel Therapeutic Strategies for Diabetes Mellitus and Related Metabolic Diseases. Front Immunol. 2017;8:1882. [PMID: 29326727 DOI: 10.3389/fimmu.2017.01882] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 13.8] [Reference Citation Analysis]
278 Neto AG, Whitaker A, Pei Z. Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma. Semin Oncol. 2016;43:86-96. [PMID: 26970127 DOI: 10.1053/j.seminoncol.2015.09.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
279 Dattaroy D, Seth RK, Das S, Alhasson F, Chandrashekaran V, Michelotti G, Fan D, Nagarkatti M, Nagarkatti P, Diehl AM, Chatterjee S. Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation. Am J Physiol Gastrointest Liver Physiol. 2016;310:G510-G525. [PMID: 26718771 DOI: 10.1152/ajpgi.00259.2015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
280 Sanyal AJ. Novel therapeutic targets for steatohepatitis. Clinics and Research in Hepatology and Gastroenterology 2015;39:S46-50. [DOI: 10.1016/j.clinre.2015.05.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
281 Nicolson GL, Ash ME. Membrane Lipid Replacement for chronic illnesses, aging and cancer using oral glycerolphospholipid formulations with fructooligosaccharides to restore phospholipid function in cellular membranes, organelles, cells and tissues. Biochim Biophys Acta Biomembr 2017;1859:1704-24. [PMID: 28432031 DOI: 10.1016/j.bbamem.2017.04.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 5.2] [Reference Citation Analysis]
282 Marra F, Svegliati-Baroni G. Lipotoxicity and the gut-liver axis in NASH pathogenesis. J Hepatol. 2018;68:280-295. [PMID: 29154964 DOI: 10.1016/j.jhep.2017.11.014] [Cited by in Crossref: 257] [Cited by in F6Publishing: 247] [Article Influence: 51.4] [Reference Citation Analysis]
283 Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, Guy CD, Seed PC, Rawls JF, David LA, Hunault G, Oberti F, Calès P, Diehl AM. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 2016;63:764-75. [PMID: 26600078 DOI: 10.1002/hep.28356] [Cited by in Crossref: 512] [Cited by in F6Publishing: 488] [Article Influence: 85.3] [Reference Citation Analysis]
284 de Zoete MR, Palm NW, Zhu S, Flavell RA. Inflammasomes. Cold Spring Harb Perspect Biol. 2014;6:a016287. [PMID: 25324215 DOI: 10.1101/cshperspect.a016287] [Cited by in Crossref: 172] [Cited by in F6Publishing: 170] [Article Influence: 21.5] [Reference Citation Analysis]
285 DeSantis DA, Ko CW, Liu Y, Liu X, Hise AG, Nunez G, Croniger CM. Alcohol-induced liver injury is modulated by Nlrp3 and Nlrc4 inflammasomes in mice. Mediators Inflamm. 2013;2013:751374. [PMID: 24453428 DOI: 10.1155/2013/751374] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
286 Medina-Reyes EI, Delgado-Buenrostro NL, Díaz-Urbina D, Rodríguez-Ibarra C, Déciga-Alcaraz A, González MI, Reyes JL, Villamar-Duque TE, Flores-Sánchez ML, Hernández-Pando R, Mancilla-Díaz JM, Chirino YI, Pedraza-Chaverri J. Food-grade titanium dioxide (E171) induces anxiety, adenomas in colon and goblet cells hyperplasia in a regular diet model and microvesicular steatosis in a high fat diet model. Food Chem Toxicol 2020;146:111786. [PMID: 33038453 DOI: 10.1016/j.fct.2020.111786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
287 Lee SY, Sung JH. Gut-liver on a chip toward an in vitro model of hepatic steatosis. Biotechnol Bioeng 2018;115:2817-27. [PMID: 29981260 DOI: 10.1002/bit.26793] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
288 Yao H, Wan JY, Wang CZ, Li L, Wang J, Li Y, Huang WH, Zeng J, Wang Q, Yuan CS. Bibliometric analysis of research on the role of intestinal microbiota in obesity. PeerJ. 2018;6:e5091. [PMID: 29967745 DOI: 10.7717/peerj.5091] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
289 Bruneau A, Hundertmark J, Guillot A, Tacke F. Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases. Front Med (Lausanne) 2021;8:725390. [PMID: 34650994 DOI: 10.3389/fmed.2021.725390] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
290 Yang X, Feng H, Zhan X, Zhang C, Cui R, Zhong L, Ying S, Chen Z. Early-life vancomycin treatment promotes airway inflammation and impairs microbiome homeostasis. Aging (Albany NY) 2019;11:2071-81. [PMID: 30981206 DOI: 10.18632/aging.101901] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
291 Dewdney B, Roberts A, Qiao L, George J, Hebbard L. A Sweet Connection? Fructose's Role in Hepatocellular Carcinoma. Biomolecules 2020;10:E496. [PMID: 32218179 DOI: 10.3390/biom10040496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
292 Brandl K, Schnabl B. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease? Expert Rev Gastroenterol Hepatol. 2015;9:1069-1076. [PMID: 26088524 DOI: 10.1586/17474124.2015.1057122] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
293 Wang T, Pan W, Hu J, Zhang Z, Li G, Liang Y. Circular RNAs in Metabolic Diseases. Adv Exp Med Biol 2018;1087:275-85. [PMID: 30259374 DOI: 10.1007/978-981-13-1426-1_22] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
294 Mardinoglu A, Shoaie S, Bergentall M, Ghaffari P, Zhang C, Larsson E, Bäckhed F, Nielsen J. The gut microbiota modulates host amino acid and glutathione metabolism in mice. Mol Syst Biol 2015;11:834. [PMID: 26475342 DOI: 10.15252/msb.20156487] [Cited by in Crossref: 182] [Cited by in F6Publishing: 163] [Article Influence: 26.0] [Reference Citation Analysis]
295 Man SM. Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis. Nat Rev Gastroenterol Hepatol 2018;15:721-37. [PMID: 30185915 DOI: 10.1038/s41575-018-0054-1] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 23.7] [Reference Citation Analysis]
296 Weir V, Reddy KR. Nonpharmacologic Management of Hepatic Encephalopathy. Clinics in Liver Disease 2020;24:243-61. [DOI: 10.1016/j.cld.2020.01.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
297 Darisipudi MN, Knauf F. An update on the role of the inflammasomes in the pathogenesis of kidney diseases. Pediatr Nephrol 2016;31:535-44. [PMID: 26178650 DOI: 10.1007/s00467-015-3153-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
298 Sun WW, ShangGuan T, Zhu P, Li HK, Jiang M, Yang P, Li LY, Zhang ZH. Role of hepatic neuropeptide Y-Y1 receptors in a methionine-choline-deficient model of non-alcoholic steatohepatitis. Life Sci 2020;245:117356. [PMID: 31991181 DOI: 10.1016/j.lfs.2020.117356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
299 Harasymowicz NS, Rashidi N, Savadipour A, Wu CL, Tang R, Bramley J, Buchser W, Guilak F. Single-cell RNA sequencing reveals the induction of novel myeloid and myeloid-associated cell populations in visceral fat with long-term obesity. FASEB J 2021;35:e21417. [PMID: 33566380 DOI: 10.1096/fj.202001970R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
300 Mouries J, Brescia P, Silvestri A, Spadoni I, Sorribas M, Wiest R, Mileti E, Galbiati M, Invernizzi P, Adorini L, Penna G, Rescigno M. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. J Hepatol. 2019;71:1216-1228. [PMID: 31419514 DOI: 10.1016/j.jhep.2019.08.005] [Cited by in Crossref: 103] [Cited by in F6Publishing: 107] [Article Influence: 34.3] [Reference Citation Analysis]
301 Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014;28:1221-1238. [PMID: 24892638 DOI: 10.1210/me.2014-1108] [Cited by in Crossref: 476] [Cited by in F6Publishing: 418] [Article Influence: 59.5] [Reference Citation Analysis]
302 Gingold JA, Zhu D, Lee DF, Kaseb A, Chen J. Genomic Profiling and Metabolic Homeostasis in Primary Liver Cancers. Trends Mol Med. 2018;24:395-411. [PMID: 29530485 DOI: 10.1016/j.molmed.2018.02.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
303 Rotman Y, Sanyal AJ. Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease. Gut. 2017;66:180-190. [PMID: 27646933 DOI: 10.1136/gutjnl-2016-312431] [Cited by in Crossref: 214] [Cited by in F6Publishing: 213] [Article Influence: 35.7] [Reference Citation Analysis]
304 Kim YG, Udayanga KG, Totsuka N, Weinberg JB, Núñez G, Shibuya A. Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂. Cell Host Microbe 2014;15:95-102. [PMID: 24439901 DOI: 10.1016/j.chom.2013.12.010] [Cited by in Crossref: 181] [Cited by in F6Publishing: 163] [Article Influence: 22.6] [Reference Citation Analysis]
305 Ng TM, Kortmann J, Monack DM. Policing the cytosol--bacterial-sensing inflammasome receptors and pathways. Curr Opin Immunol 2013;25:34-9. [PMID: 23261344 DOI: 10.1016/j.coi.2012.11.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
306 Stinkens R, Goossens GH, Jocken JWE, Blaak EE. Targeting fatty acid metabolism to improve glucose metabolism: Targeting fatty acid metabolism. Obes Rev 2015;16:715-57. [DOI: 10.1111/obr.12298] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 11.3] [Reference Citation Analysis]
307 Jovicic N, Jeftic I, Jovanovic I, Radosavljevic G, Arsenijevic N, Lukic ML, Pejnovic N. Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding. PLoS One. 2015;10:e0134089. [PMID: 26218873 DOI: 10.1371/journal.pone.0134089] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 7.9] [Reference Citation Analysis]
308 Morrison M. Looking large, to make more, out of gut metagenomics. Current Opinion in Microbiology 2013;16:630-5. [DOI: 10.1016/j.mib.2013.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
309 Haneklaus M, O'neill LAJ. NLRP3 at the interface of metabolism and inflammation. Immunol Rev 2015;265:53-62. [DOI: 10.1111/imr.12285] [Cited by in Crossref: 139] [Cited by in F6Publishing: 139] [Article Influence: 19.9] [Reference Citation Analysis]
310 Belinchón-Romero I, Bellot P, Romero-Pérez D, Herraiz-Romero I, Marco F, Frances R, Ramos-Rincón JM. Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients. Sci Rep 2021;11:8593. [PMID: 33883616 DOI: 10.1038/s41598-021-88043-8] [Reference Citation Analysis]
311 Calzadilla Bertot L, Adams LA. The Natural Course of Non-Alcoholic Fatty Liver Disease. Int J Mol Sci. 2016;17. [PMID: 27213358 DOI: 10.3390/ijms17050774] [Cited by in Crossref: 248] [Cited by in F6Publishing: 242] [Article Influence: 41.3] [Reference Citation Analysis]
312 Woloszynek S, Pastor S, Mell JC, Nandi N, Sokhansanj B, Rosen GL. Engineering Human Microbiota: Influencing Cellular and Community Dynamics for Therapeutic Applications. Int Rev Cell Mol Biol 2016;324:67-124. [PMID: 27017007 DOI: 10.1016/bs.ircmb.2016.01.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
313 Vitkov L, Muñoz LE, Schoen J, Knopf J, Schauer C, Minnich B, Herrmann M, Hannig M. Neutrophils Orchestrate the Periodontal Pocket. Front Immunol 2021;12:788766. [PMID: 34899756 DOI: 10.3389/fimmu.2021.788766] [Reference Citation Analysis]
314 Chen M, Hui S, Lang H, Zhou M, Zhang Y, Kang C, Zeng X, Zhang Q, Yi L, Mi M. SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis. Mol Nutr Food Res 2019;63:e1800612. [PMID: 30525304 DOI: 10.1002/mnfr.201800612] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
315 Ma Y, Liu G, Tang M, Fang J, Jiang H. Epigallocatechin Gallate Can Protect Mice From Acute Stress Induced by LPS While Stabilizing Gut Microbes and Serum Metabolites Levels. Front Immunol 2021;12:640305. [PMID: 33868268 DOI: 10.3389/fimmu.2021.640305] [Reference Citation Analysis]
316 Castaño-Rodríguez N, Mitchell HM, Kaakoush NO. NAFLD, Helicobacter species and the intestinal microbiome. Best Pract Res Clin Gastroenterol 2017;31:657-68. [PMID: 29566909 DOI: 10.1016/j.bpg.2017.09.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
317 Liu S, Murakami E, Nakahara T, Ohya K, Teraoka Y, Makokha GN, Uchida T, Morio K, Fujino H, Ono A, Yamauchi M, Kawaoka T, Miki D, Tsuge M, Hiramatsu A, Abe-Chayama H, Hayes NC, Imamura M, Aikata H, Chayama K. In vitro analysis of hepatic stellate cell activation influenced by transmembrane 6 superfamily 2 polymorphism. Mol Med Rep 2021;23:16. [PMID: 33179077 DOI: 10.3892/mmr.2020.11654] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
318 Zhang Z, Zhou H, Zhou X, Sun J, Liang X, Lv Y, Bai L, Zhang J, Gong P, Liu T, Yi H, Wang J, Zhang L. Lactobacillus casei YRL577 ameliorates markers of non-alcoholic fatty liver and alters expression of genes within the intestinal bile acid pathway. Br J Nutr 2021;125:521-9. [PMID: 32718371 DOI: 10.1017/S0007114520003001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
319 Guan Y, Cao WJ, Zhang ZY. Relationship between gut microbiota and non-alcoholic fatty liver disease. Shijie Huaren Xiaohua Zazhi 2015; 23(36): 5797-5802 [DOI: 10.11569/wcjd.v23.i36.5797] [Reference Citation Analysis]
320 Arumugam MK, Paal MC, Donohue TM Jr, Ganesan M, Osna NA, Kharbanda KK. Beneficial Effects of Betaine: A Comprehensive Review. Biology (Basel) 2021;10:456. [PMID: 34067313 DOI: 10.3390/biology10060456] [Reference Citation Analysis]
321 Zhang Y, Wu B, Zhang H, Ge X, Ying S, Hu M, Li W, Huang Y, Wang L, Chen C, Shan X, Liang G. Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease. J Cell Mol Med 2018;22:936-47. [PMID: 29077272 DOI: 10.1111/jcmm.13395] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
322 Deng Y, Tang D, Hou P, Shen W, Li H, Wang T, Liu R. Dysbiosis of gut microbiota in patients with esophageal cancer. Microb Pathog 2021;150:104709. [PMID: 33378710 DOI: 10.1016/j.micpath.2020.104709] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
323 Zhang Y, Bobe G, Miranda CL, Lowry MB, Hsu VL, Lohr CV, Wong CP, Jump DB, Robinson MM, Sharpton TJ, Maier CS, Stevens JF, Gombart AF. Tetrahydroxanthohumol, a xanthohumol derivative, attenuates high-fat diet-induced hepatic steatosis by antagonizing PPARγ. Elife 2021;10:e66398. [PMID: 34128467 DOI: 10.7554/eLife.66398] [Reference Citation Analysis]
324 Sethi JK, Hotamisligil GS. Metabolic Messengers: tumour necrosis factor. Nat Metab 2021;3:1302-12. [PMID: 34650277 DOI: 10.1038/s42255-021-00470-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
325 Rosenbaum JT, Lin P, Asquith M. The microbiome, HLA, and the pathogenesis of uveitis. Jpn J Ophthalmol 2016;60:1-6. [DOI: 10.1007/s10384-015-0416-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
326 Xu X, Xu P, Ma C, Tang J, Zhang X. Gut microbiota, host health, and polysaccharides. Biotechnol Adv. 2013;31:318-337. [PMID: 23280014 DOI: 10.1016/j.biotechadv.2012.12.009] [Cited by in Crossref: 111] [Cited by in F6Publishing: 105] [Article Influence: 11.1] [Reference Citation Analysis]
327 Ntandja Wandji LC, Gnemmi V, Mathurin P, Louvet A. Combined alcoholic and non-alcoholic steatohepatitis. JHEP Rep 2020;2:100101. [PMID: 32514497 DOI: 10.1016/j.jhepr.2020.100101] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
328 Nowarski R, Jackson R, Gagliani N, de Zoete MR, Palm NW, Bailis W, Low JS, Harman CC, Graham M, Elinav E, Flavell RA. Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis. Cell 2015;163:1444-56. [PMID: 26638073 DOI: 10.1016/j.cell.2015.10.072] [Cited by in Crossref: 239] [Cited by in F6Publishing: 221] [Article Influence: 39.8] [Reference Citation Analysis]
329 Wallace JG, Gohir W, Sloboda DM. The impact of early life gut colonization on metabolic and obesogenic outcomes: what have animal models shown us? J Dev Orig Health Dis 2016;7:15-24. [DOI: 10.1017/s2040174415001518] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
330 Anand G, Zarrinpar A, Loomba R. Targeting Dysbiosis for the Treatment of Liver Disease. Semin Liver Dis. 2016;36:37-47. [PMID: 26870931 DOI: 10.1055/s-0035-1571276] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
331 Xu G, Fu S, Zhan X, Wang Z, Zhang P, Shi W, Qin N, Chen Y, Wang C, Niu M, Guo Y, Wang J, Bai Z, Xiao X. Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90. JCI Insight 2021;6:134601. [PMID: 33350984 DOI: 10.1172/jci.insight.134601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
332 Skeldon AM, Morizot A, Douglas T, Santoro N, Kursawe R, Kozlitina J, Caprio S, Mehal WZ, Saleh M. Caspase-12, but Not Caspase-11, Inhibits Obesity and Insulin Resistance. J Immunol 2016;196:437-47. [PMID: 26582949 DOI: 10.4049/jimmunol.1501529] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
333 Calder PC, Bosco N, Bourdet-sicard R, Capuron L, Delzenne N, Doré J, Franceschi C, Lehtinen MJ, Recker T, Salvioli S, Visioli F. Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition. Ageing Research Reviews 2017;40:95-119. [DOI: 10.1016/j.arr.2017.09.001] [Cited by in Crossref: 163] [Cited by in F6Publishing: 139] [Article Influence: 32.6] [Reference Citation Analysis]
334 Scholz F, Badgley BD, Sadowsky MJ, Kaplan DH. Immune mediated shaping of microflora community composition depends on barrier site. PLoS One 2014;9:e84019. [PMID: 24416190 DOI: 10.1371/journal.pone.0084019] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
335 Ussar S, Griffin NW, Bezy O, Fujisaka S, Vienberg S, Softic S, Deng L, Bry L, Gordon JI, Kahn CR. Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome. Cell Metab 2015;22:516-30. [PMID: 26299453 DOI: 10.1016/j.cmet.2015.07.007] [Cited by in Crossref: 293] [Cited by in F6Publishing: 282] [Article Influence: 41.9] [Reference Citation Analysis]
336 Alí A, Boutjdir M, Aromolaran AS. Cardiolipotoxicity, Inflammation, and Arrhythmias: Role for Interleukin-6 Molecular Mechanisms. Front Physiol 2018;9:1866. [PMID: 30666212 DOI: 10.3389/fphys.2018.01866] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
337 Pang G, Xie J, Chen Q, Hu Z. How functional foods play critical roles in human health. Food Science and Human Wellness 2012;1:26-60. [DOI: 10.1016/j.fshw.2012.10.001] [Cited by in Crossref: 58] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
338 Bartman C, Chong AS, Alegre ML. The influence of the microbiota on the immune response to transplantation. Curr Opin Organ Transplant 2015;20:1-7. [PMID: 25563985 DOI: 10.1097/MOT.0000000000000150] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
339 Nakamura K, Sakuragi N, Takakuwa A, Ayabe T. Paneth cell α-defensins and enteric microbiota in health and disease. Biosci Microbiota Food Health 2016;35:57-67. [PMID: 27200259 DOI: 10.12938/bmfh.2015-019] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 6.9] [Reference Citation Analysis]
340 Zheng T, Yang X, Li W, Wang Q, Chen L, Wu D, Bian F, Xing S, Jin S. Salidroside Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via AMPK-Dependent TXNIP/NLRP3 Pathway. Oxid Med Cell Longev 2018;2018:8597897. [PMID: 30140371 DOI: 10.1155/2018/8597897] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
341 Aw W, Fukuda S. Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach. Semin Immunopathol 2015;37:5-16. [PMID: 25338280 DOI: 10.1007/s00281-014-0456-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
342 Lamkanfi M, Kanneganti TD. The inflammasome: a remote control for metabolic syndrome. Cell Res. 2012;22:1095-1098. [PMID: 22491474 DOI: 10.1038/cr.2012.55] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
343 Cheng C, Tan J, Qian W, Zhang L, Hou X. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction. Life Sci. 2018;209:157-166. [PMID: 30096384 DOI: 10.1016/j.lfs.2018.08.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
344 Amar J, Lange C, Payros G, Garret C, Chabo C, Lantieri O, Courtney M, Marre M, Charles MA, Balkau B, Burcelin R; D.E.S.I.R. Study Group. Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study. PLoS One 2013;8:e54461. [PMID: 23372728 DOI: 10.1371/journal.pone.0054461] [Cited by in Crossref: 120] [Cited by in F6Publishing: 101] [Article Influence: 13.3] [Reference Citation Analysis]
345 Blesl A, Stadlbauer V. The Gut-Liver Axis in Cholestatic Liver Diseases. Nutrients 2021;13:1018. [PMID: 33801133 DOI: 10.3390/nu13031018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
346 Wullaert A, Lamkanfi M, McCoy KD. Defining the Impact of Host Genotypes on Microbiota Composition Requires Meticulous Control of Experimental Variables. Immunity 2018;48:605-7. [PMID: 29669239 DOI: 10.1016/j.immuni.2018.04.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
347 Idalsoaga F, Kulkarni AV, Mousa OY, Arrese M, Arab JP. Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities. Front Med (Lausanne) 2020;7:448. [PMID: 32974366 DOI: 10.3389/fmed.2020.00448] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
348 Jennison E, Byrne CD. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease. Clin Mol Hepatol 2021;27:22-43. [PMID: 33291863 DOI: 10.3350/cmh.2020.0129] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
349 Velloso LA, Folli F, Saad MJ. TLR4 at the Crossroads of Nutrients, Gut Microbiota, and Metabolic Inflammation. Endocr Rev. 2015;36:245-271. [PMID: 25811237 DOI: 10.1210/er.2014-1100] [Cited by in Crossref: 141] [Cited by in F6Publishing: 136] [Article Influence: 20.1] [Reference Citation Analysis]
350 Lv Q, Xu D, Ma J, Wang Y, Yang X, Zhao P, Ma L, Li Z, Yang W, Liu X, Yang G, Xing S. Uric acid drives intestinal barrier dysfunction through TSPO-mediated NLRP3 inflammasome activation. Inflamm Res 2021;70:127-37. [DOI: 10.1007/s00011-020-01409-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
351 Tian X, Sun H, Casbon AJ, Lim E, Francis KP, Hellman J, Prakash A. NLRP3 Inflammasome Mediates Dormant Neutrophil Recruitment following Sterile Lung Injury and Protects against Subsequent Bacterial Pneumonia in Mice. Front Immunol 2017;8:1337. [PMID: 29163464 DOI: 10.3389/fimmu.2017.01337] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
352 Bence KK, Birnbaum MJ. Metabolic drivers of non-alcoholic fatty liver disease. Mol Metab 2021;50:101143. [PMID: 33346069 DOI: 10.1016/j.molmet.2020.101143] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
353 Guicciardi ME, Malhi H, Mott JL, Gores GJ. Apoptosis and necrosis in the liver. Compr Physiol. 2013;3:977-1010. [PMID: 23720337 DOI: 10.1002/cphy.c120020] [Cited by in Crossref: 50] [Cited by in F6Publishing: 102] [Article Influence: 5.6] [Reference Citation Analysis]
354 Wan X, Xu C, Lin Y, Lu C, Li D, Sang J, He H, Liu X, Li Y, Yu C. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 2016;64:925-932. [PMID: 26639394 DOI: 10.1016/j.jhep.2015.11.022] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 10.6] [Reference Citation Analysis]
355 Palm NW, de Zoete MR, Flavell RA. Immune-microbiota interactions in health and disease. Clin Immunol. 2015;159:122-127. [PMID: 26141651 DOI: 10.1016/j.clim.2015.05.014] [Cited by in Crossref: 158] [Cited by in F6Publishing: 135] [Article Influence: 22.6] [Reference Citation Analysis]
356 Pimentel GD, Micheletti TO, Pace F. Nutritional Targets for Modulation of the Microbiota in Obesity: Nutritional Targets for Obesity. Drug Dev Res 2013;74:393-402. [DOI: 10.1002/ddr.21092] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
357 Machado MV, Cortez-Pinto H. Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. Int J Mol Sci. 2016;17:481. [PMID: 27043550 DOI: 10.3390/ijms17040481] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 8.8] [Reference Citation Analysis]
358 Wu S, Liu Y, Jiang P, Xu Y, Zheng W, Song S, Ai C. Effect of sulfate group on sulfated polysaccharides-induced improvement of metabolic syndrome and gut microbiota dysbiosis in high fat diet-fed mice. Int J Biol Macromol 2020;164:2062-72. [PMID: 32768480 DOI: 10.1016/j.ijbiomac.2020.08.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
359 Biedermann L, Rogler G. The intestinal microbiota: its role in health and disease. Eur J Pediatr. 2015;174:151-167. [PMID: 25563215 DOI: 10.1007/s00431-014-2476-2] [Cited by in Crossref: 85] [Cited by in F6Publishing: 70] [Article Influence: 12.1] [Reference Citation Analysis]
360 Saita D, Ferrarese R, Foglieni C, Esposito A, Canu T, Perani L, Ceresola ER, Visconti L, Burioni R, Clementi M, Canducci F. Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation. Sci Rep 2016;6:29353. [PMID: 27383250 DOI: 10.1038/srep29353] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
361 Chen GY. Regulation of the gut microbiome by inflammasomes. Free Radic Biol Med 2017;105:35-40. [PMID: 27845186 DOI: 10.1016/j.freeradbiomed.2016.11.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
362 Niu J, Zhang J, Wei L, Ma X, Zhang W, Nie C. Cottonseed meal fermented by Candida tropical reduces the fat deposition in white-feather broilers through cecum bacteria-host metabolic cross-talk. Appl Microbiol Biotechnol 2020;104:4345-57. [PMID: 32232527 DOI: 10.1007/s00253-020-10538-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
363 Mikami Y, Mizuno S, Nakamoto N, Hayashi A, Sujino T, Sato T, Kamada N, Matsuoka K, Hisamatsu T, Ebinuma H, Hibi T, Yoshimura A, Kanai T. Macrophages and dendritic cells emerge in the liver during intestinal inflammation and predispose the liver to inflammation. PLoS One 2014;9:e84619. [PMID: 24392145 DOI: 10.1371/journal.pone.0084619] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
364 Lassailly G, Caiazzo R, Pattou F, Mathurin P. Perspectives on Treatment for Nonalcoholic Steatohepatitis. Gastroenterology. 2016;150:1835-1848. [PMID: 26971824 DOI: 10.1053/j.gastro.2016.03.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 8.5] [Reference Citation Analysis]
365 Mokhtari Z, Gibson DL, Hekmatdoost A. Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet. Adv Nutr 2017;8:240-52. [PMID: 28298269 DOI: 10.3945/an.116.013151] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 14.0] [Reference Citation Analysis]
366 Ji X, Li L, Lu P, Li X, Tian D, Liu M. NLRP6 exerts a protective role via NF-kB with involvement of CCL20 in a mouse model of alcoholic hepatitis. Biochem Biophys Res Commun 2020;528:485-92. [PMID: 32507279 DOI: 10.1016/j.bbrc.2020.05.171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
367 Kalantar-zadeh K, Berean KJ, Ha N, Chrimes AF, Xu K, Grando D, Ou JZ, Pillai N, Campbell JL, Brkljača R, Taylor KM, Burgell RE, Yao CK, Ward SA, Mcsweeney CS, Muir JG, Gibson PR. A human pilot trial of ingestible electronic capsules capable of sensing different gases in the gut. Nat Electron 2018;1:79-87. [DOI: 10.1038/s41928-017-0004-x] [Cited by in Crossref: 124] [Cited by in F6Publishing: 59] [Article Influence: 31.0] [Reference Citation Analysis]
368 Ko JS. The Intestinal Microbiota and Human Disease. Korean J Gastroenterol 2013;62:85. [DOI: 10.4166/kjg.2013.62.2.85] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
369 Chen C, Liu Q, Liu L, Hu YY, Feng Q. Potential Biological Effects of (-)-Epigallocatechin-3-gallate on the Treatment of Nonalcoholic Fatty Liver Disease. Mol Nutr Food Res 2018;62. [PMID: 28799714 DOI: 10.1002/mnfr.201700483] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
370 Blekhman R, Goodrich JK, Huang K, Sun Q, Bukowski R, Bell JT, Spector TD, Keinan A, Ley RE, Gevers D, Clark AG. Host genetic variation impacts microbiome composition across human body sites. Genome Biol 2015;16:191. [PMID: 26374288 DOI: 10.1186/s13059-015-0759-1] [Cited by in Crossref: 394] [Cited by in F6Publishing: 326] [Article Influence: 56.3] [Reference Citation Analysis]
371 Freigang S, Ampenberger F, Weiss A, Kanneganti TD, Iwakura Y, Hersberger M, Kopf M. Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis. Nat Immunol 2013;14:1045-53. [PMID: 23995233 DOI: 10.1038/ni.2704] [Cited by in Crossref: 205] [Cited by in F6Publishing: 196] [Article Influence: 22.8] [Reference Citation Analysis]
372 Ziegler M, Wallert M, Lorkowski S, Peter K. Cardiovascular and Metabolic Protection by Vitamin E: A Matter of Treatment Strategy? Antioxidants (Basel) 2020;9:E935. [PMID: 33003543 DOI: 10.3390/antiox9100935] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
373 Shojaie L, Iorga A, Dara L. Cell Death in Liver Diseases: A Review. Int J Mol Sci 2020;21:E9682. [PMID: 33353156 DOI: 10.3390/ijms21249682] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
374 Magusto J, Majdi A, Gautheron J. [Cell death mechanisms in non-alcoholic steatohepatitis]. Biol Aujourdhui 2020;214:1-13. [PMID: 32773025 DOI: 10.1051/jbio/2020002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
375 Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 2016;14:20-32. [PMID: 26499895 DOI: 10.1038/nrmicro3552] [Cited by in Crossref: 980] [Cited by in F6Publishing: 837] [Article Influence: 140.0] [Reference Citation Analysis]
376 Hartmann P, Seebauer CT, Mazagova M, Horvath A, Wang L, Llorente C, Varki NM, Brandl K, Ho SB, Schnabl B. Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity. Am J Physiol Gastrointest Liver Physiol 2016;310:G310-22. [PMID: 26702135 DOI: 10.1152/ajpgi.00094.2015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
377 Shi C, Yang H, Zhang Z. Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver Diseases. Front Cell Dev Biol 2020;8:139. [PMID: 32211410 DOI: 10.3389/fcell.2020.00139] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
378 Bhattacharjee A, Burr AHP, Overacre-Delgoffe AE, Tometich JT, Yang D, Huckestein BR, Linehan JL, Spencer SP, Hall JA, Harrison OJ, Morais da Fonseca D, Norton EB, Belkaid Y, Hand TW. Environmental enteric dysfunction induces regulatory T cells that inhibit local CD4+ T cell responses and impair oral vaccine efficacy. Immunity 2021;54:1745-1757.e7. [PMID: 34348118 DOI: 10.1016/j.immuni.2021.07.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
379 Di Virgilio F, Alexander SPH. The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors. Pharmacol Rev 2013;65:872-905. [DOI: 10.1124/pr.112.006171] [Cited by in Crossref: 98] [Cited by in F6Publishing: 90] [Article Influence: 10.9] [Reference Citation Analysis]
380 Gasmi Benahmed A, Gasmi A, Doşa A, Chirumbolo S, Mujawdiya PK, Aaseth J, Dadar M, Bjørklund G. Association between the gut and oral microbiome with obesity. Anaerobe 2021;70:102248. [PMID: 32805390 DOI: 10.1016/j.anaerobe.2020.102248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
381 Janda L, Mihalčin M, Šťastná M. Is a healthy microbiome responsible for lower mortality in COVID-19? Biologia (Bratisl) 2020;:1-11. [PMID: 33078028 DOI: 10.2478/s11756-020-00614-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
382 He W, Rahimnejad S, Wang L, Song K, Lu K, Zhang C. Effects of organic acids and essential oils blend on growth, gut microbiota, immune response and disease resistance of Pacific white shrimp (Litopenaeus vannamei) against Vibrio parahaemolyticus. Fish Shellfish Immunol 2017;70:164-73. [PMID: 28882791 DOI: 10.1016/j.fsi.2017.09.007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 37] [Article Influence: 11.8] [Reference Citation Analysis]
383 Zhou X, Han D, Xu R, Wu H, Qu C, Wang F, Wang X, Zhao Y. Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats. Oncotarget 2016;7:80223-37. [PMID: 27784003 DOI: 10.18632/oncotarget.12831] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
384 Hughes AN, Oxford JT. A lipid-rich gestational diet predisposes offspring to nonalcoholic fatty liver disease: a potential sequence of events. Hepat Med 2014;6:15-23. [PMID: 24696627 DOI: 10.2147/HMER.S57500] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
385 Marques TM, Wall R, O'Sullivan O, Fitzgerald GF, Shanahan F, Quigley EM, Cotter PD, Cryan JF, Dinan TG, Ross RP, Stanton C. Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice. Br J Nutr 2015;113:728-38. [PMID: 25697178 DOI: 10.1017/S0007114514004206] [Cited by in Crossref: 58] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
386 Tilg H, Cani PD, Mayer EA. Gut microbiome and liver diseases. Gut. 2016;65:2035-2044. [PMID: 27802157 DOI: 10.1136/gutjnl-2016-312729] [Cited by in Crossref: 202] [Cited by in F6Publishing: 186] [Article Influence: 33.7] [Reference Citation Analysis]
387 Zhang H, Yan A, Liu X, Ma Y, Zhao F, Wang M, Loor JJ, Wang H. Melatonin ameliorates ochratoxin A induced liver inflammation, oxidative stress and mitophagy in mice involving in intestinal microbiota and restoring the intestinal barrier function. Journal of Hazardous Materials 2021;407:124489. [DOI: 10.1016/j.jhazmat.2020.124489] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
388 Menini S, Iacobini C, Vitale M, Pugliese G. The Inflammasome in Chronic Complications of Diabetes and Related Metabolic Disorders. Cells 2020;9:E1812. [PMID: 32751658 DOI: 10.3390/cells9081812] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
389 Sun K, Wang J, Lan Z, Li L, Wang Y, Li A, Liu S, Li Y. Sleeve Gastroplasty Combined with the NLRP3 Inflammasome Inhibitor CY-09 Reduces Body Weight, Improves Insulin Resistance and Alleviates Hepatic Steatosis in Mouse Model. OBES SURG 2020;30:3435-43. [DOI: 10.1007/s11695-020-04571-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
390 Bluemel S, Wang L, Martino C, Lee S, Wang Y, Williams B, Horvath A, Stadlbauer V, Zengler K, Schnabl B. The Role of Intestinal C-type Regenerating Islet Derived-3 Lectins for Nonalcoholic Steatohepatitis. Hepatol Commun 2018;2:393-406. [PMID: 29619418 DOI: 10.1002/hep4.1165] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
391 Soderborg TK, Carpenter CM, Janssen RC, Weir TL, Robertson CE, Ir D, Young BE, Krebs NF, Hernandez TL, Barbour LA, Frank DN, Kroehl M, Friedman JE. Gestational Diabetes Is Uniquely Associated With Altered Early Seeding of the Infant Gut Microbiota. Front Endocrinol (Lausanne) 2020;11:603021. [PMID: 33329403 DOI: 10.3389/fendo.2020.603021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
392 Porras D, Nistal E, Martínez-Flórez S, González-Gallego J, García-Mediavilla MV, Sánchez-Campos S. Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease. Front Physiol 2018;9:1813. [PMID: 30618824 DOI: 10.3389/fphys.2018.01813] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
393 Lin DM, Lin HC. A theoretical model of temperate phages as mediators of gut microbiome dysbiosis. F1000Res 2019;8:F1000 Faculty Rev-997. [PMID: 31316751 DOI: 10.12688/f1000research.18480.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
394 Liu J, Dong C, Zhai Z, Tang L, Wang L. Glyphosate-induced lipid metabolism disorder contributes to hepatotoxicity in juvenile common carp. Environmental Pollution 2021;269:116186. [DOI: 10.1016/j.envpol.2020.116186] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
395 Suez J, Korem T, Zilberman-Schapira G, Segal E, Elinav E. Non-caloric artificial sweeteners and the microbiome: findings and challenges. Gut Microbes 2015;6:149-55. [PMID: 25831243 DOI: 10.1080/19490976.2015.1017700] [Cited by in Crossref: 97] [Cited by in F6Publishing: 81] [Article Influence: 13.9] [Reference Citation Analysis]
396 Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria P. Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome. Digestive and Liver Disease 2015;47:181-90. [DOI: 10.1016/j.dld.2014.09.020] [Cited by in Crossref: 371] [Cited by in F6Publishing: 346] [Article Influence: 53.0] [Reference Citation Analysis]
397 Kurilenko N, Fatkhullina AR, Mazitova A, Koltsova EK. Act Locally, Act Globally-Microbiota, Barriers, and Cytokines in Atherosclerosis. Cells 2021;10:348. [PMID: 33562334 DOI: 10.3390/cells10020348] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
398 Yang X, Zhang X, Yang W, Yu H, He Q, Xu H, Li S, Shang Z, Gao X, Wang Y, Tong Q. Gut Microbiota in Adipose Tissue Dysfunction Induced Cardiovascular Disease: Role as a Metabolic Organ. Front Endocrinol (Lausanne) 2021;12:749125. [PMID: 34552566 DOI: 10.3389/fendo.2021.749125] [Reference Citation Analysis]
399 Ilan Y. Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment. Ann Gastroenterol 2018;31:296-304. [PMID: 29720855 DOI: 10.20524/aog.2018.0248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
400 Thaiss CA, Zeevi D, Levy M, Zilberman-Schapira G, Suez J, Tengeler AC, Abramson L, Katz MN, Korem T, Zmora N, Kuperman Y, Biton I, Gilad S, Harmelin A, Shapiro H, Halpern Z, Segal E, Elinav E. Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell. 2014;159:514-529. [PMID: 25417104 DOI: 10.1016/j.cell.2014.09.048] [Cited by in Crossref: 570] [Cited by in F6Publishing: 493] [Article Influence: 71.3] [Reference Citation Analysis]
401 Wolf MJ, Adili A, Piotrowitz K, Abdullah Z, Boege Y, Stemmer K, Ringelhan M, Simonavicius N, Egger M, Wohlleber D. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell. 2014;26:549-564. [PMID: 25314080 DOI: 10.1016/j.ccell.2014.09.003] [Cited by in Crossref: 297] [Cited by in F6Publishing: 289] [Article Influence: 37.1] [Reference Citation Analysis]
402 Youm YH, Grant RW, McCabe LR, Albarado DC, Nguyen KY, Ravussin A, Pistell P, Newman S, Carter R, Laque A, Münzberg H, Rosen CJ, Ingram DK, Salbaum JM, Dixit VD. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab 2013;18:519-32. [PMID: 24093676 DOI: 10.1016/j.cmet.2013.09.010] [Cited by in Crossref: 307] [Cited by in F6Publishing: 289] [Article Influence: 38.4] [Reference Citation Analysis]
403 Wen S, Wang C, Gong M, Zhou L. An overview of energy and metabolic regulation. Sci China Life Sci 2019;62:771-90. [PMID: 30367342 DOI: 10.1007/s11427-018-9371-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
404 Flores-Guerrero JL, Post A, van Dijk PR, Connelly MA, Garcia E, Navis G, Bakker SJL, Dullaart RPF. Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease. Liver Int 2021. [PMID: 33993608 DOI: 10.1111/liv.14963] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
405 Schwenger KJ, Clermont-Dejean N, Allard JP. The role of the gut microbiome in chronic liver disease: the clinical evidence revised. JHEP Rep 2019;1:214-26. [PMID: 32039372 DOI: 10.1016/j.jhepr.2019.04.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
406 Xiao C, Fedirko V, Beitler J, Bai J, Peng G, Zhou C, Gu J, Zhao H, Lin IH, Chico CE, Jeon S, Knobf TM, Conneely KN, Higgins K, Shin DM, Saba N, Miller A, Bruner D. The role of the gut microbiome in cancer-related fatigue: pilot study on epigenetic mechanisms. Support Care Cancer 2021;29:3173-82. [PMID: 33078326 DOI: 10.1007/s00520-020-05820-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
407 Perez-Pardo P, Dodiya HB, Engen PA, Forsyth CB, Huschens AM, Shaikh M, Voigt RM, Naqib A, Green SJ, Kordower JH, Shannon KM, Garssen J, Kraneveld AD, Keshavarzian A. Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice. Gut. 2019;68:829-843. [PMID: 30554160 DOI: 10.1136/gutjnl-2018-316844] [Cited by in Crossref: 106] [Cited by in F6Publishing: 93] [Article Influence: 26.5] [Reference Citation Analysis]
408 Koda Y, Teratani T, Chu PS, Hagihara Y, Mikami Y, Harada Y, Tsujikawa H, Miyamoto K, Suzuki T, Taniki N, Sujino T, Sakamoto M, Kanai T, Nakamoto N. CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells. Nat Commun 2021;12:4474. [PMID: 34294714 DOI: 10.1038/s41467-021-24734-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
409 Chu H, Duan Y, Yang L, Schnabl B. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. Gut. 2019;68:359-370. [PMID: 30171065 DOI: 10.1136/gutjnl-2018-316307] [Cited by in Crossref: 115] [Cited by in F6Publishing: 116] [Article Influence: 28.8] [Reference Citation Analysis]
410 Morgan AP, Crowley JJ, Nonneman RJ, Quackenbush CR, Miller CN, Ryan AK, Bogue MA, Paredes SH, Yourstone S, Carroll IM, Kawula TH, Bower MA, Sartor RB, Sullivan PF. The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse. PLoS One 2014;9:e115225. [PMID: 25506936 DOI: 10.1371/journal.pone.0115225] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 10.5] [Reference Citation Analysis]
411 Lennicke C, Rahn J, Kipp AP, Dojčinović BP, Müller AS, Wessjohann LA, Lichtenfels R, Seliger B. Individual effects of different selenocompounds on the hepatic proteome and energy metabolism of mice. Biochim Biophys Acta Gen Subj 2017;1861:3323-34. [PMID: 27565357 DOI: 10.1016/j.bbagen.2016.08.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
412 Wei H, Bu R, Yang Q, Jia J, Li T, Wang Q, Chen Y. Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway. J Diabetes Res 2019;2019:8905917. [PMID: 31886288 DOI: 10.1155/2019/8905917] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
413 de Groot PF, Frissen MN, de Clercq NC, Nieuwdorp M. Fecal microbiota transplantation in metabolic syndrome: History, present and future. Gut Microbes. 2017;8:253-267. [PMID: 28609252 DOI: 10.1080/19490976.2017.1293224] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 22.0] [Reference Citation Analysis]
414 Masarone M, Rosato V, Dallio M, Gravina AG, Aglitti A, Loguercio C, Federico A, Persico M. Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease. Oxid Med Cell Longev 2018;2018:9547613. [PMID: 29991976 DOI: 10.1155/2018/9547613] [Cited by in Crossref: 205] [Cited by in F6Publishing: 209] [Article Influence: 51.3] [Reference Citation Analysis]
415 Barbier L, Ferhat M, Salamé E, Robin A, Herbelin A, Gombert JM, Silvain C, Barbarin A. Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases. Front Immunol 2019;10:2014. [PMID: 31507607 DOI: 10.3389/fimmu.2019.02014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 9.7] [Reference Citation Analysis]
416 Goel A, Gupta M, Aggarwal R. Gut microbiota and liver disease. J Gastroenterol Hepatol 2014;29:1139-48. [PMID: 24547986 DOI: 10.1111/jgh.12556] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
417 Carvalho BM, Saad MJ. Influence of gut microbiota on subclinical inflammation and insulin resistance. Mediators Inflamm. 2013;2013:986734. [PMID: 23840101 DOI: 10.1155/2013/986734] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 6.8] [Reference Citation Analysis]
418 Bai J, Bruner DW, Fedirko V, Beitler JJ, Zhou C, Gu J, Zhao H, Lin IH, Chico CE, Higgins KA, Shin DM, Saba NF, Miller AH, Xiao C. Gut Microbiome Associated with the Psychoneurological Symptom Cluster in Patients with Head and Neck Cancers. Cancers (Basel) 2020;12:E2531. [PMID: 32899975 DOI: 10.3390/cancers12092531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
419 Moreno-Fernandez ME, Giles DA, Oates JR, Chan CC, Damen MSMA, Doll JR, Stankiewicz TE, Chen X, Chetal K, Karns R, Weirauch MT, Romick-Rosendale L, Xanthakos SA, Sheridan R, Szabo S, Shah AS, Helmrath MA, Inge TH, Deshmukh H, Salomonis N, Divanovic S. PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease. Cell Metab 2021;33:1187-1204.e9. [PMID: 34004162 DOI: 10.1016/j.cmet.2021.04.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
420 Liang D, Leung RK, Guan W, Au WW. Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities. Gut Pathog. 2018;10:3. [PMID: 29416567 DOI: 10.1186/s13099-018-0230-4] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 19.8] [Reference Citation Analysis]
421 Dong TS, Jacobs JP. Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver? Exp Biol Med (Maywood) 2019;244:408-18. [PMID: 30871368 DOI: 10.1177/1535370219836739] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
422 Xu Y, Ai C, Jiang P, Sun X, Liu Y, Jiang G, Song S. Oligosaccharides from Gracilaria lemaneiformis better attenuated high fat diet-induced metabolic syndrome by promoting the Bacteroidales proliferation. Food Funct 2020;11:1049-62. [DOI: 10.1039/c9fo01996k] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
423 Goossens N, Hoshida Y, Song WM, Jung M, Morel P, Nakagawa S, Zhang B, Frossard JL, Spahr L, Friedman SL, Negro F, Rubbia-Brandt L, Giostra E. Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery. Clin Gastroenterol Hepatol. 2016;14:1619-1628. [PMID: 26492845 DOI: 10.1016/j.cgh.2015.10.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
424 Clarke SF, Murphy EF, O'Sullivan O, Ross RP, O'Toole PW, Shanahan F, Cotter PD. Targeting the microbiota to address diet-induced obesity: a time dependent challenge. PLoS One 2013;8:e65790. [PMID: 23762426 DOI: 10.1371/journal.pone.0065790] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 10.9] [Reference Citation Analysis]
425 Tilg H, Moschen AR. Microbiota and diabetes: an evolving relationship. Gut 2014;63:1513-21. [DOI: 10.1136/gutjnl-2014-306928] [Cited by in Crossref: 389] [Cited by in F6Publishing: 353] [Article Influence: 48.6] [Reference Citation Analysis]
426 Muscate F, Woestemeier A, Gagliani N. Functional heterogeneity of CD4+ T cells in liver inflammation. Semin Immunopathol 2021;43:549-61. [PMID: 34463867 DOI: 10.1007/s00281-021-00881-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
427 Matyas C, Haskó G, Liaudet L, Trojnar E, Pacher P. Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications. Nat Rev Cardiol 2021;18:117-35. [PMID: 32999450 DOI: 10.1038/s41569-020-0433-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
428 Macpherson AJ, Heikenwalder M, Ganal-Vonarburg SC. The Liver at the Nexus of Host-Microbial Interactions. Cell Host Microbe 2016;20:561-71. [PMID: 27832587 DOI: 10.1016/j.chom.2016.10.016] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
429 Xiao J, Wang F, Liong EC, So K, Tipoe GL. Lycium barbarum polysaccharides improve hepatic injury through NFkappa-B and NLRP3/6 pathways in a methionine choline deficient diet steatohepatitis mouse model. International Journal of Biological Macromolecules 2018;120:1480-9. [DOI: 10.1016/j.ijbiomac.2018.09.151] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
430 Muiños-Bühl A, González-Recio O, Muñoz M, Óvilo C, García-Casco J, Fernández AI. Evaluating Protocols for Porcine Faecal Microbiome Recollection, Storage and DNA Extraction: from the Farm to the Lab. Curr Microbiol 2018;75:651-7. [PMID: 29318340 DOI: 10.1007/s00284-017-1429-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
431 Bae HR, Kim DH, Park MH, Lee B, Kim MJ, Lee EK, Chung KW, Kim SM, Im DS, Chung HY. β-Hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation. Oncotarget 2016;7:66444-54. [PMID: 27661104 DOI: 10.18632/oncotarget.12119] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 18.8] [Reference Citation Analysis]
432 Kemis JH, Linke V, Barrett KL, Boehm FJ, Traeger LL, Keller MP, Rabaglia ME, Schueler KL, Stapleton DS, Gatti DM, Churchill GA, Amador-Noguez D, Russell JD, Yandell BS, Broman KW, Coon JJ, Attie AD, Rey FE. Genetic determinants of gut microbiota composition and bile acid profiles in mice. PLoS Genet 2019;15:e1008073. [PMID: 31465442 DOI: 10.1371/journal.pgen.1008073] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
433 Sanduzzi Zamparelli M, Compare D, Coccoli P, Rocco A, Nardone OM, Marrone G, Gasbarrini A, Grieco A, Nardone G, Miele L. The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease. Int J Mol Sci. 2016;17. [PMID: 27483246 DOI: 10.3390/ijms17081225] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
434 Xie M, Tang H, Li F, Wu S, Dong Y, Yang Y, Baker JS, Ma J. Mediating Roles of hsCRP, TNF-α and Adiponectin on the Associations between Body Fat and Fatty Liver Disease among Overweight and Obese Adults. Biology (Basel) 2021;10:895. [PMID: 34571772 DOI: 10.3390/biology10090895] [Reference Citation Analysis]
435 Han M, Zhang T, Gu W, Yang X, Zhao R, Yu J. 2,3,5,4'-tetrahydroxy-stilbene-2-O-β-D-glucoside attenuates methionine and choline-deficient diet-induced non-alcoholic fatty liver disease. Exp Ther Med 2018;16:1087-94. [PMID: 30116360 DOI: 10.3892/etm.2018.6300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
436 Li TT, Tong AJ, Liu YY, Huang ZR, Wan XZ, Pan YY, Jia RB, Liu B, Chen XH, Zhao C. Polyunsaturated fatty acids from microalgae Spirulina platensis modulates lipid metabolism disorders and gut microbiota in high-fat diet rats. Food Chem Toxicol 2019;131:110558. [PMID: 31175915 DOI: 10.1016/j.fct.2019.06.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
437 Ivanov II, Honda K. Intestinal commensal microbes as immune modulators. Cell Host Microbe. 2012;12:496-508. [PMID: 23084918 DOI: 10.1016/j.chom.2012.09.009] [Cited by in Crossref: 240] [Cited by in F6Publishing: 221] [Article Influence: 26.7] [Reference Citation Analysis]
438 Pathak P, Helsley RN, Brown AL, Buffa JA, Choucair I, Nemet I, Gogonea CB, Gogonea V, Wang Z, Garcia-Garcia JC, Cai L, Temel R, Sangwan N, Hazen SL, Brown JM. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism. Am J Physiol Heart Circ Physiol 2020;318:H1474-86. [PMID: 32330092 DOI: 10.1152/ajpheart.00584.2019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
439 Harley IT, Stankiewicz TE, Giles DA, Softic S, Flick LM, Cappelletti M, Sheridan R, Xanthakos SA, Steinbrecher KA, Sartor RB, Kohli R, Karp CL, Divanovic S. IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice. Hepatology. 2014;59:1830-1839. [PMID: 24115079 DOI: 10.1002/hep.26746] [Cited by in Crossref: 122] [Cited by in F6Publishing: 123] [Article Influence: 15.3] [Reference Citation Analysis]
440 Takaki A, Kawai D, Yamamoto K. Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). Int J Mol Sci. 2013;14:20704-20728. [PMID: 24132155 DOI: 10.3390/ijms141020704] [Cited by in Crossref: 189] [Cited by in F6Publishing: 182] [Article Influence: 21.0] [Reference Citation Analysis]
441 Lv Y, Gao X, Luo Y, Fan W, Shen T, Ding C, Yao M, Song S, Yan L. Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways. J Nutr Biochem 2019;71:110-21. [PMID: 31325892 DOI: 10.1016/j.jnutbio.2019.05.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
442 Lequoy M, Gigante E, Couty JP, Desbois-Mouthon C. Hepatocellular carcinoma in the context of non-alcoholic steatohepatitis (NASH): recent advances in the pathogenic mechanisms. Horm Mol Biol Clin Investig 2020;41:/j/hmbci. [PMID: 32112699 DOI: 10.1515/hmbci-2019-0044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
443 Szabo G, Csak T. Role of MicroRNAs in NAFLD/NASH. Dig Dis Sci. 2016;61:1314-1324. [PMID: 26769057 DOI: 10.1007/s10620-015-4002-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 8.3] [Reference Citation Analysis]
444 Guillonneau X, Eandi CM, Paques M, Sahel J, Sapieha P, Sennlaub F. On phagocytes and macular degeneration. Progress in Retinal and Eye Research 2017;61:98-128. [DOI: 10.1016/j.preteyeres.2017.06.002] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 14.0] [Reference Citation Analysis]
445 Qu LL, Yu B, Li Z, Jiang WX, Jiang JD, Kong WJ. Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway. Phytother Res 2016;30:402-11. [PMID: 26634892 DOI: 10.1002/ptr.5541] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
446 Einer C, Hohenester S, Wimmer R, Wottke L, Artmann R, Schulz S, Gosmann C, Simmons A, Leitzinger C, Eberhagen C, Borchard S, Schmitt S, Hauck SM, von Toerne C, Jastroch M, Walheim E, Rust C, Gerbes AL, Popper B, Mayr D, Schnurr M, Vollmar AM, Denk G, Zischka H. Mitochondrial adaptation in steatotic mice. Mitochondrion 2018;40:1-12. [PMID: 28935446 DOI: 10.1016/j.mito.2017.08.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
447 Devaraj S, Hemarajata P, Versalovic J. The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem. 2013;59:617-628. [PMID: 23401286 DOI: 10.1373/clinchem.2012.187617] [Cited by in Crossref: 172] [Cited by in F6Publishing: 146] [Article Influence: 19.1] [Reference Citation Analysis]
448 González-Navajas JM. Inflammasome activation in decompensated liver cirrhosis. World J Hepatol 2016; 8(4): 207-210 [PMID: 26855691 DOI: 10.4254/wjh.v8.i4.207] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
449 Upadhyay V, Poroyko V, Kim TJ, Devkota S, Fu S, Liu D, Tumanov AV, Koroleva EP, Deng L, Nagler C, Chang EB, Tang H, Fu YX. Lymphotoxin regulates commensal responses to enable diet-induced obesity. Nat Immunol. 2012;13:947-953. [PMID: 22922363 DOI: 10.1038/ni.2403] [Cited by in Crossref: 99] [Cited by in F6Publishing: 87] [Article Influence: 9.9] [Reference Citation Analysis]
450 Antonson AM, Evans MV, Galley JD, Chen HJ, Rajasekera TA, Lammers SM, Hale VL, Bailey MT, Gur TL. Unique maternal immune and functional microbial profiles during prenatal stress. Sci Rep 2020;10:20288. [PMID: 33219314 DOI: 10.1038/s41598-020-77265-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
451 Huang Z, Kraus VB. Does lipopolysaccharide-mediated inflammation have a role in OA? Nat Rev Rheumatol 2016;12:123-9. [PMID: 26656661 DOI: 10.1038/nrrheum.2015.158] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 11.3] [Reference Citation Analysis]
452 Bibbò S, Ianiro G, Dore MP, Simonelli C, Newton EE, Cammarota G. Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease. Mediators Inflamm 2018;2018:9321643. [PMID: 29563854 DOI: 10.1155/2018/9321643] [Cited by in Crossref: 20] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
453 Pearson JA, Wong FS, Wen L. Inflammasomes and Type 1 Diabetes. Front Immunol 2021;12:686956. [PMID: 34177937 DOI: 10.3389/fimmu.2021.686956] [Reference Citation Analysis]
454 Kelley NS. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans. Metabolic Syndrome and Related Disorders 2016;14:417-30. [DOI: 10.1089/met.2016.0051] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
455 Quigley EM, Stanton C, Murphy EF. The gut microbiota and the liver. Pathophysiological and clinical implications. J Hepatol. 2013;58:1020-1027. [PMID: 23183530 DOI: 10.1016/j.jhep.2012.11.023] [Cited by in Crossref: 75] [Cited by in F6Publishing: 68] [Article Influence: 7.5] [Reference Citation Analysis]
456 Szabo G, Petrasek J. Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol. 2015;12:387-400. [PMID: 26055245 DOI: 10.1038/nrgastro.2015.94] [Cited by in Crossref: 270] [Cited by in F6Publishing: 262] [Article Influence: 38.6] [Reference Citation Analysis]
457 Li X, Lian F, Liu C, Hu KQ, Wang XD. Isocaloric Pair-Fed High-Carbohydrate Diet Induced More Hepatic Steatosis and Inflammation than High-Fat Diet Mediated by miR-34a/SIRT1 Axis in Mice. Sci Rep 2015;5:16774. [PMID: 26608583 DOI: 10.1038/srep16774] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
458 Simbrunner B, Mandorfer M, Trauner M, Reiberger T. Gut-liver axis signaling in portal hypertension. World J Gastroenterol 2019; 25(39): 5897-5917 [PMID: 31660028 DOI: 10.3748/wjg.v25.i39.5897] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 19] [Article Influence: 8.7] [Reference Citation Analysis]
459 Delmas A, Oikonomopoulos A, Lacey PN, Fallahi M, Hommes DW, Sundrud MS. Informatics-Based Discovery of Disease-Associated Immune Profiles. PLoS One 2016;11:e0163305. [PMID: 27669154 DOI: 10.1371/journal.pone.0163305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
460 Verduci E, Carbone MT, Borghi E, Ottaviano E, Burlina A, Biasucci G. Nutrition, Microbiota and Role of Gut-Brain Axis in Subjects with Phenylketonuria (PKU): A Review. Nutrients 2020;12:E3319. [PMID: 33138040 DOI: 10.3390/nu12113319] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
461 Mei L, Tang Y, Li M, Yang P, Liu Z, Yuan J, Zheng P. Co-Administration of Cholesterol-Lowering Probiotics and Anthraquinone from Cassia obtusifolia L. Ameliorate Non-Alcoholic Fatty Liver. PLoS One 2015;10:e0138078. [PMID: 26375281 DOI: 10.1371/journal.pone.0138078] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
462 Dietrich P, Hellerbrand C. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Clin Gastroenterol. 2014;28:637-653. [PMID: 25194181 DOI: 10.1016/j.bpg.2014.07.008] [Cited by in Crossref: 189] [Cited by in F6Publishing: 167] [Article Influence: 23.6] [Reference Citation Analysis]
463 Canfora EE, Meex RCR, Venema K, Blaak EE. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol. 2019;15:261-273. [PMID: 30670819 DOI: 10.1038/s41574-019-0156-z] [Cited by in Crossref: 288] [Cited by in F6Publishing: 271] [Article Influence: 96.0] [Reference Citation Analysis]
464 Okushin K, Tsutsumi T, Ikeuchi K, Kado A, Enooku K, Fujinaga H, Moriya K, Yotsuyanagi H, Koike K. Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis. World J Gastroenterol 2018; 24(32): 3617-3625 [PMID: 30166857 DOI: 10.3748/wjg.v24.i32.3617] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
465 Wu G, Shi Y, Han L, Feng C, Ge Y, Yu Y, Tang X, Cheng X, Sun J, Le G. Dietary Methionine Restriction Ameliorated Fat Accumulation, Systemic Inflammation, and Increased Energy Metabolism by Altering Gut Microbiota in Middle-Aged Mice Administered Different Fat Diets. J Agric Food Chem 2020;68:7745-56. [DOI: 10.1021/acs.jafc.0c02965] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
466 Negash AA, Gale M Jr. Hepatitis regulation by the inflammasome signaling pathway. Immunol Rev. 2015;265:143-155. [PMID: 25879290 DOI: 10.1111/imr.12279] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
467 Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012;489:242-9. [PMID: 22972297 DOI: 10.1038/nature11552] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
468 Kappel BA, Lehrke M. Mikrobiom, Diabetes und Herz: neue Zusammenhänge? Herz 2019;44:223-30. [DOI: 10.1007/s00059-019-4791-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
469 Tashiro H, Cho Y, Kasahara DI, Brand JD, Bry L, Yeliseyev V, Abu-Ali G, Huttenhower C, Shore SA. Microbiota Contribute to Obesity-related Increases in the Pulmonary Response to Ozone. Am J Respir Cell Mol Biol 2019;61:702-12. [PMID: 31144984 DOI: 10.1165/rcmb.2019-0144OC] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
470 Jacobs SR, Damania B. NLRs, inflammasomes, and viral infection. J Leukoc Biol 2012;92:469-77. [PMID: 22581934 DOI: 10.1189/jlb.0312132] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
471 Grayson MH, Camarda LE, Hussain SA, Zemple SJ, Hayward M, Lam V, Hunter DA, Santoro JL, Rohlfing M, Cheung DS, Salzman NH. Intestinal Microbiota Disruption Reduces Regulatory T Cells and Increases Respiratory Viral Infection Mortality Through Increased IFNγ Production. Front Immunol 2018;9:1587. [PMID: 30042764 DOI: 10.3389/fimmu.2018.01587] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
472 Townsend SA, Newsome PN. Non-alcoholic fatty liver disease in 2016. Br Med Bull 2016;119:143-56. [PMID: 27543499 DOI: 10.1093/bmb/ldw031] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
473 Lukens JR, Vogel P, Johnson GR, Kelliher MA, Iwakura Y, Lamkanfi M, Kanneganti TD. RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3. Nature 2013;498:224-7. [PMID: 23708968 DOI: 10.1038/nature12174] [Cited by in Crossref: 118] [Cited by in F6Publishing: 112] [Article Influence: 13.1] [Reference Citation Analysis]
474 Shen TD, Pyrsopoulos N, Rustgi VK. Microbiota and the liver: Microbiota and the Liver. Liver Transpl 2018;24:539-50. [DOI: 10.1002/lt.25008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
475 Chiu Y, Lin S, Ou C, Lu Y, Huang H, Lin M. Anti-inflammatory effect of lactobacilli bacteria on HepG2 cells is through cross-regulation of TLR4 and NOD2 signalling. Journal of Functional Foods 2013;5:820-8. [DOI: 10.1016/j.jff.2013.01.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
476 Agosti P, Sabbà C, Mazzocca A. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864:607-17. [DOI: 10.1016/j.bbadis.2017.11.026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
477 Gao M, Ma Y, Liu D. Rutin suppresses palmitic acids-triggered inflammation in macrophages and blocks high fat diet-induced obesity and fatty liver in mice. Pharm Res. 2013;30:2940-2950. [PMID: 23783345 DOI: 10.1007/s11095-013-1125-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 6.2] [Reference Citation Analysis]
478 Neuman MG, French SW, Zakhari S, Malnick S, Seitz HK, Cohen LB, Salaspuro M, Voinea-Griffin A, Barasch A, Kirpich IA, Thomes PG, Schrum LW, Donohue TM Jr, Kharbanda KK, Cruz M, Opris M. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. Exp Mol Pathol 2017;102:162-80. [PMID: 28077318 DOI: 10.1016/j.yexmp.2017.01.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
479 Mann J, Armstrong M. Fructose, uric acid, and zonal differences in NASH. Journal of Hepatology 2017;67:1117-8. [DOI: 10.1016/j.jhep.2017.06.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
480 Chen L, Garmaeva S, Zhernakova A, Fu J, Wijmenga C. A system biology perspective on environment–host–microbe interactions. Human Molecular Genetics 2018;27:R187-94. [DOI: 10.1093/hmg/ddy137] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
481 Elinav E, Thaiss CA, Flavell RA. Analysis of microbiota alterations in inflammasome-deficient mice. Methods Mol Biol 2013;1040:185-94. [PMID: 23852605 DOI: 10.1007/978-1-62703-523-1_14] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
482 Elliott EI, Sutterwala FS. Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev 2015;265:35-52. [PMID: 25879282 DOI: 10.1111/imr.12286] [Cited by in Crossref: 354] [Cited by in F6Publishing: 347] [Article Influence: 59.0] [Reference Citation Analysis]
483 Caussy C, Aubin A, Loomba R. The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk. Curr Diab Rep 2021;21:15. [PMID: 33742318 DOI: 10.1007/s11892-021-01383-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
484 Leblanc S. Reproductive tract inflammatory disease in postpartum dairy cows. Animal 2014;8:54-63. [DOI: 10.1017/s1751731114000524] [Cited by in Crossref: 61] [Cited by in F6Publishing: 11] [Article Influence: 7.6] [Reference Citation Analysis]
485 Bakker PJ, Scantlebery AM, Butter LM, Claessen N, Teske GJ, van der Poll T, Florquin S, Leemans JC. TLR9 Mediates Remote Liver Injury following Severe Renal Ischemia Reperfusion. PLoS One 2015;10:e0137511. [PMID: 26361210 DOI: 10.1371/journal.pone.0137511] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
486 Chen Y, Kidd J, Bhat OM, Yuan X, Hong J, He X, Li PL. Suppression of Glucagon-Like Peptide-1 Release by Inhibition of Intestinal NLRP3 Inflammasome Activation in Asc-/- and Nlrp3-/- Mice. Front Physiol 2019;10:1213. [PMID: 31632284 DOI: 10.3389/fphys.2019.01213] [Reference Citation Analysis]
487 Sato Y. Encounter with childbirth in a sitting position. Josanpu Zasshi. 1985;39:802-803. [PMID: 3854811 DOI: 10.7812/tpp/12-144] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
488 Lang S, Schnabl B. Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future. Cell Host Microbe 2020;28:233-44. [PMID: 32791115 DOI: 10.1016/j.chom.2020.07.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
489 Jadhav K, Cohen TS. Can You Trust Your Gut? Front Endocrinol (Lausanne). 2020;11:592157. [PMID: 33193105 DOI: 10.3389/fendo.2020.592157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
490 Zhang P, Wang W, Mao M, Gao R, Shi W, Li D, Calderone R, Sui B, Tian X, Meng X. Similarities and Differences: A Comparative Review of the Molecular Mechanisms and Effectors of NAFLD and AFLD. Front Physiol 2021;12:710285. [PMID: 34393826 DOI: 10.3389/fphys.2021.710285] [Reference Citation Analysis]
491 Nati M, Haddad D, Birkenfeld AL, Koch CA, Chavakis T, Chatzigeorgiou A. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). Rev Endocr Metab Disord. 2016;17:29-39. [PMID: 26847547 DOI: 10.1007/s11154-016-9339-2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 12.8] [Reference Citation Analysis]
492 Vujkovic-Cvijin I, Sortino O, Verheij E, Sklar J, Wit FW, Kootstra NA, Sellers B, Brenchley JM, Ananworanich J, Loeff MSV, Belkaid Y, Reiss P, Sereti I. HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases. Nat Commun 2020;11:2448. [PMID: 32415070 DOI: 10.1038/s41467-020-16222-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
493 Berthoud HR. The neurobiology of food intake in an obesogenic environment. Proc Nutr Soc 2012;71:478-87. [PMID: 22800810 DOI: 10.1017/S0029665112000602] [Cited by in Crossref: 155] [Cited by in F6Publishing: 94] [Article Influence: 15.5] [Reference Citation Analysis]
494 He LH, Yao DH, Wang LY, Zhang L, Bai XL. Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease. Front Microbiol 2021;12:761836. [PMID: 34795655 DOI: 10.3389/fmicb.2021.761836] [Reference Citation Analysis]
495 Holmes E, Kinross J, Gibson GR, Burcelin R, Jia W, Pettersson S, Nicholson JK. Therapeutic Modulation of Microbiota-Host Metabolic Interactions. Science Translational Medicine 2012;4:137rv6-137rv6. [DOI: 10.1126/scitranslmed.3004244] [Cited by in Crossref: 159] [Cited by in F6Publishing: 141] [Article Influence: 15.9] [Reference Citation Analysis]
496 Xu C, Wan X, Xu L, Weng H, Yan M, Miao M, Sun Y, Xu G, Dooley S, Li Y, Yu C. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds. Journal of Hepatology 2015;62:1412-9. [DOI: 10.1016/j.jhep.2015.01.019] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 10.0] [Reference Citation Analysis]
497 Zhu LY, Liu C, Li ZR, Niu C, Wu J. NLRP3 deficiency did not attenuate NASH development under high fat calorie diet plus high fructose and glucose in drinking water. Lab Invest 2021;101:588-99. [PMID: 33526807 DOI: 10.1038/s41374-021-00535-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
498 van Olden C, Groen AK, Nieuwdorp M. Role of Intestinal Microbiome in Lipid and Glucose Metabolism in Diabetes Mellitus. Clin Ther. 2015;37:1172-1177. [PMID: 25922340 DOI: 10.1016/j.clinthera.2015.03.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
499 Kim M, Choi S. Can Walnut Serve as a Magic Bullet for the Management of Non-Alcoholic Fatty Liver Disease? Applied Sciences 2021;11:218. [DOI: 10.3390/app11010218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
500 Petersen MC, Shulman GI. Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance. Trends Pharmacol Sci. 2017;38:649-665. [PMID: 28551355 DOI: 10.1016/j.tips.2017.04.004] [Cited by in Crossref: 151] [Cited by in F6Publishing: 143] [Article Influence: 30.2] [Reference Citation Analysis]
501 Chauhan P, Sarkar A, Saha B. Interplay Between Metabolic Sensors and Immune Cell Signaling. Exp Suppl 2018;109:115-96. [PMID: 30535599 DOI: 10.1007/978-3-319-74932-7_3] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
502 Di Ciaula A, Baj J, Garruti G, Celano G, De Angelis M, Wang HH, Di Palo DM, Bonfrate L, Wang DQ, Portincasa P. Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk. J Clin Med 2020;9:E2648. [PMID: 32823983 DOI: 10.3390/jcm9082648] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
503 Keely S, Walker MM, Marks E, Talley NJ. Immune dysregulation in the functional gastrointestinal disorders. Eur J Clin Invest. 2015;45:1350-1359. [PMID: 26444549 DOI: 10.1111/eci.12548] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
504 Pierantonelli I, Svegliati-baroni G. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH. Transplantation 2019;103:e1-e13. [DOI: 10.1097/tp.0000000000002480] [Cited by in Crossref: 73] [Cited by in F6Publishing: 50] [Article Influence: 24.3] [Reference Citation Analysis]
505 Bergheim I, Schuppan D. Microbiome and Diseases: Hepatic Disorders. In: Haller D, editor. The Gut Microbiome in Health and Disease. Cham: Springer International Publishing; 2018. pp. 279-93. [DOI: 10.1007/978-3-319-90545-7_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
506 Kanda T, Goto T, Hirotsu Y, Masuzaki R, Moriyama M, Omata M. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma. Int J Mol Sci 2020;21:E1525. [PMID: 32102237 DOI: 10.3390/ijms21041525] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
507 Torok NJ, Dranoff JA, Schuppan D, Friedman SL. Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014. Hepatology. 2015;62:627-634. [PMID: 25626988 DOI: 10.1002/hep.27720] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
508 Yoshida H, Ishii M, Akagawa M. Propionate suppresses hepatic gluconeogenesis via GPR43/AMPK signaling pathway. Arch Biochem Biophys. 2019;672:108057. [PMID: 31356781 DOI: 10.1016/j.abb.2019.07.022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
509 Bi C, Xiao G, Liu C, Yan J, Chen J, Si W, Zhang J, Liu Z. Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer. Front Cell Dev Biol 2021;9:702414. [PMID: 34957088 DOI: 10.3389/fcell.2021.702414] [Reference Citation Analysis]
510 McCaughey LC, Grinter R, Josts I, Roszak AW, Waløen KI, Cogdell RJ, Milner J, Evans T, Kelly S, Tucker NP, Byron O, Smith B, Walker D. Lectin-like bacteriocins from Pseudomonas spp. utilise D-rhamnose containing lipopolysaccharide as a cellular receptor. PLoS Pathog 2014;10:e1003898. [PMID: 24516380 DOI: 10.1371/journal.ppat.1003898] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
511 Henao-Mejia J, Elinav E, Thaiss CA, Flavell RA. The intestinal microbiota in chronic liver disease. Adv Immunol. 2013;117:73-97. [PMID: 23611286 DOI: 10.1016/b978-0-12-410524-9.00003-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
512 Janssen AWF, Kersten S. The role of the gut microbiota in metabolic health. The FASEB Journal 2015;29:3111-23. [DOI: 10.1096/fj.14-269514] [Cited by in Crossref: 99] [Cited by in F6Publishing: 84] [Article Influence: 14.1] [Reference Citation Analysis]
513 Park H, Bourla AB, Kastner DL, Colbert RA, Siegel RM. Lighting the fires within: the cell biology of autoinflammatory diseases. Nat Rev Immunol 2012;12:570-80. [PMID: 22828911 DOI: 10.1038/nri3261] [Cited by in Crossref: 111] [Cited by in F6Publishing: 91] [Article Influence: 11.1] [Reference Citation Analysis]
514 Jia W, Rajani C. The Influence of Gut Microbial Metabolism on the Development and Progression of Non-alcoholic Fatty Liver Disease. Adv Exp Med Biol 2018;1061:95-110. [PMID: 29956209 DOI: 10.1007/978-981-10-8684-7_8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
515 Hohenester S, Kanitz V, Schiergens T, Einer C, Nagel J, Wimmer R, Reiter FP, Gerbes AL, De Toni EN, Bauer C, Holdt L, Mayr D, Rust C, Schnurr M, Zischka H, Geier A, Denk G. IL-18 but Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver Disease. Int J Mol Sci 2020;21:E8602. [PMID: 33202693 DOI: 10.3390/ijms21228602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
516 Wu J, Lin S, Wan B, Velani B, Zhu Y. Pyroptosis in Liver Disease: New Insights into Disease Mechanisms. Aging Dis. 2019;10:1094-1108. [PMID: 31595205 DOI: 10.14336/ad.2019.0116] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
517 Wong VW, Wong GL, Chim AM, Chu WC, Yeung DK, Li KC, Chan HL. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Annals of Hepatology 2013;12:256-62. [DOI: 10.1016/s1665-2681(19)31364-x] [Cited by in Crossref: 158] [Article Influence: 17.6] [Reference Citation Analysis]
518 Lambert JE, Parnell JA, Eksteen B, Raman M, Bomhof MR, Rioux KP, Madsen KL, Reimer RA. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol. BMC Gastroenterol 2015;15:169. [PMID: 26635079 DOI: 10.1186/s12876-015-0400-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
519 Douhara A, Moriya K, Yoshiji H, Noguchi R, Namisaki T, Kitade M, Kaji K, Aihara Y, Nishimura N, Takeda K. Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model. Mol Med Rep. 2015;11:1693-1700. [PMID: 25421042 DOI: 10.3892/mmr.2014.2995] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
520 Rubio C, Puerto M, García-Rodríquez JJ, Lu VB, García-Martínez I, Alén R, Sanmartín-Salinas P, Toledo-Lobo MV, Saiz J, Ruperez J, Barbas C, Menchén L, Gribble FM, Reimann F, Guijarro LG, Carrascosa JM, Valverde ÁM. Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice. Mol Metab 2020;35:100954. [PMID: 32244182 DOI: 10.1016/j.molmet.2020.01.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
521 Takaki A, Kawai D, Yamamoto K. Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). Int J Mol Sci. 2014;15:7352-7379. [PMID: 24786095 DOI: 10.3390/ijms15057352] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 9.9] [Reference Citation Analysis]
522 Llorente C, Jepsen P, Inamine T, Wang L, Bluemel S, Wang HJ, Loomba R, Bajaj JS, Schubert ML, Sikaroodi M, Gillevet PM, Xu J, Kisseleva T, Ho SB, DePew J, Du X, Sørensen HT, Vilstrup H, Nelson KE, Brenner DA, Fouts DE, Schnabl B. Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nat Commun 2017;8:837. [PMID: 29038503 DOI: 10.1038/s41467-017-00796-x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 92] [Article Influence: 19.4] [Reference Citation Analysis]
523 Inoue D, Tsujimoto G, Kimura I. Regulation of Energy Homeostasis by GPR41. Front Endocrinol (Lausanne) 2014;5:81. [PMID: 24904531 DOI: 10.3389/fendo.2014.00081] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
524 Mayoral Monibas R, Johnson AM, Osborn O, Traves PG, Mahata SK. Distinct Hepatic Macrophage Populations in Lean and Obese Mice. Front Endocrinol (Lausanne) 2016;7:152. [PMID: 27999564 DOI: 10.3389/fendo.2016.00152] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
525 Ertunc ME, Hotamisligil GS. Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment. J Lipid Res. 2016;57:2099-2114. [PMID: 27330055 DOI: 10.1194/jlr.r066514] [Cited by in Crossref: 209] [Cited by in F6Publishing: 108] [Article Influence: 34.8] [Reference Citation Analysis]
526 Shepard CR. TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism. Front Endocrinol (Lausanne) 2020;11:613639. [PMID: 33584545 DOI: 10.3389/fendo.2020.613639] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
527 Buchta Rosean CM, Rutkowski MR. The influence of the commensal microbiota on distal tumor-promoting inflammation. Semin Immunol 2017;32:62-73. [PMID: 28687194 DOI: 10.1016/j.smim.2017.06.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
528 Klymiuk I, Högenauer C, Halwachs B, Thallinger GG, Fricke WF, Steininger C. A physicians' wish list for the clinical application of intestinal metagenomics. PLoS Med 2014;11:e1001627. [PMID: 24736271 DOI: 10.1371/journal.pmed.1001627] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
529 Wang H, Xu G, Huang Z, Li W, Cai H, Zhang Y, Xiong D, Liu G, Wang S, Xue Z, Luo Q. LRP6 targeting suppresses gastric tumorigenesis via P14ARF-Mdm2-P53-dependent cellular senescence. Oncotarget 2017;8:111597-607. [PMID: 29340077 DOI: 10.18632/oncotarget.22876] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
530 Scapaticci S, D'Adamo E, Mohn A, Chiarelli F, Giannini C. Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes.Front Endocrinol (Lausanne). 2021;12:639548. [PMID: 33889132 DOI: 10.3389/fendo.2021.639548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
531 Ma C, Yang X, Lv Q, Yan Z, Chen Z, Xu D, Liu X, Yang W, Xing S. Soluble uric acid induces inflammation via TLR4/NLRP3 pathway in intestinal epithelial cells. Iran J Basic Med Sci 2020;23:744-50. [PMID: 32695290 DOI: 10.22038/ijbms.2020.44948.10482] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
532 Wu Y, Sun H, Yi R, Tan F, Zhao X. Anti‐obesity effect of Liupao tea extract by modulating lipid metabolism and oxidative stress in high‐fat‐diet‐induced obese mice. Journal of Food Science 2021;86:215-27. [DOI: 10.1111/1750-3841.15551] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
533 Varelias A, Ormerod KL, Bunting MD, Koyama M, Gartlan KH, Kuns RD, Lachner N, Locke KR, Lim CY, Henden AS, Zhang P, Clouston AD, Hasnain SZ, McGuckin MA, Blazar BR, MacDonald KP, Hugenholtz P, Hill GR. Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome. Blood 2017;129:2172-85. [PMID: 28137828 DOI: 10.1182/blood-2016-08-732628] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 10.0] [Reference Citation Analysis]
534 Simon H, Vartanian V, Wong MH, Nakabeppu Y, Sharma P, Lloyd RS, Sampath H. OGG1 deficiency alters the intestinal microbiome and increases intestinal inflammation in a mouse model. PLoS One 2020;15:e0227501. [PMID: 31935236 DOI: 10.1371/journal.pone.0227501] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
535 Hyun CK. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:9139. [PMID: 34502047 DOI: 10.3390/ijms22179139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
536 Wang F, Park JS, Ma Y, Ma H, Lee YJ, Lee GR, Yoo HS, Hong JT, Roh YS. Ginseng Saponin Enriched in Rh1 and Rg2 Ameliorates Nonalcoholic Fatty Liver Disease by Inhibiting Inflammasome Activation. Nutrients 2021;13:856. [PMID: 33807927 DOI: 10.3390/nu13030856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
537 Lytle KA, Depner CM, Wong CP, Jump DB. Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway. J Lipid Res 2015;56:1936-46. [PMID: 26315048 DOI: 10.1194/jlr.M061275] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
538 Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab. 2013;17:851-859. [PMID: 23747244 DOI: 10.1016/j.cmet.2013.05.008] [Cited by in Crossref: 264] [Cited by in F6Publishing: 253] [Article Influence: 33.0] [Reference Citation Analysis]
539 Zheng Y, Wu W, Hu G, Qiu L, Meng S, Song C, Fan L, Zhao Z, Bing X, Chen J. Gut microbiota analysis of juvenile genetically improved farmed tilapia (Oreochromis niloticus) by dietary supplementation of different resveratrol concentrations. Fish Shellfish Immunol 2018;77:200-7. [PMID: 29574130 DOI: 10.1016/j.fsi.2018.03.040] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
540 Fouladi F, Brooks AE, Fodor AA, Carroll IM, Bulik-Sullivan EC, Tsilimigras MCB, Sioda M, Steffen KJ. The Role of the Gut Microbiota in Sustained Weight Loss Following Roux-en-Y Gastric Bypass Surgery. Obes Surg 2019;29:1259-67. [PMID: 30604078 DOI: 10.1007/s11695-018-03653-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
541 Ceccarelli S, Panera N, Mina M, Gnani D, De Stefanis C, Crudele A, Rychlicki C, Petrini S, Bruscalupi G, Agostinelli L, Stronati L, Cucchiara S, Musso G, Furlanello C, Svegliati-Baroni G, Nobili V, Alisi A. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease. Oncotarget 2015;6:41434-52. [PMID: 26573228 DOI: 10.18632/oncotarget.5163] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 10.3] [Reference Citation Analysis]
542 Chang C, Lin H. Dysbiosis in gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2016;30:3-15. [PMID: 27048892 DOI: 10.1016/j.bpg.2016.02.001] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
543 Simon LM, Karg S, Westermann AJ, Engel M, Elbehery AHA, Hense B, Heinig M, Deng L, Theis FJ. MetaMap: an atlas of metatranscriptomic reads in human disease-related RNA-seq data. Gigascience 2018;7. [PMID: 29901703 DOI: 10.1093/gigascience/giy070] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
544 Chashmniam S, Mirhafez SR, Dehabeh M, Hariri M, Azimi Nezhad M, Nobakht M Gh BF. A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr 2019;73:1224-35. [PMID: 30647436 DOI: 10.1038/s41430-018-0386-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
545 Niederseer D, Wernly B, Aigner E, Stickel F, Datz C. NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations. J Clin Med 2021;10:467. [PMID: 33530440 DOI: 10.3390/jcm10030467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
546 Ji G, Wang Y, Deng Y, Li X, Jiang Z. Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy. Lipids Health Dis. 2015;14:134. [PMID: 26498332 DOI: 10.1186/s12944-015-0139-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
547 Xiao J, Wang J, Xing F, Han T, Jiao R, Liong EC, Fung ML, So KF, Tipoe GL. Zeaxanthin dipalmitate therapeutically improves hepatic functions in an alcoholic fatty liver disease model through modulating MAPK pathway. PLoS One 2014;9:e95214. [PMID: 24740309 DOI: 10.1371/journal.pone.0095214] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
548 Uygun A. Is That Possible to Stop or Cease the NASH to Turn into HCC? J Gastrointest Cancer 2017;48:250-5. [PMID: 28733789 DOI: 10.1007/s12029-017-9961-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
549 Chiu L, Bazin T, Truchetet ME, Schaeverbeke T, Delhaes L, Pradeu T. Protective Microbiota: From Localized to Long-Reaching Co-Immunity. Front Immunol 2017;8:1678. [PMID: 29270167 DOI: 10.3389/fimmu.2017.01678] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 11.0] [Reference Citation Analysis]
550 Zheng Y, Fang Z, Xue Y, Zhang J, Zhu J, Gao R, Yao S, Ye Y, Wang S, Lin C, Chen S, Huang H, Hu L, Jiang GN, Qin H, Zhang P, Chen J, Ji H. Specific gut microbiome signature predicts the early-stage lung cancer. Gut Microbes 2020;11:1030-42. [PMID: 32240032 DOI: 10.1080/19490976.2020.1737487] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 10.5] [Reference Citation Analysis]
551 Pocha C, Xie C. Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease-one of a kind or two different enemies? Transl Gastroenterol Hepatol 2019;4:72. [PMID: 31728429 DOI: 10.21037/tgh.2019.09.01] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
552 Neudecker V, Haneklaus M, Jensen O, Khailova L, Masterson JC, Tye H, Biette K, Jedlicka P, Brodsky KS, Gerich ME, Mack M, Robertson AAB, Cooper MA, Furuta GT, Dinarello CA, O'Neill LA, Eltzschig HK, Masters SL, McNamee EN. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. J Exp Med. 2017;214:1737-1752. [PMID: 28487310 DOI: 10.1084/jem.20160462] [Cited by in Crossref: 168] [Cited by in F6Publishing: 167] [Article Influence: 33.6] [Reference Citation Analysis]
553 Hendrikx T, Bieghs V, Walenbergh SM, van Gorp PJ, Verheyen F, Jeurissen ML, Steinbusch MM, Vaes N, Binder CJ, Koek GH, Stienstra R, Netea MG, Hofker MH, Shiri-Sverdlov R. Macrophage specific caspase-1/11 deficiency protects against cholesterol crystallization and hepatic inflammation in hyperlipidemic mice. PLoS One 2013;8:e78792. [PMID: 24312444 DOI: 10.1371/journal.pone.0078792] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
554 Schrumpf E, Kummen M, Valestrand L, Greiner TU, Holm K, Arulampalam V, Reims HM, Baines J, Bäckhed F, Karlsen TH, Blumberg RS, Hov JR, Melum E. The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation. J Hepatol 2017;66:382-9. [PMID: 27720803 DOI: 10.1016/j.jhep.2016.09.020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
555 Leng W, Wu M, Pan H, Lei X, Chen L, Wu Q, Ouyang X, Liang Z. The SGLT2 inhibitor dapagliflozin attenuates the activity of ROS-NLRP3 inflammasome axis in steatohepatitis with diabetes mellitus. Ann Transl Med 2019;7:429. [PMID: 31700865 DOI: 10.21037/atm.2019.09.03] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
556 Schnabl B. Linking intestinal homeostasis and liver disease. Curr Opin Gastroenterol 2013;29:264-70. [PMID: 23493073 DOI: 10.1097/MOG.0b013e32835ff948] [Cited by in Crossref: 48] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
557 Nieuwdorp M, Gilijamse PW, Pai N, Kaplan LM. Role of the microbiome in energy regulation and metabolism. Gastroenterology. 2014;146:1525-1533. [PMID: 24560870 DOI: 10.1053/j.gastro.2014.02.008] [Cited by in Crossref: 206] [Cited by in F6Publishing: 190] [Article Influence: 25.8] [Reference Citation Analysis]
558 Liu M, Tan J, He Z, He X, Hou DX, He J, Wu S. Inhibitory effect of blue honeysuckle extract on high-fat-diet-induced fatty liver in mice. Anim Nutr 2018;4:288-93. [PMID: 30175257 DOI: 10.1016/j.aninu.2018.06.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
559 Gevers TJG, Marcel Spanier BW, Veendrick PB, Vrolijk JM. Regression of hepatocellular adenoma after bariatric surgery in severe obese patients. Liver Int 2018;38:2134-6. [PMID: 30025198 DOI: 10.1111/liv.13934] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
560 Ramakrishna BS. Role of the gut microbiota in human nutrition and metabolism: Role of the gut microbiota. J Gastroenterol Hepatol 2013;28:9-17. [DOI: 10.1111/jgh.12294] [Cited by in Crossref: 198] [Cited by in F6Publishing: 173] [Article Influence: 22.0] [Reference Citation Analysis]
561 Xia Y, Wang P, Yan N, Gonzalez FJ, Yan T. Withaferin A alleviates fulminant hepatitis by targeting macrophage and NLRP3. Cell Death Dis 2021;12:174. [PMID: 33574236 DOI: 10.1038/s41419-020-03243-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
562 Vernocchi P, Del Chierico F, Putignani L. Gut Microbiota Metabolism and Interaction with Food Components. Int J Mol Sci 2020;21:E3688. [PMID: 32456257 DOI: 10.3390/ijms21103688] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
563 Cho YE, Kim DK, Seo W, Gao B, Yoo SH, Song BJ. Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol-Inducible Cytochrome P450-2E1-Mediated Oxidative and Nitrative Stress. Hepatology 2021;73:2180-95. [PMID: 30959577 DOI: 10.1002/hep.30652] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
564 de Moraes Rodrigues J, Souza de Lima D, Leal VNC, Bosco AA, Sandrim V, Pontillo A. Gain-of-function SNPs in NLRP3 and IL1B genes confer protection against obesity and T2D: undiscovered role of inflammasome genetics in metabolic homeostasis? Endocrine 2018;60:368-71. [PMID: 28634744 DOI: 10.1007/s12020-017-1343-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
565 Mendel I, Yacov N, Shoham A, Ishai E, Breitbart E. Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis. Dig Dis Sci 2016;61:2545-53. [PMID: 27074921 DOI: 10.1007/s10620-016-4159-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
566 Daemen S, Schilling JD. The Interplay Between Tissue Niche and Macrophage Cellular Metabolism in Obesity. Front Immunol 2019;10:3133. [PMID: 32038642 DOI: 10.3389/fimmu.2019.03133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
567 Wang F, Yu P, Gui X, Wang Y, Xue C, Wang J. Sialoglycoprotein isolated from the eggs of Carassius auratus prevents bone loss: an effect associated with the regulation of gut microbiota in ovariectomized rats. Food Funct 2016;7:4764-71. [PMID: 27808338 DOI: 10.1039/c6fo01103a] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
568 Knorr J, Wree A, Tacke F, Feldstein AE. The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis. Semin Liver Dis 2020;40:298-306. [PMID: 32526788 DOI: 10.1055/s-0040-1708540] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
569 Ip BC, Hu KQ, Liu C, Smith DE, Obin MS, Ausman LM, Wang XD. Lycopene metabolite, apo-10'-lycopenoic acid, inhibits diethylnitrosamine-initiated, high fat diet-promoted hepatic inflammation and tumorigenesis in mice. Cancer Prev Res (Phila). 2013;6:1304-1316. [PMID: 24085778 DOI: 10.1158/1940-6207.capr-13-0178] [Cited by in Crossref: 59] [Cited by in F6Publishing: 37] [Article Influence: 6.6] [Reference Citation Analysis]
570 Xu M, Liu PP, Li H. Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases. Physiol Rev. 2019;99:893-948. [PMID: 30565509 DOI: 10.1152/physrev.00065.2017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
571 Albhaisi SAM, Bajaj JS, Sanyal AJ. Role of gut microbiota in liver disease. Am J Physiol Gastrointest Liver Physiol 2020;318:G84-98. [PMID: 31657225 DOI: 10.1152/ajpgi.00118.2019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
572 Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clément K. Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity? Gastroenterology 2020;158:1881-98. [PMID: 32044317 DOI: 10.1053/j.gastro.2020.01.049] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 12.5] [Reference Citation Analysis]
573 Bahr SM, Weidemann BJ, Castro AN, Walsh JW, deLeon O, Burnett CM, Pearson NA, Murry DJ, Grobe JL, Kirby JR. Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure. EBioMedicine 2015;2:1725-34. [PMID: 26870798 DOI: 10.1016/j.ebiom.2015.10.018] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 11.7] [Reference Citation Analysis]
574 Mills S, Stanton C, Lane JA, Smith GJ, Ross RP. Precision Nutrition and the Microbiome, Part I: Current State of the Science. Nutrients. 2019;11:923. [PMID: 31022973 DOI: 10.3390/nu11040923] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 25.7] [Reference Citation Analysis]
575 He K, Zhu X, Liu Y, Miao C, Wang T, Li P, Zhao L, Chen Y, Gong J, Cai C, Li J, Li S, Ruan XZ, Gong J. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development. Oncotarget 2017;8:37657-72. [PMID: 28499273 DOI: 10.18632/oncotarget.17489] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
576 Khan MT, Nieuwdorp M, Bäckhed F. Microbial modulation of insulin sensitivity. Cell Metab 2014;20:753-60. [PMID: 25176147 DOI: 10.1016/j.cmet.2014.07.006] [Cited by in Crossref: 147] [Cited by in F6Publishing: 133] [Article Influence: 21.0] [Reference Citation Analysis]
577 Pyo JH, Kim TJ, Lee H, Choi SC, Cho SJ, Choi YH, Min YW, Min BH, Lee JH, Kang M, Lee YC, Kim JJ. Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study. J Gastroenterol Hepatol 2021;36:1235-43. [PMID: 32886822 DOI: 10.1111/jgh.15236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
578 Than NN, Newsome PN. A concise review of non-alcoholic fatty liver disease. Atherosclerosis. 2015;239:192-202. [PMID: 25617860 DOI: 10.1016/j.atherosclerosis.2015.01.001] [Cited by in Crossref: 175] [Cited by in F6Publishing: 164] [Article Influence: 25.0] [Reference Citation Analysis]
579 Kolodziejczyk AA, Federici S, Zmora N, Mohapatra G, Dori-bachash M, Hornstein S, Leshem A, Reuveni D, Zigmond E, Tobar A, Salame TM, Harmelin A, Shlomai A, Shapiro H, Amit I, Elinav E. Acute liver failure is regulated by MYC- and microbiome-dependent programs. Nat Med 2020;26:1899-911. [DOI: 10.1038/s41591-020-1102-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
580 Pimentel GD, Micheletti TO, Pace F, Rosa JC, Santos RV, Lira FS. Gut-central nervous system axis is a target for nutritional therapies. Nutr J 2012;11:22. [PMID: 22490672 DOI: 10.1186/1475-2891-11-22] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
581 Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014;514:181-186. [PMID: 25231862 DOI: 10.1038/nature13793] [Cited by in Crossref: 951] [Cited by in F6Publishing: 813] [Article Influence: 118.9] [Reference Citation Analysis]
582 Howitt MR, Garrett WS. A complex microworld in the gut: gut microbiota and cardiovascular disease connectivity. Nat Med 2012;18:1188-9. [PMID: 22869188 DOI: 10.1038/nm.2895] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
583 Roychowdhury S, Selvakumar PC, Cresci GAM. The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease. Med Sci (Basel) 2018;6:E47. [PMID: 29874807 DOI: 10.3390/medsci6020047] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
584 Li H, Qu J, Li T, Li J, Lin Q, Li X. Pika Population Density Is Associated with the Composition and Diversity of Gut Microbiota. Front Microbiol 2016;7:758. [PMID: 27242770 DOI: 10.3389/fmicb.2016.00758] [Cited by in Crossref: 19] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
585 Ubeda C, Pamer EG. Antibiotics, microbiota, and immune defense. Trends Immunol. 2012;33:459-466. [PMID: 22677185 DOI: 10.1016/j.it.2012.05.003] [Cited by in Crossref: 188] [Cited by in F6Publishing: 173] [Article Influence: 18.8] [Reference Citation Analysis]
586 Wlodarska M, Thaiss CA, Nowarski R, Henao-Mejia J, Zhang JP, Brown EM, Frankel G, Levy M, Katz MN, Philbrick WM, Elinav E, Finlay BB, Flavell RA. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 2014;156:1045-59. [PMID: 24581500 DOI: 10.1016/j.cell.2014.01.026] [Cited by in Crossref: 383] [Cited by in F6Publishing: 383] [Article Influence: 47.9] [Reference Citation Analysis]
587 Zhang HF, Shi LJ, Song GY, Cai ZG, Wang C, An RJ. Protective effects of matrine against progression of high-fructose diet-induced steatohepatitis by enhancing antioxidant and anti-inflammatory defences involving Nrf2 translocation. Food Chem Toxicol 2013;55:70-7. [PMID: 23295629 DOI: 10.1016/j.fct.2012.12.043] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
588 Athyros VG, Katsiki N, Karagiannis A, Mikhailidis DP. Statins and nonalcoholic fatty liver disease: a bright future? Expert Opin Investig Drugs. 2013;22:1089-1093. [PMID: 23889731 DOI: 10.1517/13543784.2013.824423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
589 Levy M, Shapiro H, Thaiss CA, Elinav E. NLRP6: A Multifaceted Innate Immune Sensor. Trends Immunol 2017;38:248-60. [PMID: 28214100 DOI: 10.1016/j.it.2017.01.001] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 13.0] [Reference Citation Analysis]
590 Giraud J, Saleh M. Host-Microbiota Interactions in Liver Inflammation and Cancer. Cancers (Basel) 2021;13:4342. [PMID: 34503151 DOI: 10.3390/cancers13174342] [Reference Citation Analysis]
591 Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res 2020;30:492-506. [PMID: 32433595 DOI: 10.1038/s41422-020-0332-7] [Cited by in Crossref: 410] [Cited by in F6Publishing: 1] [Article Influence: 205.0] [Reference Citation Analysis]
592 Ebrahimzadeh Leylabadlo H, Ghotaslou R, Samadi Kafil H, Feizabadi MM, Moaddab SY, Farajnia S, Sheykhsaran E, Sanaie S, Shanehbandi D, Bannazadeh Baghi H. Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies. Eur J Clin Microbiol Infect Dis 2020;39:613-27. [PMID: 31828683 DOI: 10.1007/s10096-019-03746-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
593 Schnabl B. Transplanting a fibrogenic microbiota. Hepatology 2014;59:1660-1. [PMID: 24676698 DOI: 10.1002/hep.26785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
594 Aron-wisnewsky J, Gaborit B, Dutour A, Clement K. Gut microbiota and non-alcoholic fatty liver disease: new insights. Clinical Microbiology and Infection 2013;19:338-48. [DOI: 10.1111/1469-0691.12140] [Cited by in Crossref: 141] [Cited by in F6Publishing: 134] [Article Influence: 15.7] [Reference Citation Analysis]
595 Wada J, Makino H. Innate immunity in diabetes and diabetic nephropathy. Nat Rev Nephrol. 2016;12:13-26. [PMID: 26568190 DOI: 10.1038/nrneph.2015.175] [Cited by in Crossref: 149] [Cited by in F6Publishing: 152] [Article Influence: 21.3] [Reference Citation Analysis]
596 Wan X, Xu C, Yu C, Li Y. Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH. Can J Gastroenterol Hepatol 2016;2016:6489012. [PMID: 27446858 DOI: 10.1155/2016/6489012] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 8.7] [Reference Citation Analysis]
597 Yu Q, Lee YY, Xia ZY, Liong EC, Xiao J, Tipoe GL. S-allylmercaptocysteine improves nonalcoholic steatohepatitis by enhancing AHR/NRF2-mediated drug metabolising enzymes and reducing NF-κB/IκBα and NLRP3/6-mediated inflammation. Eur J Nutr 2021;60:961-73. [PMID: 32556446 DOI: 10.1007/s00394-020-02305-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
598 Duarte N, Coelho IC, Patarrão RS, Almeida JI, Penha-Gonçalves C, Macedo MP. How Inflammation Impinges on NAFLD: A Role for Kupffer Cells. Biomed Res Int 2015;2015:984578. [PMID: 26090470 DOI: 10.1155/2015/984578] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 7.7] [Reference Citation Analysis]
599 Sauerbruch T, Schierwagen R, Trebicka J. Managing portal hypertension in patients with liver cirrhosis. F1000Res 2018;7:F1000 Faculty Rev-533. [PMID: 29780579 DOI: 10.12688/f1000research.13943.1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
600 Jin C, Flavell RA. Innate sensors of pathogen and stress: linking inflammation to obesity. J Allergy Clin Immunol 2013;132:287-94. [PMID: 23905917 DOI: 10.1016/j.jaci.2013.06.022] [Cited by in Crossref: 128] [Cited by in F6Publishing: 115] [Article Influence: 14.2] [Reference Citation Analysis]
601 Hendrikx T, Walenbergh SM, Jeurissen ML, Houben T, van Gorp PJ, Lindsey PJ, Koek GH, Kalhan S, Pihlajamaki J, Hofker MH, Shiri-sverdlov R. Plasma IL-1 receptor antagonist levels correlate with the development of non-alcoholic steatohepatitis. Biomarkers in Medicine 2015;9:1301-9. [DOI: 10.2217/bmm.15.71] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
602 He X, Ji G, Jia W, Li H. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics. Int J Mol Sci. 2016;17:300. [PMID: 26999104 DOI: 10.3390/ijms17030300] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
603 Ralston JC, Mitchelson KAJ, Lynch GM, Tran TTT, Wang H, Strain CR, Lenighan YM, Kennedy EB, Stanton C, McGillicuddy FC, Su Q, O'Toole PW, Roche HM. Microbiome Transfer Partly Overrides Lack of IL-1RI Signaling to Alter Hepatic but not Adipose Tissue Phenotype and Lipid Handling following a High-Fat Diet Challenge. Mol Nutr Food Res 2021;65:e2000202. [PMID: 32558187 DOI: 10.1002/mnfr.202000202] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
604 Norris GH, Blesso CN. Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease. Nutr Rev 2017;75:274-85. [PMID: 28383715 DOI: 10.1093/nutrit/nux004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
605 Jha P, Knopf A, Koefeler H, Mueller M, Lackner C, Hoefler G, Claudel T, Trauner M. Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH). Biochim Biophys Acta 2014;1842:959-70. [PMID: 24594481 DOI: 10.1016/j.bbadis.2014.02.012] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 6.5] [Reference Citation Analysis]
606 Shi J, Yang Y, Xu W, Cai H, Wu J, Long J, Cai Q, Zheng W, Flynn CR, Shu XO, Yu D. Sex-Specific Associations between Gut Microbiome and Non-Alcoholic Fatty Liver Disease among Urban Chinese Adults. Microorganisms 2021;9:2118. [PMID: 34683439 DOI: 10.3390/microorganisms9102118] [Reference Citation Analysis]
607 Lee SW, Baek SM, Kang KK, Lee AR, Kim TU, Choi SK, Roh YS, Hong IH, Park SJ, Kim TH, Jeong KS, Park JK. Vitamin C Deficiency Inhibits Nonalcoholic Fatty Liver Disease Progression through Impaired de Novo Lipogenesis. Am J Pathol 2021;191:1550-63. [PMID: 34126083 DOI: 10.1016/j.ajpath.2021.05.020] [Reference Citation Analysis]
608 Della Torre S. Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling. Front Endocrinol (Lausanne) 2020;11:572490. [PMID: 33071979 DOI: 10.3389/fendo.2020.572490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
609 Aron-Wisnewsky J, Doré J, Clement K. The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2012;9:590-598. [PMID: 22926153 DOI: 10.1038/nrgastro.2012.161] [Cited by in Crossref: 145] [Cited by in F6Publishing: 125] [Article Influence: 14.5] [Reference Citation Analysis]
610 Marra F, Lotersztajn S. Pathophysiology of NASH: perspectives for a targeted treatment. Curr Pharm Des. 2013;19:5250-5269. [PMID: 23394092 DOI: 10.2174/1381612811399990344] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
611 Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I, Kim SG, Li H, Gao Z, Mahana D, Zárate Rodriguez JG, Rogers AB, Robine N, Loke P, Blaser MJ. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 2014;158:705-21. [PMID: 25126780 DOI: 10.1016/j.cell.2014.05.052] [Cited by in Crossref: 1008] [Cited by in F6Publishing: 925] [Article Influence: 126.0] [Reference Citation Analysis]
612 Li J, Hu Q, Xiao-Yu D, Zhu L, Miao YF, Kang HX, Zhao XL, Yao JQ, Long D, Tang WF, Wan MH. Effect of Sheng-Jiang Powder on Gut Microbiota in High-Fat Diet-Induced NAFLD. Evid Based Complement Alternat Med 2020;2020:6697638. [PMID: 33293992 DOI: 10.1155/2020/6697638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
613 Wang L, Peng F, Peng C, Du JR. Gut Microbiota in Tumor Microenvironment: A Critical Regulator in Cancer Initiation and Development as Potential Targets for Chinese Medicine. Am J Chin Med 2021;49:609-26. [PMID: 33683187 DOI: 10.1142/S0192415X21500270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
614 Zhang Z, Zhang XX, Wu B, Yin J, Yu Y, Yang L. Comprehensive insights into microcystin-LR effects on hepatic lipid metabolism using cross-omics technologies. J Hazard Mater 2016;315:126-34. [PMID: 27208774 DOI: 10.1016/j.jhazmat.2016.05.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
615 Asgharpour A, Cazanave SC, Pacana T, Seneshaw M, Vincent R, Banini BA, Kumar DP, Daita K, Min HK, Mirshahi F. A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. J Hepatol. 2016;65:579-588. [PMID: 27261415 DOI: 10.1016/j.jhep.2016.05.005] [Cited by in Crossref: 198] [Cited by in F6Publishing: 187] [Article Influence: 33.0] [Reference Citation Analysis]
616 Kim HS, Whon TW, Sung H, Jeong YS, Jung ES, Shin NR, Hyun DW, Kim PS, Lee JY, Lee CH, Bae JW. Longitudinal evaluation of fecal microbiota transplantation for ameliorating calf diarrhea and improving growth performance. Nat Commun 2021;12:161. [PMID: 33420064 DOI: 10.1038/s41467-020-20389-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
617 Pang G, Xie J, Chen Q, Hu Z. Energy intake, metabolic homeostasis, and human health. Food Science and Human Wellness 2014;3:89-103. [DOI: 10.1016/j.fshw.2015.01.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
618 Kotas ME, Jurczak MJ, Annicelli C, Gillum MP, Cline GW, Shulman GI, Medzhitov R. Role of caspase-1 in regulation of triglyceride metabolism. Proc Natl Acad Sci U S A 2013;110:4810-5. [PMID: 23487794 DOI: 10.1073/pnas.1301996110] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
619 Boursi B, Mamtani R, Haynes K, Yang YX. The effect of past antibiotic exposure on diabetes risk. Eur J Endocrinol. 2015;172:639-648. [PMID: 25805893 DOI: 10.1530/eje-14-1163] [Cited by in Crossref: 84] [Cited by in F6Publishing: 40] [Article Influence: 12.0] [Reference Citation Analysis]
620 Lin SH, Chung PH, Wu YY, Fung CP, Hsu CM, Chen LW. Inhibition of nitric oxide production reverses diabetes-induced Kupffer cell activation and Klebsiella pneumonia liver translocation. PLoS One 2017;12:e0177269. [PMID: 28493939 DOI: 10.1371/journal.pone.0177269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
621 Org E, Mehrabian M, Lusis AJ. Unraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota. Atherosclerosis. 2015;241:387-399. [PMID: 26071662 DOI: 10.1016/j.atherosclerosis.2015.05.035] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
622 De Roza MA, Kai L, Kam JW, Chan YH, Kwek A, Ang TL, Hsiang JC. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis. World J Gastroenterol 2019; 25(33): 4933-4944 [PMID: 31543684 DOI: 10.3748/wjg.v25.i33.4933] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
623 Levy M, Thaiss CA, Katz MN, Suez J, Elinav E. Inflammasomes and the microbiota--partners in the preservation of mucosal homeostasis. Semin Immunopathol 2015;37:39-46. [PMID: 25315349 DOI: 10.1007/s00281-014-0451-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
624 Porras D, Nistal E, Martínez-flórez S, Pisonero-vaquero S, Olcoz JL, Jover R, González-gallego J, García-mediavilla MV, Sánchez-campos S. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Free Radical Biology and Medicine 2017;102:188-202. [DOI: 10.1016/j.freeradbiomed.2016.11.037] [Cited by in Crossref: 184] [Cited by in F6Publishing: 176] [Article Influence: 36.8] [Reference Citation Analysis]
625 Brandsma E, Houben T, Fu J, Shiri-Sverdlov R, Hofker MH. The immunity-diet-microbiota axis in the development of metabolic syndrome. Curr Opin Lipidol 2015;26:73-81. [PMID: 25692344 DOI: 10.1097/MOL.0000000000000154] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
626 Meroni M, Longo M, Dongiovanni P. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies. Nutrients. 2019;11. [PMID: 31689910 DOI: 10.3390/nu11112642] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
627 Desai P, Tamarapu Parthasarathy P, Galam L, Lockey R, Kolliputi N. A new role for inflammasomes: sensing the disturbances in non-alcoholic fatty liver disease. Front Physiol 2013;4:156. [PMID: 23847540 DOI: 10.3389/fphys.2013.00156] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
628 Song CY, Zeng X, Wang Y, Shi J, Qian H, Zhang Y, Fang JQ, Sheng X, Zheng JM, Chen YX. Sophocarpine attenuates toll-like receptor 4 in steatotic hepatocytes to suppress pro-inflammatory cytokines synthesis. J Gastroenterol Hepatol 2015;30:405-12. [PMID: 25089018 DOI: 10.1111/jgh.12691] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
629 Kanak MA, Shindo Y, Saikumar P, Naziruddin B. Role of Inflammasomes in the Development of Gastrointestinal Diseases. In: Cordero MD, Alcocer-gómez E, editors. Inflammasomes: Clinical and Therapeutic Implications. Cham: Springer International Publishing; 2018. pp. 235-68. [DOI: 10.1007/978-3-319-89390-7_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
630 Thaiss CA, Zmora N, Levy M, Elinav E. The microbiome and innate immunity. Nature. 2016;535:65-74. [PMID: 27383981 DOI: 10.1038/nature18847] [Cited by in Crossref: 796] [Cited by in F6Publishing: 700] [Article Influence: 132.7] [Reference Citation Analysis]
631 Naik A, Belič A, Zanger UM, Rozman D. Molecular Interactions between NAFLD and Xenobiotic Metabolism. Front Genet 2013;4:2. [PMID: 23346097 DOI: 10.3389/fgene.2013.00002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
632 Martínez I, Lattimer JM, Hubach KL, Case JA, Yang J, Weber CG, Louk JA, Rose DJ, Kyureghian G, Peterson DA, Haub MD, Walter J. Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J 2013;7:269-80. [PMID: 23038174 DOI: 10.1038/ismej.2012.104] [Cited by in Crossref: 320] [Cited by in F6Publishing: 289] [Article Influence: 32.0] [Reference Citation Analysis]
633 Wood NJ. Microbiota: Dysbiosis driven by inflammasome deficiency exacerbates hepatic steatosis and governs rate of NAFLD progression. Nat Rev Gastroenterol Hepatol. 2012;9:123. [PMID: 22349167 DOI: 10.1038/nrgastro.2012.21] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
634 Aissa AF, Tryndyak V, de Conti A, Melnyk S, Gomes TD, Bianchi ML, James SJ, Beland FA, Antunes LM, Pogribny IP. Effect of methionine-deficient and methionine-supplemented diets on the hepatic one-carbon and lipid metabolism in mice. Mol Nutr Food Res 2014;58:1502-12. [PMID: 24827819 DOI: 10.1002/mnfr.201300726] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
635 Guo Y, Liu C, Shan C, Chen Y, Li H, Huang Z, Zou D. Gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a diabetic rat model: Increased diversity and associations of discriminant genera with metabolic changes: Microbiota and bariatric surgery. Diabetes Metab Res Rev 2017;33:e2857. [DOI: 10.1002/dmrr.2857] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
636 Peiseler M, Tacke F. Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma. Cancers (Basel) 2021;13:730. [PMID: 33578800 DOI: 10.3390/cancers13040730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
637 Chen L, Wilson JE, Koenigsknecht MJ, Chou WC, Montgomery SA, Truax AD, Brickey WJ, Packey CD, Maharshak N, Matsushima GK. NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth. Nat Immunol. 2017;18:541-551. [PMID: 28288099 DOI: 10.1038/ni.3690] [Cited by in Crossref: 131] [Cited by in F6Publishing: 125] [Article Influence: 26.2] [Reference Citation Analysis]
638 Ishikawa H, Takaki A, Tsuzaki R, Yasunaka T, Koike K, Shimomura Y, Seki H, Matsushita H, Miyake Y, Ikeda F. L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway. PLoS One. 2014;9:e100627. [PMID: 24983359 DOI: 10.1371/journal.pone.0100627] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
639 Csak T, Pillai A, Ganz M, Lippai D, Petrasek J, Park JK, Kodys K, Dolganiuc A, Kurt-Jones EA, Szabo G. Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis. Liver Int 2014;34:1402-13. [PMID: 24650018 DOI: 10.1111/liv.12537] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
640 Ibrahim SH, Hirsova P, Malhi H, Gores GJ. Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame. Dig Dis Sci 2016;61:1325-36. [PMID: 26626909 DOI: 10.1007/s10620-015-3977-1] [Cited by in Crossref: 111] [Cited by in F6Publishing: 108] [Article Influence: 15.9] [Reference Citation Analysis]
641 Chi M, Ma K, Wang J, Ding Z, Li Y, Zhu S, Liang X, Zhang Q, Song L, Liu C. The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease. J Immunol Res 2021;2021:5516035. [PMID: 34095319 DOI: 10.1155/2021/5516035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
642 Colonetti K, Roesch LF, Schwartz IVD. The microbiome and inborn errors of metabolism: Why we should look carefully at their interplay? Genet Mol Biol 2018;41:515-32. [PMID: 30235399 DOI: 10.1590/1678-4685-GMB-2017-0235] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
643 Darnaud M, Faivre J, Moniaux N. Targeting gut flora to prevent progression of hepatocellular carcinoma. J Hepatol. 2013;58:385-387. [PMID: 22940407 DOI: 10.1016/j.jhep.2012.08.019] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
644 Sun CC, Zhang CY, Duan JX, Guan XX, Yang HH, Jiang HL, Hammock BD, Hwang SH, Zhou Y, Guan CX, Liu SK, Zhang J. PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice. Biochem Biophys Res Commun 2020;523:1020-6. [PMID: 31973813 DOI: 10.1016/j.bbrc.2019.12.131] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
645 Ducheix S, Montagner A, Theodorou V, Ferrier L, Guillou H. The liver X receptor: A master regulator of the gut–liver axis and a target for non alcoholic fatty liver disease. Biochemical Pharmacology 2013;86:96-105. [DOI: 10.1016/j.bcp.2013.03.016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
646 Scheithauer TPM, Rampanelli E, Nieuwdorp M, Vallance BA, Verchere CB, van Raalte DH, Herrema H. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes. Front Immunol 2020;11:571731. [PMID: 33178196 DOI: 10.3389/fimmu.2020.571731] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
647 Grant RW, Dixit VD. Adipose tissue as an immunological organ. Obesity (Silver Spring) 2015;23:512-8. [PMID: 25612251 DOI: 10.1002/oby.21003] [Cited by in Crossref: 216] [Cited by in F6Publishing: 211] [Article Influence: 30.9] [Reference Citation Analysis]
648 He Y, Hwang S, Ahmed YA, Feng D, Li N, Ribeiro M, Lafdil F, Kisseleva T, Szabo G, Gao B. Immunopathobiology and therapeutic targets related to cytokines in liver diseases. Cell Mol Immunol 2021;18:18-37. [PMID: 33203939 DOI: 10.1038/s41423-020-00580-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
649 Guo Y, Ding PH, Liu LJ, Shi L, Mao TY, Li JX, Wang YL. Gegen Qinlian Decoction Attenuates High-Fat Diet-Induced Steatohepatitis in Rats via Gut Microbiota. Evid Based Complement Alternat Med 2018;2018:7370891. [PMID: 30671129 DOI: 10.1155/2018/7370891] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
650 Radian AD, de Almeida L, Dorfleutner A, Stehlik C. NLRP7 and related inflammasome activating pattern recognition receptors and their function in host defense and disease. Microbes Infect 2013;15:630-9. [PMID: 23618810 DOI: 10.1016/j.micinf.2013.04.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
651 Wang X, Xia J, Jiang C. Role of gut microbiota in the development of non-alcoholic fatty liver disease. Liver Research 2019;3:25-30. [DOI: 10.1016/j.livres.2019.01.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
652 Burcelin R, Serino M, Chabo C, Garidou L, Pomié C, Courtney M, Amar J, Bouloumié A. Metagenome and metabolism: the tissue microbiota hypothesis: Burcelin et al. Diabetes Obes Metab 2013;15:61-70. [DOI: 10.1111/dom.12157] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 8.7] [Reference Citation Analysis]
653 Duan N, Liu X, Wu J. Palmitic acid elicits hepatic stellate cell activation through inflammasomes and hedgehog signaling. Life Sciences 2017;176:42-53. [DOI: 10.1016/j.lfs.2017.03.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
654 Adkins Y, Fedor DM, Mackey BE, Wu J, Kelley DS. Dietary docosahexaenoic acid reverses nonalcoholic steatohepatitis and fibrosis caused by conjugated linoleic acid supplementation in mice. Journal of Functional Foods 2016;20:443-52. [DOI: 10.1016/j.jff.2015.11.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
655 Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 2021;184:2537-64. [PMID: 33989548 DOI: 10.1016/j.cell.2021.04.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
656 Zhang Y, Zhang XJ, Wang PX, Zhang P, Li H. Reprogramming Innate Immune Signaling in Cardiometabolic Disease. Hypertension 2017;69:747-60. [PMID: 28320852 DOI: 10.1161/HYPERTENSIONAHA.116.08192] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 3.4] [Reference Citation Analysis]
657 Wernstedt Asterholm I, Tao C, Morley TS, Wang QA, Delgado-Lopez F, Wang ZV, Scherer PE. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab. 2014;20:103-118. [PMID: 24930973 DOI: 10.1016/j.cmet.2014.05.005] [Cited by in Crossref: 373] [Cited by in F6Publishing: 361] [Article Influence: 46.6] [Reference Citation Analysis]
658 Gkolfakis P, Dimitriadis G, Triantafyllou K. Gut microbiota and non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int 2015;14:572-81. [PMID: 26663004 DOI: 10.1016/s1499-3872(15)60026-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
659 Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov 2018;17:588-606. [PMID: 30026524 DOI: 10.1038/nrd.2018.97] [Cited by in Crossref: 375] [Cited by in F6Publishing: 365] [Article Influence: 93.8] [Reference Citation Analysis]
660 Seregin SS, Golovchenko N, Schaf B, Chen J, Pudlo NA, Mitchell J, Baxter NT, Zhao L, Schloss PD, Martens EC, Eaton KA, Chen GY. NLRP6 Protects Il10-/- Mice from Colitis by Limiting Colonization of Akkermansia muciniphila. Cell Rep 2017;19:733-45. [PMID: 28445725 DOI: 10.1016/j.celrep.2017.03.080] [Cited by in Crossref: 116] [Cited by in F6Publishing: 113] [Article Influence: 29.0] [Reference Citation Analysis]
661 Wang W, Zhang Y, Yang L, Li H. The innate immune signaling in cancer and cardiometabolic diseases: Friends or foes? Cancer Letters 2017;387:46-60. [DOI: 10.1016/j.canlet.2016.06.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
662 Neumann K, Schiller B, Tiegs G. NLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver Inflammation. Int J Mol Sci 2018;19:E2732. [PMID: 30213101 DOI: 10.3390/ijms19092732] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
663 Trivedi PJ, Adams DH. Gut-liver immunity. J Hepatol. 2016;64:1187-1189. [PMID: 26686270 DOI: 10.1016/j.jhep.2015.12.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 6.1] [Reference Citation Analysis]
664 Du RH, Tan J, Yan N, Wang L, Qiao C, Ding JH, Lu M, Hu G. Kir6.2 knockout aggravates lipopolysaccharide-induced mouse liver injury via enhancing NLRP3 inflammasome activation. J Gastroenterol 2014;49:727-36. [PMID: 23771404 DOI: 10.1007/s00535-013-0823-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
665 Zhu X, Lin X, Zhang P, Liu Y, Ling W, Guo H. Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study. Clin Res Hepatol Gastroenterol 2021;:101843. [PMID: 34922061 DOI: 10.1016/j.clinre.2021.101843] [Reference Citation Analysis]
666 Li X, Liu L, Cao Z, Li W, Li H, Lu C, Yang X, Liu Y. Gut microbiota as an "invisible organ" that modulates the function of drugs. Biomed Pharmacother 2020;121:109653. [PMID: 31810138 DOI: 10.1016/j.biopha.2019.109653] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
667 Okeke F, Roland BC, Mullin GE. The role of the gut microbiome in the pathogenesis and treatment of obesity. Glob Adv Health Med 2014;3:44-57. [PMID: 24891993 DOI: 10.7453/gahmj.2014.018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
668 Ayres JS. Cooperative Microbial Tolerance Behaviors in Host-Microbiota Mutualism. Cell. 2016;165:1323-1331. [PMID: 27259146 DOI: 10.1016/j.cell.2016.05.049] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 9.7] [Reference Citation Analysis]
669 Robbins GR, Wen H, Ting JP. Inflammasomes and metabolic disorders: old genes in modern diseases. Mol Cell 2014;54:297-308. [PMID: 24766894 DOI: 10.1016/j.molcel.2014.03.029] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 8.6] [Reference Citation Analysis]
670 Antonini M, Lo Conte M, Sorini C, Falcone M. How the Interplay Between the Commensal Microbiota, Gut Barrier Integrity, and Mucosal Immunity Regulates Brain Autoimmunity. Front Immunol 2019;10:1937. [PMID: 31475000 DOI: 10.3389/fimmu.2019.01937] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
671 Zhou WN, Zhang YM, Qiao X, Pan J, Yin LF, Zhu L, Zhao JN, Lu S, Lu T, Chen YD, Liu HC. Virtual Screening Strategy Combined Bayesian Classification Model, Molecular Docking for Acetyl-CoA Carboxylases Inhibitors. Curr Comput Aided Drug Des 2019;15:193-205. [PMID: 30411690 DOI: 10.2174/1573409914666181109110030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
672 Zmora N, Bashiardes S, Levy M, Elinav E. The Role of the Immune System in Metabolic Health and Disease. Cell Metab 2017;25:506-21. [PMID: 28273474 DOI: 10.1016/j.cmet.2017.02.006] [Cited by in Crossref: 115] [Cited by in F6Publishing: 94] [Article Influence: 23.0] [Reference Citation Analysis]
673 Burz SD, Monnoye M, Philippe C, Farin W, Ratziu V, Strozzi F, Paillarse JM, Chêne L, Blottière HM, Gérard P. Fecal Microbiota Transplant from Human to Mice Gives Insights into the Role of the Gut Microbiota in Non-Alcoholic Fatty Liver Disease (NAFLD). Microorganisms 2021;9:199. [PMID: 33477939 DOI: 10.3390/microorganisms9010199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
674 Nseir WB, Hussein SHH, Farah R, Mahamid MN, Khatib HH, Mograbi JM, Peretz A, Amara AE. Nonalcoholic fatty liver disease as a risk factor for Clostridium difficile-associated diarrhea. QJM 2020;113:320-3. [PMID: 31688897 DOI: 10.1093/qjmed/hcz283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
675 Poupeau A, Garde C, Sulek K, Citirikkaya K, Treebak JT, Arumugam M, Simar D, Olofsson LE, Bäckhed F, Barrès R. Genes controlling the activation of natural killer lymphocytes are epigenetically remodeled in intestinal cells from germ-free mice. FASEB J 2019;33:2719-31. [PMID: 30303739 DOI: 10.1096/fj.201800787R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
676 Jacobs JP, Braun J. Immune and genetic gardening of the intestinal microbiome. FEBS Lett 2014;588:4102-11. [PMID: 24613921 DOI: 10.1016/j.febslet.2014.02.052] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
677 Baffy G. Potential mechanisms linking gut microbiota and portal hypertension. Liver Int. 2019;39:598-609. [PMID: 30312513 DOI: 10.1111/liv.13986] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
678 Ignacio A, Morales CI, Câmara NO, Almeida RR. Innate Sensing of the Gut Microbiota: Modulation of Inflammatory and Autoimmune Diseases. Front Immunol 2016;7:54. [PMID: 26925061 DOI: 10.3389/fimmu.2016.00054] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
679 Hellerbrand C, Schattenberg JM, Peterburs P, Lechner A, Brignoli R. The potential of silymarin for the treatment of hepatic disorders. Clin Phytosci 2017;2. [DOI: 10.1186/s40816-016-0019-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
680 Aitken JD, Gewirtz AT. Gut microbiota in 2012: Toward understanding and manipulating the gut microbiota. Nat Rev Gastroenterol Hepatol 2013;10:72-4. [PMID: 23296245 DOI: 10.1038/nrgastro.2012.252] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
681 Lv H, Ren D, Yan W, Wang Y, Liu H, Shen M. Linoleic acid inhibits Lactobacillus activity by destroying cell membrane and affecting normal metabolism. J Sci Food Agric 2020;100:2057-64. [PMID: 31875968 DOI: 10.1002/jsfa.10228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
682 Fulde M, Sommer F, Chassaing B, van Vorst K, Dupont A, Hensel M, Basic M, Klopfleisch R, Rosenstiel P, Bleich A, Bäckhed F, Gewirtz AT, Hornef MW. Neonatal selection by Toll-like receptor 5 influences long-term gut microbiota composition. Nature 2018;560:489-93. [PMID: 30089902 DOI: 10.1038/s41586-018-0395-5] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 20.3] [Reference Citation Analysis]
683 Baghai Arassi M, Zeller G, Karcher N, Zimmermann M, Toenshoff B. The gut microbiome in solid organ transplantation. Pediatr Transplant 2020;24:e13866. [PMID: 32997434 DOI: 10.1111/petr.13866] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
684 Russell WR, Hoyles L, Flint HJ, Dumas ME. Colonic bacterial metabolites and human health. Curr Opin Microbiol. 2013;16:246-254. [PMID: 23880135 DOI: 10.1016/j.mib.2013.07.002] [Cited by in Crossref: 213] [Cited by in F6Publishing: 196] [Article Influence: 23.7] [Reference Citation Analysis]
685 Zarrinpar A, Chaix A, Yooseph S, Panda S. Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. Cell Metab. 2014;20:1006-1017. [PMID: 25470548 DOI: 10.1016/j.cmet.2014.11.008] [Cited by in Crossref: 349] [Cited by in F6Publishing: 328] [Article Influence: 49.9] [Reference Citation Analysis]
686 Jia N, Lin X, Ma S, Ge S, Mu S, Yang C, Shi S, Gao L, Xu J,